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Abstract
Using a combination of hypothesis and discovery based approaches, the goal of this thesis
was to better describe novel probiotic functions and their mechanisms while striving to better
understand the effect of formulation on Bifidobacterium animalis subsp. lactis, Lactobacillus
paracasei and L. rhamnosus.
Using RNA-Seq, a bacterial metatranscriptome analysis of a commonly consumed probiotic
yogurt showed that the organisms adapted to storage time and flavor additions. This led to
the discovery that in addition to the probiotic health benefits, members of the L. casei group
(L. rhamnosus and L. paracasei) produce volatile sulfur compounds mediated by a novel
sulfur/taurine metabolism gene cluster that affect taste and texture. The benefits of selected
probiotic strains were tested in a further series of human studies.
A systems biology approach was developed and a double-blind, placebo-controlled clinical
trial of post-menopausal women showed that vaginally administered probiotics could
influence the microbiota and host responses. Changes in the vaginal microbiota were noted in
late pregnancy in a rural Tanzanian population, and maternal intake of Moringa
supplemented L. rhamnosus GR-1 yogurt appeared to improve the gut microbiota profile of
the newborn babies. Having discovered that L. rhamnosus GR-1, and selected other
lactobacilli, could sequester heavy metals in vitro, a randomized open-label pilot study was
performed and showed a reduction in toxic metal uptake in Tanzanian pregnant women and
school children. The latter series of findings led to the discovery, development and
characterization of a new strain, L. rhamnosus Lr60, with high potential to reduce toxic metal
accumulation in the host. Using a mouse model, strains of L. rhamnosus were tested to better
understand mechanisms of protection against mercury as well as to examine potential
modulation of host xenobiotic metabolism by probiotics. Data suggest it is possible to
sequester mercury and prevent it from entering the bloodstream.
Collectively, these studies have increased our knowledge of probiotic mechanisms as well as
lead to the development of novel applications of relevance to human health.
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Chapter 1

1

General Introduction

Microbes inhabited the earth long before humans and will remain long after we are gone.
They were our earliest ancestors and according to the endosymbiont theory, their
descendants live within our own cells in the form of mitochondria (Thrash et al., 2011).
Microbes have shaped our evolution both genetically and culturally (Diamond, 2000).
We are born coated in microbes, we live immersed in microbes and eventually we die
only to be recycled by microbes. In short, microbes are an intrinsic part of what it means
to be human.
Traditionally, science has focused on the detrimental effects of microbes to human
populations such as the fall of the Incan Empire due to smallpox (Diamond, 2000), or the
emergence of new diseases like sickle cell anemia (Aidoo et al., 2002) and cystic fibrosis
(Gabriel et al., 1994) as a result of microbial selective pressure. Beginning in the early
1900s with the fringe hypotheses of Nobel Laureate Élie Metchnikoff, the evidence for
the beneficial effects of microbes has been slowly building (Mackowiak, 2013). The
study of the body’s microbial communities is now one of the fastest growing areas of
science, with numerous implications for both human and animal health and disease.

1.1

The human microbiome

The human microbiome is the sum of all the microbial communities (the microbiota),
their genes, transcripts and metabolic byproducts both on, and within the human host. It
has been estimated that, by absolute count, microbes outnumber their human host’s cells
by a 10-to-1 ratio (Savage, 1977). Despite being ubiquitous in the literature, I would
suggest this figure is misleading for many reasons, including the size difference between
a prokaryotic and eukaryotic cell, and the varied sizes of humans. What is far more
tangible is that on the genomic level, our microbes encode ~150-fold more unique genes
than our own DNA (Qin et al., 2010). Many of these genes include novel metabolic
pathways which can have profound impacts on human physiology such as: recycling sex
hormones including estrogen (DeRossi and Hersh, 1994; Flores et al., 2012; Plottel and
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Blaser, 2011), synthesizing nutrients for the host including folate and vitamin B12
(LeBlanc et al., 2013), and fermenting compounds with immunomodulatory activity
important in disease such as short chain fatty acids in inflammatory bowel disease (Veiga
et al., 2010).
While much focus is on the gastrointestinal tract where cell densities can be up to 1011
CFU/mL, the microbiotas of other body sites are also of great interest including the skin,
oral, respiratory tract and urogenital tract communities (Costello et al., 2009).

1.2

Microbiota dysbiosis

As opposed to traditional microbiology which has focused on single organisms fulfilling
Koch’s postulates of disease (Ferreira et al., 2011), microbial dysbiosis involves altered
states of whole communities which may be associated with aberrant conditions including
those that cause disease.
Microbial dysbiosis is perhaps best typified in the human vagina. In the majority of
healthy Caucasian women, the vaginal microbiota is dominated by Lactobacillus iners
and/or L. crispatus with other species such as L. gasseri and L. jensenii occasionally
found (Ravel et al., 2011). In the dysbiotic state of bacterial vaginosis (BV), the relative
proportions of Lactobacillus spp. are decreased coinciding with an increase in anaerobes
invariably including Gardnerella vaginalis, with Prevotella spp., Atopobium vaginae and
others (Fredricks et al., 2005; Hummelen et al., 2010). BV is the most common vaginal
“infection”, with some studies showing one third of reproductive age females presenting
with BV at any given time (Koumans et al., 2007). The symptoms and signs of BV
include vaginal odor, a milk-like discharge, and irritation with the latter commonly
leading to improper self-misdiagnosis as a yeast infection.
While it is generally accepted that a Lactobacillus-dominated microbiota is favorable in
the vagina, what defines dysbiosis in the gastrointestinal tract is far more varied.
Examples of the influence of the gut microbiota on health include: obesity (Le Chatelier
et al., 2013; Turnbaugh et al., 2006), diabetes (Giongo et al., 2010), Crohn’s Disease
(Gevers et al., 2014) and colon cancer (Devkota and Turnbaugh, 2013; Feng et al., 2015).
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In obesity, many researchers have focused on the crude metric of the ratio of
Firmicutes:Bacteroidetes (Ley et al., 2005; Mariat et al., 2009) suggesting that a higher
ratio is associated with adiposity, insulin insensitivity, dyslipidemia and chronic
inflammation. More in-depth studies of individual taxa and gene-level differences have
examined bacterial richness and gene content (Le Chatelier et al., 2013). What is more
relevant is do certain microbiota put a person at higher risk of obesity, and once obese,
can alteration of the microbiota help a person lose weight?
Since there is no definition of a ‘healthy’ gut microbiome, it is difficult to define
normality or use the microbiota as a biomarker for an unhealthy state. Gut enterotypes
were proposed as a way of defining groups (Arumugam et al., 2011) with three
predominant microbiota types named by their dominant taxa: Bacteroides (enterotype 1),
Prevotella (enterotype 2), and Ruminococcus (enterotype 3). Studies have suggested that
diet may be a large driver of the enterotype (De Filippo et al., 2010; Wu et al., 2011).
While it is appealing to have such a ternary classification system, it is a contentious
notion (Jeffery et al., 2012) and it is more likely there is a gradient of normality. It is also
not unreasonable to think that there is a balance in microbiota composition wherein one
configuration may be beneficial for some conditions but deleterious for others.
Furthermore, the gut microbiota is not static and changes over life (Claesson et al., 2011;
Yatsunenko et al., 2012).

1.3

Probiotics

As our understanding of the role of the microbiota in health builds, the opportunities
increase to translate this knowledge by modulating the microbiota for health. While
antibiotics are capable of producing an immediate shift in microbiota composition
(Dethlefsen et al., 2008), other less drastic approaches include probiotics, prebiotics and
synbiotics (a combination pro/prebiotic). The recently refined FAO/WHO definition of
probiotics is “live microorganisms that, when administered in adequate amounts, confer a
health benefit on the host” (Hill et al., 2014). A prebiotic is a “non-digestible food
ingredient that beneficially affects the host by selectively stimulating the growth and/or
activity of one or a limited number of bacteria” (Manning and Gibson, 2004). The
remainder of this work will focus on studies of probiotics.
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Traditionally, the genera of Lactobacillus and Bifidobacterium have been the focus of
probiotic study due to their historical associations with fermented foods and health
(Farnworth, 2008; Naidu et al., 1999; Yang et al., 2014). Nonetheless, a number of other
species being applied as human probiotics include Bacillus coagulans (Fitzpatrick et al.,
2011), Saccharomyces boulardii (Czerucka et al., 2007), Escherichia coli (Schultz,
2008), and potentially Faecalibacterium prausnitzii (Sokol et al., 2008). Additional
species contained within a community structure analogous to an artificial stool transplant
are also being tested, such as against antibiotic-associated Clostridium difficile diarrhea
(Petrof et al., 2013).
Much of the current thesis focuses on a group of 80 prototypical probiotic strains in the L.
casei group. This group of phylogenetically similar, facultatively heterofermentative
lactobacilli consists of L. paracasei, L. rhamnosus, L. casei, and L. zeae. The
differentiation and nomenclature of the L. casei group is a matter of debate and is far
from fully established (Dellaglio et al., 2002; Dicks et al., 1996; Felis & Dellaglio, 2007;
Sato et al., 2012). This work focuses exclusively on members of the L. rhamnosus and L.
paracasei lineages. Though L. casei and L. paracasei are used interchangeably in the
literature often referring to the same strain, L. paracasei is the currently accepted
nomenclature and will be used herein to refer to a set of the 40 strains of L. paracasei
studied in this study (Klein, 2009). Further confusions relating to the delineation of this
group led to the initial recategorization of L. rhamnosus GR-1 used in many of the early
studies as L. casei GR-1 (Reid et al., 1987). Despite a high degree of phylogenetic
similarity among L. casei and L. rhamnosus strains, they can vary significantly in gene
content and probiotic traits (Douillard et al., 2013).
The intent of using this collection of strains was to uncover novel strain variable traits,
and using the available genome sequences, to search for the genetic mediators of
probiotic function.

1.4

The host-microbiota-probiotic interactome

How probiotic strains function is a million dollar question with no simple answer. There
are probably a multitude of mechanisms working synergistically in a context specific
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manor. For probiotic efficacy, the mechanisms likely involve the interactions of: (i)
probiotic strain, (ii) host and, (iii) indigenous microbes which we refer to as the hostmicrobiota-probiotic interactome (Bisanz & Reid, 2011). Traditional understanding of
probiotics has focused on only host and probiotic, or probiotic and indigenous microbes.
Classical examples of probiotic action include production of hydrogen peroxide and/or
bacteriocins to combat indigenous pathogens (Reid et al., 2011) or direct interactions of
probiotics and immune cells influencing inflammatory responses (Martins et al., 2011).
While science often takes a reductionist approach isolating individual phenomena, I
suspect this results in many missed opportunities to better understand how probiotics
work. Indeed it is becoming increasingly obvious that beneficial microbes often act
through the microbiota as an intermediate. Recent studies have indicated that probiotic
consumption does not significantly alter the microbiota composition at the community
level; however, the effects can be seen at the transcriptional and metabolomics levels
through interactions with the activity of indigenous microbes (Eloe-Fadrosh et al., 2015;
McNulty et al., 2011).
The concept of probiotic-mediated detoxication/detoxification of environmental toxins
presented later in this chapter is an example where a reductionist approach is
fundamentally flawed, as it is highly likely there are multiple mechanisms acting in
concert. We and others have known that strains of lactic acid bacteria are capable of
interactions with a variety of environmental toxins (Halttunen et al., 2008; Halttunen et
al., 2007; Peltonen et al., 2001) and some of these have shown efficacy in vivo
(Hernandez-Mendoza et al., 2011; Zhai et al., 2013). Despite predominantly surface
binding mechanisms shown in vitro, it is also clear that intestinal microbes have impacts
on host function at distal sites including xenobiotic metabolism (including pathways
relevant to metals) in the kidney and liver (Björkholm et al., 2009; Rawls et al., 2004).
Furthermore, experiments contrasting conventional and germ free animals have shown
the importance of the microbiota in protection against mercury (Nakamura et al., 1977)
lead and cadmium (Breton et al., 2013), raising the potential that modification of
microbiota structure or activity could affect metal uptake. In this case, by understanding
the probiotic-microbiota-host interactome, we will be able to capture the full spectra of
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potential mechanisms involved in probiotic-mediated detoxification. To aid in such
studies, cutting edge tools have become available for sequencing and data analysis.

1.5

Tools for studying the microbial communities

In the modern era of high-throughput sequencing technologies such as Illumina, SOLiD,
and Ion Torrent sequencing platforms, there are numerous approaches available for
studies of the human microbiota and microbiome depending on the researcher’s question.
Currently, most studies of the microbiota rely on targeted amplicon sequencing of a
particular gene or marker. The 16S rRNA gene is by far the most commonly applied
target, and it was applied in three of the chapters in this thesis. While alternative markers
such as Cpn60/GroEL can also be used, they are less common and lack the same level of
pre-existing tools (Hill et al., 2004; Schellenberg et al., 2011). The 16S rRNA gene has
been used since the 1980s (Stahl et al. 1984) and thus has large databases available for
comparison. Though many early studies of the microbiota relied on the creation of 16S
rRNA gene clone libraries followed by Sanger sequencing of individual inserts, the era of
massively parallel sequencing platforms ushered a new era in microbiota analysis.
Formerly it was necessary to ligate amplicons into plasmids, transform into E. coli and
then pick individual colonies for sequencing (Fredricks et al., 2005). Alternatively,
denaturing gradient gel electrophoresis (DGGE) was used (Burton and Reid, 2002) to
separate amplicons of individual organisms followed by subsequent reamplification and
sequencing. This approach gives limited sensitivity (Gloor et al., 2010) and is tedious and
time consuming requiring significant operator skill. By comparison, the modern approach
requires nothing more than a simple PCR carried out with carefully designed primers
(Gloor et al., 2010). By introducing multiplexing DNA barcodes during PCR, hundreds
of samples can be analyzed in a single run giving magnitudes more information at a
fraction of the price.
One major limitation of the high-throughput sequencing for 16S rRNA gene analysis is
the read length. While a typical Sanger sequencer, such as the Applied Biosystems
3730XL, can produce read lengths up to 1000 bp allowing the entire 16S rRNA gene to
be determined in paired-end sequencing, high-throughput sequencers are significantly
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limited. Due to this, it is necessary to carefully pick the region of the 16S rRNA gene to
be sequenced and there is not necessarily a single best region (Soergel et al., 2012). Much
discussion on these regions focuses on the concept of variable regions, which as the term
implies are found to be highly variable among even closely related species. The choice of
which region to target depends highly on the community being sampled. Primers
targeting the 6th variable region (V6), for example, are capable of differentiating many
species of Lactobacillus, which is beneficial if studying the vaginal microbiome or
fermented food products, but this has limited ability to differentiate the
Gammaproteobacteria in the gut. Primers targeting the V4 region, which are applied in
the Earth Microbiome Project (Earth Microbiome Project, 2012), are capable of improved
differentiation of the Gammaproteobacteria, but lack the ability to discriminate many
lactobacilli such as L. crispatus, L. rhamnosus, and L. helveticus . Other factors may
influence the choice of primer including the availability of databases and classifiers
(Wang et al., 2007).
Depending on the sequencing modality, it is also possible to cover multiple variable
regions in a single read if the given read is long enough to span the conjoining conserved
regions. For this reason, the Roche 454 pyrosequencer was the favored instrument for
many years for microbiota analysis due to its ability to provide read lengths of >500 bp at
the cost of lower read output (Caporaso et al., 2010; Finegold et al., 2010; Turnbaugh et
al., 2009; Yatsunenko et al., 2012). The first study to use Illumina sequencing to capture
the entire V6 region with paired end sequencing covering 76 bases was performed on
vaginal samples (Hummelen et al., 2010). The newest incarnations of the Illumina HiSeq
and MiSeq are capable of generating >600 bp reads and have now supplanted the 454
sequencer as the method of choice for most microbiota studies (Di Bella et al., 2014).
The computational analysis of microbiota datasets is time-consuming, complex and with
no one correct method. QIIME, Quantitative Insights into Microbial Ecology (Caporaso
et al., 2010), is one of the most commonly applied packages of tools despite having
originally being designed for 454 pyrosequencing datasets. This tool allows relatively
simple analysis of alpha and beta diversity. In microbial ecology alpha diversity refers to
the within-sample diversity (such as number of species, or more complex metrics such as
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Shannon’s Diversity Index (Haegeman et al., 2013)); while beta diversity refers to
between-sample diversity. Weighted UniFrac (Lozupone and Knight, 2005) is a
commonly applied technique which considers both the phylogenetic relationship of the
organisms, as based on a user-generated tree, and also their abundances to provide a
measure of similarity.
A common issue that arises in the analysis is that the microbiota data are compositional
in nature. The resulting reads, despite being discrete count data, are but random
samplings of the sequencing library and are heavily affected by technical non-biological
factors. Thus, without extra lines of evidence such as qPCR, it is difficult to conclude that
the absolute abundance of organisms between two samples is different. Rather, it is
determined that their proportional abundance between communities is different.
Furthermore, compositional data creates a number of challenges statistically. A great
example of this lies in the attempts to carry out correlation analysis using compositional
data. Karl Pearson, creator of the Pearson correlation coefficient, coined the term
spurious correlation in 1896 to describe the false conclusions drawn as a result of the
interdependence of observations inherent to compositional data (Pearson, 1896). Various
approaches to overcome this problem include the log-ratio approach (Aitchison and
Egozcue, 2005), utilized in the tool ALDEx (Fernandes et al., 2013; Fernandes et al.,
2014) used for comparisons of individual community constituents in the following
chapters. The literature is ripe with examples of ultra-low abundance organisms
associated with disease in cross-sectional studies that are more likely to be due to
sampling variation rather than biological reality, even in high impact papers (Hsiao et al.,
2013). The ALDEx tool models technical error based on a user-defined number of
samplings from the Dirichlet distribution, as an additional tool to increase the confidence
in results.
RNA-Seq, gene expression based on digital read counts from high-throughput
sequencing, is quickly becoming the tool of choice for transcriptome studies. When the
mixed pool of RNA belonging to a bacterial community is studied, it is referred to as the
metatranscriptome. While approaches such as 16S rRNA gene sequencing determine the
constituents of a community, metatranscriptome studies answer the question of what the
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microbes are actually doing. It is more powerful than looking at just the community
composition or their metagenomes, however it is limited in its broad range use due to
sample preparation, sequencing cost and computationally intensive analysis. Given that
>95% of total RNA is not coding but rather only the rRNA (Rosenow et al., 2001), the
bulk of the RNA must be removed prior to sequencing otherwise the vast majority of
resultant data will be uninformative for gene expression. This can be accomplished
through the use of magnetic beads carrying oligonucleotide capture probes for conserved
rRNA regions such as that of MICROBExpress (Life Technologies). Additionally, in
bacterial communities associated with a eukaryotic host, a significant portion of
transcripts may be of host origin, therefore requiring further sample enrichment by
depleting 3’ poly-A tail mRNAs and host rRNAs.
While 16S rRNA gene sequencing and RNA-Seq answer the questions of what taxa are
present, and how they transcriptionally/functionally react to stimuli, metabolomics
identify a set of small molecules in a sampled environment. These molecules are the
combination of microbial and host metabolism and represent the end by-products of the
community. A limitation is that unlike sequence-based methods, it is often impossible to
tell the origin of the molecule (microbe or host). Furthermore, as the methods have
limited ability to identify all molecules given the dependence on spectra databases for
identification. Despite these limitations, unlike RNA-Seq and shotgun metagenomics that
infer functions, metabolomics is truly identifying end effector molecules.
These tools require biological questions and studies described herein sought to apply
them to understanding probiotic function.

1.6

The microbiota in maternal and child health

Successful societies share a common trait: empowerment and care of women (Kar et al.,
1999). The developmental origins of health and disease would indicate that the key to a
long healthy life begins before birth and even before conception (Fowden et al., 2006;
Myatt, 2006). The health of mothers, neonates and children is clearly crucial. Despite
this, in many parts of the world, and even within Canada, many women do not receive the
education and medical care to maximize health. Recognizing this, Canada launched the
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Muskoka Initiative focusing on improving health of women and children, resulting in an
investment of $ 2.8 billion dollars into health programs and research between 2010 and
2015.
David Barker’s seminal work in the United Kingdom showed that nutrition during fetal
development impacted health of the baby into late life through increased risk of
cardiovascular disease and metabolic syndrome (Barker et al., 1993). But, the influence
of diet on the composition and function of the gut microbiota was not considered until
recently. Excess food intake and poor nutrient content has been the focus of microbiota
studies in relation to obesity (Le Chatelier et al., 2013; Turnbaugh et al., 2006), due to its
growing prevalence in developed countries. Logic dictates that if the gut microbiota can
facilitate increased nutrient absorption resulting in obesity, it must also be able to
decrease it. Furthermore, dysbiosis in the vagina (BV) certainly affects the fetus,
increasing the risk of premature delivery (Mysorekar and Cao, 2014). Early neonatal
sepsis, infection by group B streptococci and risk of necrotizing enterocolitis show the
impact of an aberrant microbiota on infant health (Eickhoff et al., 1964; Wang et al.,
2009). The ability of probiotics, particularly L. rhamnosus GR-1 and L. reuteri RC-14 to
counter BV and restore vaginal health (Reid, 2014) as well as improve infant immune
status (Isolauri et al., 2001) and resolution of rotavirus diarrhea (Grandy et al., 2010),
illustrates benefits of microbial species in maternal and child health. Of additional
interest to maternal and children’s health is the issue of exposure to environmental
pollutants and toxins.

1.7
Environmental toxin exposure and relevance to
human health
As opposed to the definition of toxin in a microbiological context, environmental toxins
are a broad group of synthetic and naturally occurring compounds which pose threats to
human health in both chronic and acute doses (Grigg, 2004). The focus of much of this
thesis lies on toxic metals, namely mercury, arsenic, cadmium, and lead. Toxic metals
occur naturally in the environment, although anthropomorphic activity has served to
increase their levels greatly since the industrial revolution (Lamborg et al., 2014;
Schwikowski et al., 2004). While we may falsely assume the matters of toxic metal
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exposure are limited to the developing world (Hossain, 2006) the reality is that it is a
clear and present problem all over the world. In southwestern Ontario, a recent study
conducted at the University of Western Ontario identified that 15% of women of
reproductive age in Toronto have levels of mercury surpassing the minimum limit for
adverse effects on cognitive development of their offspring (Schoeman et al., 2010). The
massive pollution from industry around Sarnia and Windsor would suggest that levels
could be even higher west of Toronto. The situation is worrisome in all parts of the
developed world, with an estimated 2 million children in the European Union born with
unacceptably high levels of mercury estimated to result in a loss of 9 billion euros (12.5
billion CAD) to the EU economy (Bellanger et al., 2013).
Mercury is one of the most toxic substances known to man. It is all around us and can be
found in our food (Xue, 2007), drinking water (Mohapatra et al., 2012) and air (Tian et
al., 2011). The diet is the most significant source of mercury in the body (Hrubá et al.,
2012; Koren and Bend, 2010). Mercury levels are low in natural water reservoirs but the
metal is readily absorbed by algae and bioaccumulates in larger fish (Morel and Kraepiel,
1998) resulting in tissue concentrations of up to 1 part per million (ppm) (FDA, 2010). It
is for this reason that public health agencies such as the FDA and EPA advise limiting
consumption of fish for children and pregnant women as it can affect development (EPA,
2004; FDA, 2010). While high-level mercury poisoning results in acute neurological
damage, chronic low-level exposure is associated with delayed neurological development
in children, induction of preterm labor, as well as cardiovascular and autoimmune
diseases (Karagas et al., 2012). Limiting fish intake is not always easy, as it is one of the
most plentiful and nutritious food sources on earth and is the primary source of dietary
protein for many societies (Tidwell, 2001).

1.8

Toxicology and human metabolism of mercury

Mercury exists in three forms in nature: elemental (Hg0), inorganic (Hg2+, Hg1+) and the
organic form, predominantly as methylmercury (MeHg) (Morel & Kraepiel, 1998). The
World Health Organization reports that people in North America and Europe consume
daily 4.3 µg and 2.4 µg of inorganic and organic mercury respectively (ICPS, 1991). A
significant source of MeHg occurs through conversion of inorganic mercury by microbial
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processes including those performed by sulfate-reducing bacteria Desulfovibrio through a
mechanism that has only recently been understood (Parks et al., 2013). Inorganic
mercury is not easily absorbed in the gastrointestinal tract, however MeHg and salts of
Hg2+ are, and may enter systemic circulation. Once in the body, mercury has a half life of
40 and/or 70 days (Hg2+ and MeHg respectively) (Clarkson et al., 2003). The metal is
highly mobile forming complexes with thiols such as cysteine and being co-transported
through the body (Clarkson et al., 2007). In the case of MeHg, it is easily able to cross
the blood-brain barrier which is why it is associated with cognitive development issues in
children.

1.9

Interactions of microbes and metals

Because these toxic metals are elements, they can not truly be broken down or destroyed,
rather they can only be transferred to less toxic forms, sequestered away from cellular
processes to, or effluxed from, the cell (Bruins et al., 2000). Given that many of the
metals have unique properties, the mechanisms of resistance often differ. Resistance to
some metals (lead and cadmium) is predominantly mediated by efflux transporters (Naik
and Dubey, 2013). Cadmium resistance is often mediated by the cadCA operon wherein
cadA is an ATP dependent cadmium efflux protein and cadC is a transcriptional repressor
(Bruins et al., 2000). Resistance to arsenic similarly involves the ars operon frequently
containing arsB (encoding an efflux transporter), arsC (encoding arsenate reductase) and
arsR (a transcriptional regulator)(Bruins et al., 2000). The ArsC enzyme is particularly
interesting as it converts arsenate to arsenite, a more toxic form of the metal, but one that
is more easily transferred out of the cell (Rahman & Hassler, 2013).
In lactobacilli, toxic metals are often imported by nutrients acquisition systems, for
example cadmium is imported through manganese transporters (Archibald and Duong,
1985). It is thought that cadmium sensitive organisms accumulate 3-15 more cadmium
than resistant counterparts (Trevors et al., 1986).
Mercury is unique among the toxic heavy metals in that mechanisms of resistance
involve a true detoxification. Classical bacterial resistance to mercury involves the
subsequent demethylation of organic mercury to inorganic mercury (organomercurial
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lyase MerB), followed by the reduction of inorganic mercury to elemental mercury
(mercuric reductase MerA) (Figure 1-1). While organic mercury can diffuse into the cell
due to its lipophilic nature, inorganic mercury (Hg2+) may be actively imported by the
MerT transporter though this is variable among species (Bruins et al., 2000). The operon
is regulated by MerR which is a trans-acting repressor/activator protein which acts as a
repressor in the absence of mercury, but an activator its presence (Condee and Summers,
1992).
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Much of the early study of metals focused on environmental bacteria. Much of the field
of bacterial/metal interactions was pioneered by Simon Silver and his trainees (Silver,
2011). It wasn’t until 1972 that the nature of mercury resistance by volatilization of
elemental mercury was discovered (Summers and Silver, 1972) and 1987 when the
genetic basis was uncovered (Laddaga et al., 1987). Since these early discoveries,
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mercury resistance has been observed across a wide range of organisms including
Escherichia, Pseudomonas, Bacillus, Staphyloccocus, and Streptococcus. Despite being
present in a wide range of phylogenies, there has never been a published report of
mercury resistance elements present in species of Lactobacillus.
Not all biotransformations of mercury are favorable. It has long been known that certain
organisms such as Desulfovibrio and Geobacter are capable of converting inorganic
mercury to the more toxic methylmercury species (Schaefer et al., 2011). The mechanism
was not well understood until recently (Parks et al., 2013) where it was determined
through comparative genomics that a two-gene cluster (hgcA and hgcB) is sufficient and
capable of methylating mercury by acting as a corrinoid protein and a methyl
carrier/electron donor respectively. Furthermore, not all interactions of microbes and
metals are enzymatically mediated, and passive electrostatic interactions with the cellular
surface represent a major mechanism of interaction.
Early studies on interactions of bacterial cell wall used heavy metals as contrast agents in
electronic microscopy (which was taken advantage of in Chapter 7 for imaging
purposes). Much of this work was carried out at Western University and the University of
Guelph in the 1980s and greatly contributed to the understanding of mechanisms in this
thesis (Beveridge and Murray, 1980; Beveridge and Koval, 1981; Beveridge and Murray,
1985, Beveridge, 1985; Mullen et al., 1989; Beveridge, 1989). Metals are normally found
in association with the membrane, peptidoglycan and teichoic acid of bacterial cells
where they have biological functions. For example, Mg2+ is essential for outer membrane
integrity in E. coli. (Beveridge and Koval, 1981). While divalent calcium and magnesium
are usually the preferred metals on the cell surface, it is perhaps not surprising that heavy
metals can also be found in association with the cell surface. Some years ago, it was
noted that different cells have varying metal binding capacities reflecting variations in the
cell wall’s chemistry, structure and constituent polymers. Lipopolysaccharide, for
example, contains phosphoryl groups that are thought to be a main site for metal
interactions in Gram-negative bacteria (Couglin et al., 1983). In Gram-positive cells, the
negatively charged phosphates of teichoic acid are the most likely repository of metals on
the cell surface as extraction of teichoic acid from cells walls depletes most of the metal
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content (Beveridge, 1989). Furthermore, additional cell surface features, such as the
presence of capsule, may alter interactions. Capsule can block metals from interacting
with the cell surface (Bitton and Frichofer, 1978) but may positively affect binding with
the cell depending on the chemical nature of the capsule (McLean et al., 1990). While
many studies have examined metal/microbe interactions for environmental
bioremediation, few have considered toxic metal interactions with members of the gutmicrobiota.
Two studies have provided strong proof for a role of the gut microbiota in modulating
toxic metal uptake from the gut. Nakamura et al. (1977) showed that germ-free mice
lacking a gut microbiota absorbed considerably more mercury than their conventional
counterparts, and Breton et al. (2013) showed the same effect with both lead and
cadmium. While the germ-free mouse is a relatively extreme model for the role of a gut
microbiota, more subtle microbiota modulating interventions have been tested using
antibiotics (Seko et al., 1981) and altered dietary fiber consumption (Rowland et al.,
1986). These have further implicated the gut microbiota in modulating host-mercury
uptake. Little is known about mercury metabolism by the gut microbiota, but reference
genomes available from the Human Microbiome Project, shotgun metagenomic
sequencing of fecal samples by the MetaHit consortium show evidence of both mercury
detoxifying and methylating enzymes at the genetic level (unpublished observations, JE
Bisanz).
Motivated by the results of studies on mercury uptake at different stages of early life
(Rowland et al., 1983), it was hypothesized that a gut microbiota enriched in
Bifidobacterium and Lactobacillus (prototypical probiotics) has a decreased ability to
favorably metabolize mercury due to the lack of mercury detoxifying enzymes normally
found in these two genera. This puts an even greater emphasis on the need to develop
probiotic strains with these traits.
While germ-free mouse models provided proof that the gut microbiota affects metal
uptake from the gut, these early studies did not address an important potential mechanism
independent of direct metal sequestration: modulation of host xenobiotic metabolism.
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1.10

Effect of microbes on xenobiotic metabolism

Along with the boom of microbiome studies in the mid 2000s came studies of how the
presence of the gut microbiota affects host gene expression. One of the earliest findings
involved differential expression cytochrome p450 oxidases (CYP enzymes) including
CYP1A1, CYP2B6 and CYP2C19 (Rawls et al., 2004; Toda et al., 2009, Claus et al.,
2011; Bjorkholm et al., 2009). A simple explanation for this phenomenon is via the
TLR2 receptor (Do et al., 2011) that is known to affect xenobiotic metabolism pathways.
However, relatively little is known about how the gut microbiota and/or probiotics affect
xenobiotic metabolism in the host and so this represents a novel field that will surely
have profound impact on the field of pharmacology and toxicology. A recent example is
of digoxin metabolism in the GI tract by strains of Eggerthella lenta, which metabolizes
the drug contributing greatly to its inter-individual variability in effective dosing regimes
(Haiser et al., 2013).

1.11 The rationale for probiotic interventions to counter
toxic metals
Given that consumption of mercury and other environmental toxins is more or less
unavoidable, how does the body counter the potentially harmful effects? We
hypothesized that bacteria can prevent heavy metal uptake into the host. The term
detoxication is used in this thesis to describe the microbial role of preventing uptake
while detoxification is used to describe the formation of less toxic products from the
parent substance. There are three foreseeable mechanisms by which microbes may
function to protect humans and other species from environmental toxins ingested in food
and drink: (i) enzymatic conversion of toxic compounds to less toxic metabolites, (ii)
manipulation of host processes to decrease uptake or increase xenobiotic metabolism, and
(iii) microbial binding or sequestering of the toxin. These potential mechanisms are
addressed in the context of mercury in Figure 1-2 and in the following paragraph.
We propose a model wherein lactobacilli, known to exist in the mouth, intestine and
urogenital tract and commonly used as probiotics, can reduce mercury uptake into the
host. This action, mediated primarily in the small intestine and colon, could be directed at
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both organic and inorganic forms acting to make them less toxic, by sequestering or
volatilizing them. Volatilized mercury is poorly absorbed in the GI tract and is of low
toxicity. Lactobacilli acting on mercury may also prevent conversion of dietary inorganic
mercury to methylmercury by resident microbes. Few probiotic strains appear able to
colonize the gastrointestinal tract to any significant degree for a prolonged period
(McNulty et al., 2011; Smith et al., 2011), but their administration and passage through
the gut could sequester the toxins from the intestinal contents and carry them out in the
feces. Such toxin-binding mediated detoxication has been demonstrated in murine models
(Hathout et al., 2011; Hernandez-Mendoza et al., 2011; Kumar et al., 2011). In addition,
lactobacilli could act on the host to reduce intestinal permeability and modulate host
detoxication pathways such as those involved in xenobiotic metabolism and efflux.
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Figure 1-2. Potential mechanisms of probiotic mediated protection against dietary
mercury exposure.
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Scope and purpose

Probiotic function and mechanisms of action remain widely unknown. The purpose of the
studies presented in this thesis was to increase our understanding of probiotic function
and formulation as well as to develop the necessary tools to examine probiotic strain
activity. Chapter 2 presents metatranscriptome studies of a commercially available
probiotic yogurt, emphasising how formulation and storage can affect probiotic function.
While being a pilot study performed early in my PhD studies (2010-2011), its primary
purpose was to develop protocols and tools required for RNA sequencing. These were
then used in other projects in our laboratory and are now being used to study the
microbiota in the context of metal exposure. Chapter 3 describes a fortuitous discovery of
a novel pathway involved in fermented food flavor and aroma. This work was initially
focused on production of hydrogen sulfide as a potential mechanism of mercury
precipitation; however, it is likely to be irrelevant in vivo. The discovery is important as
production of hydrogen sulfide and volatile sulfur compounds is of great interest to food
microbiology for their role in flavor and aroma of fermented foods. This work also
increases knowledge of how L. casei group members adapt to their environment in
fermented foods, and it may have yet unforeseen implications for probiotic function.
Chapter 4 describes a clinical study of vaginally administered probiotics to treat vaginal
dysbiosis in post-menopausal women. It was the follow up to a previous study in which I
was a co-first author (not included in this thesis: Hummelen et al., 2011). The design of
the study was constructed around the probiotic-microbiota-host interactome concept.
Despite not showing a major impact on clinical parameters, novel observations were
made in terms of how probiotics affect both host and microbiota, thereby adding to our
understanding of how lactobacilli function in the vagina.
The work carried out in Chapter 5 describes a study in which I am co-first author (Bisanz
et al., 2015) on probiotic yogurt in pregnant Tanzanian women. This was the first study
of its kind in pregnant women. It provided insight both into how the microbiota changes
over pregnancy and how probiotic yogurt can modulate the microbiota of the newborn.
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The human study in Chapter 6 was the first to test the probiotic-detoxication concept in
vulnerable human populations and is the main translational component to the work
presented in Chapter 7. We were the first to show a positive effect of yogurt containing
probiotic lactobacilli on uptake of mercury and arsenic in pregnant women and school
children, albeit the latter did not reach statistical significance. The study has many
immediate real world applications. The work in chapter 7 builds on the lessons learned
from the human studies with the intent of developing novel metal-detoxication oriented
strains. The objective was to understand the mechanisms involved in vivo. It culminated
in animal studies using the interactome approach of the microbiome, host and probiotic.
We identified a new L. rhamnosus candidate probiotic strain for mercury remediation
activity and genetically characterized a novel mercuric resistance operon in L.
rhamnosus.
The unifying theme of this work is the desire to understand probiotic function. Through a
combination of discovery and hypothesis driven research, we have increased our
knowledge of how probiotics function in the human vagina and gut, and set the path for
further investigations. As a result of these studies, I helped establish many platforms at
Western University and Lawson Health Research including high throughput DNA
extraction/amplification/sequencing and tools for genetic manipulations of L. rhamnosus
strains which was previously not possible in our laboratory. It is my hope that the results
contained within this thesis and the other publications resulting from my PhD studies will
have translational impacts on medical and agricultural practice while increasing our
understanding of how microbes function in host health.
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Chapter 2

2

Bacterial metatranscriptome analysis of a probiotic
yogurt using an RNA-Seq approach

This chapter is reproduced with permission (Appendix A) from:
Bisanz JE, Macklaim JM, Gloor GB and G Reid. 2014. Bacterial metatranscriptome
analysis of a probiotic yogurt using an RNA-Seq approach. International Dairy Journal
39:284-292.

2.1

Introduction

Yogurt is a fermented milk product created through the synergistic actions of a defined
mixture of microbes, typically Streptococcus thermophilus and Lactobacillus delbrueckii
subsp. bulgaricus (L. bulgaricus). It is one of the most common delivery vessels for
probiotics, and many strains have been granted the “Generally Recognized as Safe” status
by the American Food and Drug Administration allowing their use as food additives.
Microbial fermentation of milk can have many effects on its contents including reduction
of lactose allowing consumption for lactose intolerant individuals (Savaiano et al., 1984).
Bacteria may also produce metabolites beneficial to health during fermentation, the
classical example being bacteriocins, which are present in the food matrix and when
ingested may exert effects in addition to the actions of the live bacteria (Simova et al.,
2010). The addition of certain bacterial strains with known health benefits transforms the
yogurt from a basic fermented food to a probiotic. Thus, the probiotic strain selected and
its culture conditions are of importance, as strikingly indicated by differential antiinflammatory signalling of L. plantarum WCFS1 depending on the growth phase in
which it was administered (van Baarlen et al., 2009). This suggests that modification of
culture conditions is possible to optimize probiotics for maximum beneficial health
effects. In addition, the interactions between the organisms in the mixture can influence
the nutritional outcome of the yogurt. In point, microarray-based transcriptome studies on
one or both organisms indicate L. bulgaricus provides free amino acids for both strains
while formic acid, folic acid and fatty acids are supplied by S. thermophilus leading to
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improved growth and acid production causing fermentation (Herve-Jiminez et al., 2008;
Herve-Jiminez et al., 2009; Sieuwerts et al., 2010). Besides being of industrial
importance, better understanding of the interactions of the yogurt microbes may prove to
be important to the emerging field of probiotics research.
Given that yogurt may be stored for weeks or months after fermentation before being
consumed, we designed an experiment to analyse which genes are being expressed and
how the expression varies with flavors and time to product expiry. In the past, most
transcriptome studies on lactic acid bacteria have relied on cDNA microarrays, but
technical advances and reduced costs have made RNA-Seq, a method of obtaining digital
expression from high throughput sequencing, available to researchers. RNA-Seq has
several advantages over microarray-based assays including greater sensitivity, greater
specificity and nucleotide level resolution (Wang et al., 2009). Given the interest in the
health benefits of the commercially available probiotic yogurt in question, (Yang et al.,
2008; Guyonnet et al., 2009; Veiga et al., 2010), we sought to apply this technology to
the study of probiotic bacteria and their associated bacterial community. A deeper
understanding of how the yogurt milieu affects probiotic organisms may allow for
maximization of probiotic effects and more guided utilization of these products.

2.2
2.2.1

Materials and Methods
Yogurt source

A mixed pack of 100 g cups of strawberry and vanilla flavored yogurt containing the
probiotic bacterium Bifidobacterium animalis subsp. lactis (B. lactis) strain CNCM I2494 was obtained from a local grocery store (London, Ontario, Canada) 23 days before
expiry, and stored at 4 °C until further analysis. RNA isolation from pots of both
strawberry and vanilla flavors took place 15 days before expiry (sample names:
strawberry and vanilla) and vanilla 1 day before expiry (sample name: vanilla 2). This
roughly represents the product at the recently purchased time point and close to expiry,
though still in the time frame by which a consumer would be able to purchase and
consume the product.
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2.2.2

RNA isolation

The extraction protocol was based on previously published methods (Macklaim et al.,
2013; Smeianov et al., 2007). Each product was thoroughly mixed and an aliquot of 10
mL of was resuspended in 20 mL of Bacterial RNAprotect (Qiagen) containing 50 µg/mL
rifampicin (Sigma). The samples were mixed and incubated for 10 minutes at room
temperature to stabilize RNA. The mixture was then centrifuged at 5,000 x g for 10
minutes, the supernatant was discarded, and the pellet was immediately frozen in liquid
nitrogen and stored at -80°C until lysis and extraction. The pellet was next resuspended in
10 mL of DEPC-treated water containing 20 mg mL-1 lysozyme (Sigma), 50 U mL-1
mutanolysin (Sigma) and 100 µg mL-1 rifampicin (Sigma) and incubated at 37 °C for 30
minutes. The mixture was then centrifuged as before and the supernatant was discarded.
The pellet was then resuspended in 10 mL of TRIzol reagent (Invitrogen). The sample
was fully homogenized and the sample was centrifuged for 10 minutes at 12,000 x g to
clear excess un-dissolved milk components. The supernatant was then collected and the
manufacturers protocol was followed to isolate total RNA (TRIzol Reagent Manual,
Invitrogen). Total RNA in RNase-free water was then transferred to a RNeasy column
(Qiagen) and treated with DNaseI (Qiagen) following the manufacturers protocol. mRNA
was enriched with the MICROBExpress kit (Ambion) according to the manufacturer’s
protocol. mRNA purity was accessed using an BioPhotometer 6131 (Eppendorf) to
ensure the sample was free of contaminants. Both the total RNA and mRNA were
analysed with a Bioanalyzer 2100 (Agilent) to analyse RNA quality and confirm mRNA
enrichment. All RNA samples used for sequencing had a RIN (RNA integrity number)
>8.0 as total RNA.

2.2.3

RNA-Seq

Samples were sent to the Center for Applied Genomics (Toronto), and directional library
preparation was carried out and the samples barcoded for 50 base pair sequencing on the
ABI SOLiD 4 (Life Technologies).
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2.2.4

Read mapping

The colorspace reads were mapped to the reference genomes of the strains present in the
yogurt (B. animalis CNCM I-2494, Lactobacillus bulgaricus strains CNCM I-1632 and
CNCM I-1519, S. thermophilus CNCM I-1630 and Lactococcus lactis CNCM-1631). At
the time of publishing, these genomes are available under the following GenBank
accessions: CP002915.1, NZ_AGFO00000000, NZ_AGHW00000000,
NZ_AGFN00000000, NZ_AGHX00000000. Mapping was carried out with Bowtie
0.12.7 (bowtie-bio.sourceforge.net) using the ‘--best’ and ‘-M 1’ flags to report only best
hits, and in the case of reads with multiple best hit mappings, randomly distributing them
amongst matches. The first 10 nt at the 3’ end of each read were trimmed prior to
mapping. Using custom Perl scripts (JEB, JMM and GBG), the reads were assigned to
open reading frames and the number of reads per ORF was enumerated. Proportional
mRNA abundances per taxa were calculated by three methods: (i) finding the number of
reads mapped to the cpn60 gene of each strain and calculating the fraction of total
mapped cpn60 reads, (ii) the fraction of total mapped rpoB reads, and (iii) calculating
each strains’ total mapped reads as a fraction of reads mapping to all strains.

2.2.5

Expression analysis

For each organism’s protein coding sequence, total reads per open reading frame were
calculated. The reads per kilobase of exon model per million mapped reads (RPKM)
method was used to normalize expression of each gene (Mortazavi et al., 2008). DEseq
(bioconductor.org/packages/2.6/bioc/html/DESeq.html), an open source R package, was
used to calculate differential gene expression in each organism in each of the three
conditions (Anders and Huber, 2010). The ‘blind’ method was used to allow statistical
analysis without replicates. Genes were deemed to be significantly differentially
regulated if they had a p<0.05. Genes were functionally annotated using the Clusters of
Orthologous Proteins (COGs) database with an e-value cut off of 1E-3 to assign
annotations and functions. Genes were also compared to the SEED subsystems database
to assign function (ftp.theseed.org/subsystems/) and high quality matches were extracted
(≥80% identity and e-value<1E-3). Amino acid translations of predicted coding
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sequences were submitted to the Kyoto Encyclopaedia of Genes and GenomeAutomated Annotation Server (genome.ad.jp/tools/kaas/) for pathways analysis.

2.3
2.3.1

Results
Read mapping

A total of 48,658,804 reads (50 nt long) were successfully mapped to the reference
database of whole genomes belonging to strains in the product. The average coding
sequence coverage obtained for a given organism in a sample was 37.2-fold. Individual
coverages are shown in Table 2-1 by number of reads and fold coverage of the strains
coding sequences. Only L. lactis had poor sequencing depth having a coverage of
≤0.390.
Table 2-1. Reads mapping and coding sequence coverage of strains present in each
sample. All values are mapped reads in millions (fold-coverage of coding sequences).
Sample

B. lactis

S.
thermophilus

Strawberry 1.13 (32.2)

1.15 (48.6)

Vanilla

0.85 (24.2)

5.11 (215.4)

Vanilla 2

0.82 (23.3)

1.98 (83.3)

2.3.2

L. lactis
4.76x10-4
(0.108)
1.72x10-3
(0.390)
1.03x10-3
(0.233)

L. bulgaricus
CNCM I-1632

L. bulgaricus
CNCM I-1519

0.48 (15.3)

0.78 (25.1)

0.86 (27.9)

1.12 (37.3)

0.26 (8.34)

0.46 (24.4)

Microbial mRNA composition

Figure 2-1 is a bar plot mapping microbial abundance by fraction of total cpn60 reads,
rpoB and total reads mapped to protein coding sequence in each sample. The dominant
organism by cpn60 mapped reads was S. thermophilus, while B. lactis and L. bulgaricus
strains were also in high abundance. B. lactis and L. bulgaricus contributed a greater
proportion of both rpoB mapped reads and total reads. L. lactis appeared to be present in
relatively low abundance as compared to the other organisms both by cpn60 (≤0.01%),
rpoB (≤0.29%), which was consistent with its low transcriptome coverage. L. lactis was
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excluded from further expression analysis, as it did not have sufficient coverage for
meaningful analysis.
1.0

Fraction of Reads

0.8

0.6

0.4

0.2

0.0

cpn60 rpoB Total
Strawberry

cpn60 rpoB Total
Vanilla

cpn60 rpoB Total
Vanilla 2

L. bulgaricus CNCM I-1632
L. bulgaricus CNCM I-1519
L. lactis
S. thermophilus
B. lactis

Figure 2-1. Microbial abundance as measured by the fraction of cpn60 reads, rpoB
reads and reads mapping to all coding sequences in the organisms.
By	
  cpn60,	
  but	
  not	
  rpoB	
  and	
  total	
  reads,	
  S.	
  thermophilus	
  was	
  the	
  most	
  abundant	
  organism	
  in	
  all	
  
conditions,	
  however	
  all	
  strains,	
  with	
  the	
  exception	
  of	
  L.	
  lactis,	
  appeared	
  to	
  be	
  present	
  and	
  highly	
  
transcriptionally	
  active.	
  

2.3.3

Gene functions expressed in yogurt

In each organism an enrichment analysis was performed by analysing all COG functions
present in the genome, genes expressed with a RPKM ≥200 in all samples, and genes
expressed with a RPKM ≥1000 in all samples. This corresponds to all protein coding
genes, the most highly expressed 22.4-37.8% and 5.26-9.94% of genes respectively in a
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strain dependent manner. Of total genes with an assignable COG hit, the fraction of genes
in each top-level function was calculated and is displayed in Figure 2-2. Highly
represented functions in all organisms include translational machinery, carbohydrate
transport and metabolism, amino acid transport and metabolism. In most strains such as
B. lactis, there was an enrichment of genes involved in translation in the highly expressed
genes (from 10% in the genome to 23.6% in genes with an RPKM ≥1000) with the
exception of S. thermophilus. In this organism, at the highest RPKM cut-off, genes
involved in this category only comprise 7.4% of genes while they comprise 8.6% in the
genome. S. thermophilus showed higher enrichment in carbohydrate transport and
metabolism from 6.1% in the genome to 17.2% at an RPKM cut-off of 1000. This
included two genes annotated as LacZ beta-galactosidase, responsible for breaking down
lactose, which was also highly expressed in L. bulgaricus strains but not B. lactis. Further
KEGG pathway analysis showed the backbone genes of glycolysis were highly expressed
(RPKM≥1000) in S. thermophilus leading to its higher fraction of genes involved in
carbohydrate transport and metabolism. Both L. bulgaricus strains displayed similar
fractions of functions at all levels of enrichment. B. lactis had a higher fraction of genes
involved in energy production and conversion at an RPKM≥1000 with 8.9% of genes
involved in this category. KEGG annotation showed the presence of 6 subunits of F0F1
type ATP synthase among these genes, supported by KEGG pathway analysis.
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Genome
B. lactis

RPKM ≥200
RPKM ≥1000

Genome
S. thermophilus

RPKM ≥200
RPKM ≥1000

Genome
L. bulgaricus
CNCM I-1519

RPKM ≥200
RPKM ≥1000

Genome
L. bulgaricus
CNCM I-1632

RPKM ≥200
RPKM ≥1000

0.0

0.2

0.4

0.6

0.8

1.0

Fraction of genes assigned COG functions
Inorganic ion transport and metabolism
Nucleotide transport and metabolism
Cell envelope biogenesis, outer membrane
Function unknown
Transcription
DNA replication, recombination and repair
Carbohydrate transport and metabolism
Translation ribosomal structure and biogenesis
General fuction prediction only
Amino Acid transport and metabolism

RNA processing and modification
Secondary metabolites biosynthesis transport and catabolism
Intracellular trafficking and secretion
Cell division and chromosome partitioning
Defense mechanisms
Lipid metabolism
Coenzyme metabolism
Energy production and conversion
Posttranslational modification, protein turnover chaperones
Signal transduction mechanisms

Figure 2-2. Enrichment of COG functions in all conditions by increasing RPKM
cutoff demonstrating gene functions at different levels of expression.
Functions	
  highly	
  represented	
  at	
  the	
  highest	
  enrichment	
  levels	
  include	
  those	
  involved	
  in	
  
translation,	
  and	
  carbohydrate	
  and	
  amino	
  acid	
  transport/metabolism.	
  There	
  was	
  an	
  enrichment	
  
of	
  carbohydrate	
  transport	
  and	
  metabolism	
  genes	
  in	
  S.	
  thermophilus	
  at	
  higher	
  expression	
  levels	
  
(RPKM≥1000)	
  while	
  other	
  strains	
  displayed	
  enrichment	
  of	
  translation,	
  ribosomal	
  structure	
  and	
  
biogenesis	
  genes.	
  B.	
  lactis	
  displayed	
  an	
  enrichment	
  of	
  genes	
  involved	
  in	
  energy	
  production	
  and	
  
conversion.	
  Both	
  L.	
  bulgaricus	
  strains	
  displayed	
  similar	
  profiles	
  at	
  the	
  genome,	
  and	
  highly	
  
expressed	
  gene	
  levels.	
  

2.3.4

Differential mRNA expression due to flavor and storage time

Differential expression analysis by DESeq was performed for flavor (strawberry vs.
vanilla) and storage time (vanilla vs. vanilla 2). Statistical analysis without replicates was
based on the assumption that no difference exists for most genes between samples
compared, thus samples are treated as if they are replicates with differentially abundant
genes as outliers. This approach is generally considered to be conservative, since it
usually leads to an overestimation of variance making reported p-values conservative
(Anders and Huber, 2010). Differential expression was plotted in the context of SEED
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subsystems for all analyzed strains. Figure 2-3 shows a flavor comparison and storage
time comparison at the most general SEED subsystem level. Genes identified as
significantly differentially expressed are indicated by the strain of origin. Genes that had
differential expression values of infinity due to read count values of zero in one sample
were plotted as a 6-fold change for simplicity. Only 9 of these genes had a p<0.05
including LDBUL1519_00397, a O-acetylhomoserine sulfhydrylase. In both
comparisons, there were many up-regulated genes involved in protein metabolism in
strawberry compared to vanilla and vanilla compared to vanilla 2. Inspection of SEED
subsystem level 3 revealed most of these differentially expressed genes encode ribosomal
proteins. In particular 13 genes, 11 up-regulated, involved in protein metabolism, were
significantly differentially regulated by B. lactis in strawberry as opposed to vanilla
flavors ranging from -1.4 to 1.4 fold (log2).
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Figure 2-3. Differential expression measured by Log2(fold change) in the highest
level SEED subsystems in a comparison of flavors and storage time.
Genes	
  with	
  a	
  p<0.05	
  are	
  displayed	
  according	
  to	
  the	
  strain	
  of	
  origin:	
  B.	
  lactis	
  ( ),	
  S.	
  
thermophilus	
  ( ),	
  L.	
  bulgaricus	
  CNCM	
  I-‐1519	
  	
  ( ),	
  L.	
  bulgaricus	
  CNCM	
  I-‐	
  1632	
  ( ).	
  Genes	
  
infinitely	
  differentially	
  regulated	
  were	
  assigned	
  a	
  fold-‐change	
  value	
  of	
  	
  ±6-‐fold.	
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2.3.5

B. lactis expression

The filtered, COG-annotated gene-by-gene results of a flavor (strawberry versus vanilla)
and time comparison (vanilla versus vanilla 2) are displayed in Tables 2-2 and 2-3
respectively. In the flavor comparison, 90 genes were identified as being significantly
differentially expressed with 59 being assigned COG annotations. In the storage
comparison, 89 genes were significantly differentially expressed with 56 being assigned
COG annotations. The most up-regulated gene in strawberry as compared to vanilla was
upgE, a sugar transport permease (5.3-fold), while the most down-regulated was salX, an
antimicrobial peptide transport system (-3.0-fold). In the time point comparison of vanilla
to vanilla 2, Ssb single-stranded DNA-binding protein was most up-regulated in vanilla
(12.6-fold) while COG1073, a hydrolase, was most down-regulated (infinitely downregulated). Gene functions differentially regulated in both conditions include genes that
are predominately involved in protein translation and DNA replication, or can’t be
assigned a function, and to a lesser extent those involved in DNA replication,
recombination and repair, cell envelope biogenesis and transcription as demonstrated in
Figure 2-4 which shows differential expression of COG functions in B. lactis.
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Table 2-2. B. lactis genes with assigned COGs differentially regulated with p<0.05 in
a comparison of the strawberry and vanilla samples (flavor comparison).
Locus ID
BALAC2494_02066
BALAC2494_01335
BALAC2494_01292
BALAC2494_00517
BALAC2494_01290
BALAC2494_01337
BALAC2494_01333
BALAC2494_00723
BALAC2494_01334
BALAC2494_00235
BALAC2494_01304
BALAC2494_00734
BALAC2494_00989
BALAC2494_00987
BALAC2494_01352
BALAC2494_01336
BALAC2494_00329
BALAC2494_00130
BALAC2494_00727
BALAC2494_00651
BALAC2494_01817
BALAC2494_01248
BALAC2494_01776
BALAC2494_01354
BALAC2494_01967
BALAC2494_00758
BALAC2494_00797
BALAC2494_00510
BALAC2494_00381
BALAC2494_01353
BALAC2494_01302
BALAC2494_00554
BALAC2494_01347
BALAC2494_00785
BALAC2494_00784
BALAC2494_00780
BALAC2494_01492
BALAC2494_00746
BALAC2494_00185
BALAC2494_01079
BALAC2494_00553
BALAC2494_00168
BALAC2494_00446
BALAC2494_00316
BALAC2494_00765
BALAC2494_00398
BALAC2494_00859
BALAC2494_01319
BALAC2494_00825
BALAC2494_00591
BALAC2494_00637
BALAC2494_00865
BALAC2494_00612
BALAC2494_00415

Fold
Change
5.28
3.98
3.66
3.64
3.47
2.76
2.72
2.69
2.55
2.48
2.33
2.18
2.15
2.13
2.12
2.11
2.11
2.09
2.09
2.07
2.02
2.02
2.00
1.99
1.96
1.85
1.85
1.85
1.81
1.79
1.78
1.78
1.78
1.78
1.78
1.74
1.73
1.71
1.69
1.68
1.67
1.65
-1.91
-1.93
-2.00
-2.17
-2.23
-2.30
-2.50
-2.56
-2.63
-2.71
-2.94
-2.98

P-value

Best COG Hit

8.79E-03
1.15E-07
6.58E-07
4.95E-06
1.02E-04
3.01E-04
1.38E-04
8.28E-04
3.48E-04
3.05E-03
4.28E-03
2.01E-03
2.59E-02
7.96E-03
2.76E-03
3.50E-03
2.63E-02
4.69E-03
3.37E-03
3.59E-02
1.46E-02
7.01E-03
8.92E-03
6.60E-03
1.48E-02
3.54E-02
1.41E-02
1.43E-02
4.79E-02
2.00E-02
3.12E-02
2.09E-02
2.12E-02
2.66E-02
4.80E-02
3.29E-02
3.33E-02
3.00E-02
4.80E-02
4.42E-02
4.51E-02
4.25E-02
1.36E-02
3.55E-02
4.53E-02
1.91E-02
3.67E-03
7.10E-03
7.85E-04
2.05E-03
3.66E-02
1.54E-04
3.46E-02
1.78E-02

COG0395, UgpE, ABC-type sugar transport system, permease component
COG5017, Uncharacterized conserved protein
COG1403, McrA, Restriction endonuclease
COG3039, Transposase and inactivated derivatives, IS5 family
COG4974, XerD, Site-specific recombinase XerD
COG0451, WcaG, Nucleoside-diphosphate-sugar epimerases
COG1216, Predicted glycosyltransferases
COG0203, RplQ, Ribosomal protein L17
COG1216, Predicted glycosyltransferases
COG1507, Uncharacterized conserved protein
COG0224, AtpG, F0F1-type ATP synthase, gamma subunit
COG0256, RplR, Ribosomal protein L18
COG4177, LivM, ABC-type branched-chain amino acid transport system, permease component
COG0410, LivF, ABC-type branched-chain amino acid transport systems, ATPase component
COG1216, Predicted glycosyltransferases
COG0707, MurG, UDP-N-acetylglucosamine:LPS N-acetylglucosamine transferase
COG0239, CrcB, Integral membrane protein possibly involved in chromosome condensation
COG1546, CinA, Uncharacterized protein (competence- and mitomycin-induced)
COG0257, RpmJ, Ribosomal protein L36
COG4487, Uncharacterized protein conserved in bacteria
COG1203, Predicted helicases
COG0360, RpsF, Ribosomal protein S6
COG2244, RfbX, Membrane protein involved in the export of O-antigen and teichoic acid
COG0463, WcaA, Glycosyltransferases involved in cell wall biogenesis
COG0048, RpsL, Ribosomal protein S12
COG0102, RplM, Ribosomal protein L13
COG1211, IspD, 4-diphosphocytidyl-2-methyl-D-erithritol synthase
COG0049, RpsG, Ribosomal protein S7
COG0799, Uncharacterized homolog of plant Iojap protein
COG2244, RfbX, Membrane protein involved in the export of O-antigen and teichoic acid
COG0712, AtpH, F0F1-type ATP synthase, delta subunit
COG1061, SSL2, DNA or RNA helicases of superfamily II
COG1215, Glycosyltransferases, probably involved in cell wall biogenesis
COG0581, PstA, ABC-type phosphate transport system, permease component
COG1117, PstB, ABC-type phosphate transport system, ATPase component
COG0222, RplL, Ribosomal protein L7/L12
COG0118, HisH, Glutamine amidotransferase
COG0185, RpsS, Ribosomal protein S19
COG0268, RpsT, Ribosomal protein S20
COG1196, Smc, Chromosome segregation ATPases
COG1479, Uncharacterized conserved protein
COG0740, ClpP, Protease subunit of ATP-dependent Clp proteases
COG3304, Predicted membrane protein
COG0861, TerC, Membrane protein TerC, possibly involved in tellurium resistance
COG4231, Indolepyruvate ferredoxin oxidoreductase, alpha and beta subunits
COG1028, FabG, Dehydrogenases with different specificities
COG1837, Predicted RNA-binding protein (contains KH domain)
COG0251, TdcF, Putative translation initiation inhibitor, yjgF family
COG0211, RpmA, Ribosomal protein L27
COG0629, Ssb, Single-stranded DNA-binding protein
COG1874, LacA, Beta-galactosidase
COG0227, RpmB, Ribosomal protein L28
COG3507, XynB, Beta-xylosidase
COG1136, SalX, ABC-type antimicrobial peptide transport system, ATPase component

50

Table 2-3. B. lactis genes with assigned COGs differentially regulated with p<0.05
in a comparison of the vanilla and vanilla 2 samples (storage comparison).
BALAC2494_00591
BALAC2494_01069
BALAC2494_01866
BALAC2494_01860
BALAC2494_01696
BALAC2494_00118
BALAC2494_00693
BALAC2494_01466
BALAC2494_00859
BALAC2494_01771
BALAC2494_00728
BALAC2494_01326
BALAC2494_00488
BALAC2494_01696

Fold
Change
12.61
10.79
10.16
9.40
7.67
5.70
5.30
5.20
5.13
4.27
3.95
3.54
3.53
3.22

BALAC2494_00232

3.20

1.31E-02

BALAC2494_00635
BALAC2494_00865
BALAC2494_00128
BALAC2494_00398
BALAC2494_00770
BALAC2494_00031
BALAC2494_00499
BALAC2494_00364
BALAC2494_00825
BALAC2494_02024
BALAC2494_00909
BALAC2494_00389

3.11
3.00
2.89
2.80
2.77
2.73
2.71
2.66
2.66
2.55
2.47
2.35

2.45E-02
1.31E-02
2.04E-02
1.49E-02
4.57E-02
2.55E-02
2.92E-02
8.73E-03
9.15E-03
1.38E-02
1.74E-02
2.17E-02

BALAC2494_00954

2.35

2.15E-02

BALAC2494_01319
BALAC2494_00446
BALAC2494_01603
BALAC2494_01864
BALAC2494_00085
BALAC2494_01157
BALAC2494_02003
BALAC2494_00341
BALAC2494_00168
BALAC2494_01335
BALAC2494_00735
BALAC2494_00993
BALAC2494_00727
BALAC2494_01352
BALAC2494_01292
BALAC2494_01353
BALAC2494_00397
BALAC2494_01360
BALAC2494_01248
BALAC2494_00732
BALAC2494_01304
BALAC2494_00403
BALAC2494_00381
BALAC2494_01007

2.30
2.30
2.27
2.27
2.25
2.14
2.10
-2.15
-2.27
-2.35
-2.46
-2.46
-2.50
-2.55
-2.57
-2.66
-2.74
-2.77
-3.16
-3.29
-3.37
-3.46
-4.14
-Inf

3.55E-02
2.57E-02
2.95E-02
4.29E-02
3.28E-02
4.11E-02
4.97E-02
4.94E-02
3.35E-02
4.83E-02
4.24E-02
3.50E-02
2.18E-02
1.49E-02
3.86E-02
2.18E-02
4.08E-02
2.97E-02
1.41E-02
1.91E-02
2.14E-02
1.52E-03
2.97E-03
5.38E-03

Locus ID

p-value

Best COG Hit

4.83E-08
7.53E-07
1.19E-06
2.02E-06
1.39E-05
1.65E-04
1.09E-02
2.43E-04
1.10E-03
3.18E-02
1.34E-02
1.30E-03
5.57E-03
7.15E-03

COG0629, Ssb, Single-stranded DNA-binding protein
COG3464, Transposase and inactivated derivatives
COG3464, Transposase and inactivated derivatives
COG3464, Transposase and inactivated derivatives
COG3464, Transposase and inactivated derivatives
COG3464, Transposase and inactivated derivatives
COG1605, PheA, Chorismate mutase
COG1381, RecO, Recombinational DNA repair protein (RecF pathway)
COG1837, Predicted RNA-binding protein (contains KH domain)
COG0388, Predicted amidohydrolase
COG0361, InfA, Translation initiation factor 1 (IF-1)
COG1196, Smc, Chromosome segregation ATPases
COG0776, HimA, Bacterial nucleoid DNA-binding protein
COG3464, Transposase and inactivated derivatives
COG0600, TauC, ABC-type nitrate/sulfonate/bicarbonate transport system, permease
component
COG1175, UgpA, ABC-type sugar transport systems, permease components
COG0227, RpmB, Ribosomal protein L28
COG0324, MiaA, tRNA delta(2)-isopentenylpyrophosphate transferase
COG1028, FabG, Dehydrogenases with different specificities
COG0234, GroS, Co-chaperonin GroES (HSP10)
COG1974, LexA, SOS-response transcriptional repressors (RecA-mediated autopeptidases)
COG1758, RpoZ, DNA-directed RNA polymerase, subunit K/omega
COG0739, NlpD, Membrane proteins related to metalloendopeptidases
COG0211, RpmA, Ribosomal protein L27
COG0040, HisG, ATP phosphoribosyltransferase
COG0527, LysC, Aspartokinases
COG0637, Predicted phosphatase/phosphohexomutase
COG4591, LolE, ABC-type transport system, involved in lipoprotein release, permease
component
COG0251, TdcF, Putative translation initiation inhibitor, yjgF family
COG3304, Predicted membrane protein
COG1278, CspC, Cold shock proteins
COG2135, Uncharacterized conserved protein
COG0292, RplT, Ribosomal protein L20
COG2211, MelB, Na+/melibiose symporter and related transporters
COG1765, Predicted redox protein, regulator of disulfide bond formation
COG0159, TrpA, Tryptophan synthase alpha chain
COG0740, ClpP, Protease subunit of ATP-dependent Clp proteases
COG5017, Uncharacterized conserved protein
COG0097, RplF, Ribosomal protein L6P/L9E
COG0239, CrcB, Integral membrane protein possibly involved in chromosome condensation
COG0257, RpmJ, Ribosomal protein L36
COG1216, Predicted glycosyltransferases
COG1403, McrA, Restriction endonuclease
COG2244, RfbX, Membrane protein involved in the export of O-antigen and teichoic acid
COG0162, TyrS, Tyrosyl-tRNA synthetase
COG4713, Predicted membrane protein
COG0360, RpsF, Ribosomal protein S6
COG1841, RpmD, Ribosomal protein L30/L7E
COG0224, AtpG, F0F1-type ATP synthase, gamma subunit
COG1438, ArgR, Arginine repressor
COG0799, Uncharacterized homolog of plant Iojap protein
COG1073, Hydrolases of the alpha/beta superfamily
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Figure 2-4. Differential regulation of COG functions in B. lactis in both flavor (A)
and storage time (B) comparisons.
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2.4

Discussion

In this report, we describe one of the first metatranscriptome analyses of a probiotic
yogurt. High coverage of all coding sequences of the organisms present in the yogurt was
obtained with the high read output of the SOLiD 4 sequencer. We recognize the inherent
limitations of the single replicate experimental design, and have been conservative in our
analysis. However, several factors suggest that the majority of the findings are robust.
First, the high read coverage partially compensated for the single replicate experimental
design as the abundance values can be estimated with greater precision (Fernandes et al.,
2013). Second, the analysis tool used assumes that the majority of the expression values
between samples do not change, and only identifies the expression outliers. This
approach is expected to be conservative (Anders and Huber, 2010). Recent work has
determined that genes with high intrinsic variation are also identified by this tool (Li and
Tibshirani, 2013; Fernandes et al., 2014), indicating that there may be contamination with
genes of this type in the lists of differentially abundant genes. Validation thus will require
additional samples. Third, many of the differentially abundant genes that are identified
may be connected in pathways. This argues strongly for accepting as valid those genes
that are identified as differentially abundant where multiple genes in the same pathway
are also significantly different and share the same directionality of abundance difference.
Given that non-protein coding RNAs make up ≥90% of total RNA, the enrichment of
mRNA is necessary to optimize coverage of coding sequences. This makes expressed
16S rRNA an unsuitable marker of microbial abundances as it has been largely removed
and the removal may not be consistent across all strains. We used instead the cpn60 gene
and rpoB, both are single copy, highly-transcribed genes with high levels of sequence
variation allowing for unique identification of bacteria and quantification (Hill et al.,
2004; Rodrigues & Tiedje, 2007). The cpn60-mapped reads indicated that the most
abundant organism was S. thermophilus while L. bulgaricus and the probiotic B. lactis
also composed a large fraction of the population. Even though B. lactis may be rare
according to cpn60, it still appears to be highly transcriptionally active as dictated by the
proportion of total reads in the product. The proportional abundances of rpoB mapped
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reads more closely resemble the proportional abundances determined by total reads.
Given that two strains of L. bulgaricus were present, it was likely our quantitation may be
skewed by an inability to distinguish between the strains given a high level of similarity
in their 1614 bp cpn60 genes (99% nucleotide sequence identity). In all three samples we
observe L. bulgaricus CNCM I-1519 as being in higher quantities, thus we may be
underestimating its abundance, and overestimating the abundance of L. bulgaricus
CNCM I-1632 as reads with common mapping in these two organisms will be equally
assigned to both. In addition, it is possible that levels of cpn60 may fluctuate in response
to cell stress which has been identified in L. bulgaricus (Lim et al., 2000). This may also
skew quantification making fraction of cpn60 reads a good tool for identification of
bacterial strains but as with any technique, it may have its own inherent biases. Indeed,
recent studies have shown transcriptional activity is not always related to true microbial
abundances which may suggest the need for culture or DNA-based quantification
(McNulty et al., 2011).
The L. lactis had extremely low coverage of ≤0.390-fold, so we were unable to study its
role further. While we can demonstrate its presence by the detection of uniquely mapping
cpn60 reads, there are less than 100 reads in any of the samples. This suggests L. lactis
composes a small fraction of the total community and plays a minor role in the product as
delivered to the consumer. Alternatively it may be present but in an extremely dormant
state at the time of sampling with very little functional contribution in the finished
product. Presumably during the production of the yogurt it contributes to the taste or
texture of the product but could also function in improving growth and viability of the
probiotic bifidobacteria strain as suggested by recent research (Yonezawa et al., 2010;
Odamaki et al., 2011).
When comparing flavors, two genes of L. bulgaricus CNCM I-1519 involved in
methionine pathways were differentially regulated infinitely (no transcripts detected in
one condition), up-regulated in LDBUL1519_01373 (adenosylhomocysteinase) and
down-regulated in LDBUL1519_00397 (O-acetylhomoserine sulfhydrylase or Osuccinylhomoserine sulfhydrylase). The product of adenosylhomocysteinase reactions
are L-cysteine and adenosine while O-succinylhomoserine sulfhydrylase consumes L-
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cysteine to form L-cystathionine and succinate (KEGG Database). This may suggest a
cellular response in L. bulgaricus to produce maximum quantities of L-cysteine in the
strawberry flavor compared to vanilla. Cysteine can act as an antioxidant in cells (Qian et
al., 2010). It is also used in growth media to lower the redox potential and protect against
reactive oxygen species for anaerobes such as bifidobacteria (Qian et al., 2010). The
importance of cysteine was underlined by the detection of a number of highly expressed
components in the cysteine and methionine pathway during analysis of B. lactis. This
suggests a mechanism to help protect viability of probiotics in yogurt, though as a
double-edged sword, bifidobacteria grown in the absence of cysteine form anti-oxidant
granules exhibiting higher acid tolerance and higher surface hydrophobicity which are
beneficial characteristics for a probiotic to allow passage through the digestive system
(Qian et al., 2010). These antioxidant granules contain large quantities of polyphosphate
and there was corresponding up-regulation of two B. lactis phosphate specific
transporters in strawberry flavoring (PstA and PstB) that would supply phosphate for the
production of polyphosphate.
O-acetylhomoserine sulfhydrylase, the other potential function of the L. bulgaricus gene
LDBUL1519_00397 as reported by the KEGG Database, consumes methanethiol to
produce L-methionine. Methanethiol is a key volatile sulfur compound important in
giving flavor and aroma to cheese which has the potential to give rise to subtle flavor and
scent differences between yogurts (Hanniffy et al., 2009).
Components of the F0F1-ATP synthase machinery of B. lactis appeared to be highly
expressed and differentially regulated between conditions being up-regulated
(BALAC2494_1302 and BALAC2494_1304) in the strawberry flavor and in the fresher
vanilla sample. This machinery has been implicated as being key for bile and acid
resistance in both B. animalis and L. plantarum by increasing intracellular ATP and
controlling intracellular pH (Sanchez et al., 2006; Hammon et al., 2011). Improved bile
and acid resistance may aid a probiotic strain by improving resistance to stomach acid
and bile in the stomach and early small intestine allowing more viable organisms to reach
their site of action.
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The SEED subsystem analyses indicated that ribosomal proteins were differentially
regulated in all organisms in both flavor and storage comparisons. In the flavor
comparison many of these changes are relatively small, less than 4-fold, while in the
storage time comparison the changes were more drastic with up-regulation of the genes
by 2-16 fold in the fresher sample. A probable explanation of why we were able to assign
significance to relatively small 2-fold changes in the ribosomal subunits is a function of
their extremely high abundance that allows higher confidence in their change. Higher
expression of these transcripts may be indicative of higher translational activity,
especially when coupled with up-regulation of RNA polymerase subunits such as RpoZ
(BALAC2494_00499), or of significantly greater mRNA stability of these transcripts
upon prolonged shelf storage. Recent work in E. coli suggests that bacterial cells have an
upper limit on the amount of transcription supported. Scott et al. (2010) found that the
transcription of house keeping genes such as ribosomal proteins change to compensate
for increases in the transcription of genes expressed in response to environmental cues.
This implies that there may be a number of smaller changes that occurred in the cell,
however these most likely don’t pass our filters. We suggest that a larger sample set
would help improve our ability to detect smaller changes.
B. lactis adapts to its environment as indicated by the most up-regulated gene in
strawberry in comparison to vanilla: upgE. It is most likely a broad specificity sugar
uptake permease suggesting that this may be a response to differing sugar composition
between flavors. This was further supported by the down-regulation in strawberry flavor
of lacA β-galactosidase, a component of lactose metabolism, and xynB, β-xylosidase, an
enzyme responsible for the break down of xylose and xylooligosaccharides, compounds
with potential as a bifidogenic prebiotic (Lagaert et al., 2011). Up-regulation of xynB has
recently been identified as a key response of this B. lactis strain to its environment in the
human body, raising the question whether modulating its expression in yogurt may have a
positive effect on the strain once it enters the body (McNulty et al., 2011). Alternately,
the gene most up-regulated in vanilla as compared to strawberry shares significant
similarity with SalX, an antimicrobial peptide transport component. This is of interest
since the vanilla flavoring agent is from natural sources and vanillin, the primary
component in vanilla bean extract, possesses anti-microbial properties (Negishi et al.,

56

2009). Influence of flavoring agents has been studied in both starter culture bacteria and
probiotic strains (Vinderola et al., 2002). It was found that probiotic strains were often
resistant to the effects of flavoring agents and indeed our work may highlight a potential
mechanism through which this occurs.
In culture, the half-life of total bacterial RNA has been estimated at 6.8 minutes (Selinger
et al., 2003), thus the gene expression of probiotic bacteria in the small intestine or distal
colon is surely different from in the yogurt. This being said, genes expressed in the
yogurt will likely influence the ability of the bacteria to exert a probiotic effect. For
example, if the organisms are already expressing factors for improved acid and bile
tolerance they will have an increased chance of passing through the acidic stomach and
bile filled early duodenum allowing viable bacteria to reach multiple parts of the
intestinal tract to exert their effects.

2.5

Conclusions

Given that to our knowledge, no publications exist on the transcriptomes of yogurt
bacteria post-fermentation, the intent of this research was to perform a pilot study to
rigorously, and scientifically, apply RNA-Seq to study the yogurt metatranscriptome
post-fermentation and see the possible impacts on the organisms. This study offers a
method for others to examine how bacterial strains in fermented food adapt to flavor and
storage. The findings do not necessarily imply that flavor and/or storage alter clinical
effects, but they illustrate the potential to further refine yogurt as a valuable method of
delivering health through probiotics.
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Chapter 3

3

Comparative genomics demonstrates production of
volatile sulfur compounds in Lactobacillus paracasei
and Lactobacillus rhamnosus is mediated by a novel
sulfur/taurine metabolism gene cluster.

This material in this chapter is currently under review at the International Journal of Food
Microbiology as a short communication.
Bisanz JE, van Hylckama Vlieg JET, Wels M, Smokvina T and G Reid.

3.1 Introduction
Flavor of many fermented milk products is determined by a complicated interaction of
molecules acting in combination. In many fermented milk products including cheddar
cheese, the actions of non-starter microorganisms, including lactobacilli, impart much of
the characteristic flavor as a result of the amino acid metabolism (Weimer et al., 1999).
One of the most important groups of compounds in cheese flavor formation is volatile
sulfur compounds (VSCs), including hydrogen sulfide (H2S). These impart the oftendesired scent and flavor colloquially referred to as “rotting egg”, but in lower levels they
are required for basic cheese flavor. The lactic acid bacteria-mediated production of H2S
and other VSCs is of great interest for their role in this process. Some work has been
undertaken to understand this phenomenon at the molecular level (Del Carmen MartínezCuesta et al., 2013).
In the carbohydrate-limited environment of fermented milk, proteolysis is a key
metabolic pathway for lactobacilli. The resultant methionine and cysteine produced are
the intermediates from which VSCs are formed (Del Carmen Martínez-Cuesta et al.,
2013). An operon known as cysK-ctl-cysE, has been reported to putatively encode a
cysteine synthase, cystathionine lyase and serine acetyltransferase (Bogicevic et al.,
2012). Further studies have demonstrated O-acetylserine sulfhydrylase and cysteine
desulfurization activity by CysK (Bogicevic et al., 2011), as well as cystathione lyase
activity of ctl leading to the production of VSCs (Bogicevic et al., 2013). From
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heterologous expression of these enzymes (Alting et al., 1995; Aubel et al., 2002;
Bogicevic et al., 2011; Bruinenberg et al., 1997) it is clear that they function in VSC
production, but the knockout of cystathionine lyases does not lead to a complete loss of
activity (Lee et al., 2007). Thus, we sought to identify novel pathways implicated in VSC
production.
Our studies were primarily focused on screening a collection of sequenced L. rhamnosus
and L. paracasei strains for tolerance to mercury and the results initially suggested that
precipitation of mercury by hydrogen sulfide could be a potential mechanism of metal
tolerance and remediation. This led us to further study the impact of the cysK-ctl-cysE
operon in VSC production as it was found to be transcriptionally up-regulated by
exposure to sublethal concentrations of mercury (data not shown). Given the sheer
number of strains under study, a high-throughput, rapid, and economical method of
screening for VSC production was required for which we adapted the method of Lee and
Simard ( 1984). Briefly, when H2S/VSCs are produced by lactobacilli grown in agar
stabs, a black/brown PbS precipitate is formed.
The primary goal was to determine if under the assayed conditions, the presence of the
cysK-ctl-cysE operon was sufficient for H2S/VSC production.

3.2
3.2.1

Materials and Methods
Strains and genomes

A collection of 75 strains of L. paracasei and L. rhamnosus was obtained from the
Danone strain collection (Danone Nutricia Research, Palaiseau, France). All strains were
maintained on MRS agar medium (Becton Dickson and Company, Mississauga, Canada)
and incubated at 37˚C under anaerobic conditions. Lactobacillus plantarum ATCC 14917
was obtained from the ATCC as positive control as it had previously been shown to
produce H2S/VSCs under the assayed conditions. These strains have already been
sequenced by 454 GS FLX (Smokvina et al., 2013). Briefly, the predicted protein coding
sequences were determined by consensus of Genemark (Borodovsky et al., 2002),
Glimmer, ZCurve (Guo, 2003), and Prodigal (Hyatt et al., 2010). Using OrthoMCL (Li,
2003) a presence/absence matrix was created for all potential strains.
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3.2.2

Determination of H2S/VSC production

The modified lead acetate agar media was adapted from that reported by Lee and Simard
(Lee and Simard, 1984). The media contained: 5.0 g/L proteose peptone, 15.0 g/L
peptone #3, 1.0 g/L dextrose, 80 mg/L sodium thiosulfate, 200 mg/L lead acetate, 0.1%
v/v tween 80, 0.005% w/v MnSO4.4H2O, and 15 g/L agar. For phenotyping the strains,
the medium was placed in 5 mL tubes, stab inoculated and incubated for 72h at 37˚C in
anaerobic conditions to observe blackening of the media caused by the precipitation of
PbS.

3.2.3

Genomic analysis

To identify the presence or absence of the cysK-ctl-cysE pathway, a BlastP (version
2.2.28+) was carried out to identify the corresponding gene orthologs in the
presence/absence matrix using the predicted protein sequences previously identified in L.
casei FAM18149 (Genbank accessions JF272516, EU340836 and JF272515
respectively). Statistical testing of the association of gene orthologs groups with
production of VSCs/ H2S was carried out by Fisher’s exact test.
To further study genes implicated in the production of VSCs/ H2S, matrices of gene
presence/absence and phenotype were inputted into the random forest algorithm approach
implemented in Phenolink (Bayjanov et al., 2012) with default settings. GC Skew was
visualized with Artemis 14.0.0 and IVOM analysis was carried out with Alien hunter 1.7
(Vernikos and Parkhill, 2006). To create a pan-genome tree, the strains were clustered
based on gene presence/absence using the dist (binary method) and hclust (UPGMA)
functions of R (r-project.org).

3.3

Results and Discussion

It was determined, with positive control L. plantarum ATCC 14917, that 24h incubation
was insufficient to observe H2S/VSC production, but after 72h production could be
observed. Incubation for 72h gave rise to three distinct phenotypes (Figure 3-1): strong
H2S/VSC producers (positive reaction after 24h, complete blackening of media after
72h), weak H2S/VSC producers including L. plantarum ATCC 14917 (positive reaction
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after 72h) and non H2S/VSC producers (no positive reaction after 72h). H2S/VSC
production was robustly assayed in all 75 strains in three independent assays revealing
non-producers (n=45), weak producers (n=12) and strong producers (n=12) with few
strains providing ambiguous results (n=6).
Little correlation was observed between H2S/VSC production and the presence of cysKctl-cysE (Table 3-1, p=0.49, Fischer’s exact) so gene-trait matching was carried out using
a random forest algorithm approach which revealed 7 genes with the highest importance
score (Figure 3-2). Upon closer inspection the cluster was revealed at the same
chromosomal loci in each strain including L. casei Zhang (GenBank CP001084;
159190..166381). This cluster was robustly associated with strong H2S/VSC production
(p=1.8e-11, Table 3-1). The gene cluster’s organization and manually curated annotations
are shown in Fig 3-3A while the heatmap in Fig 3-3B demonstrates its association with
VSC production. The predicted functions of these genes involve the import and
metabolism of sulfur and taurine. Many of the weak producers lack the downstream
hypothetical protein of unknown function. There is a difference of 5.7% in GC content
between in the gene cluster as compared to the remainder of the genome suggesting
horizontal gene transfer (40.8% and 46.5% respectively). Additionally, application of
interpolated variable order motif analysis provides evidence of horizontal gene
acquisition.
To study the distribution of the gene cluster across L. rhamnosus and L. paracasei, a pangenomic tree was created showing two major branches separating the L. rhamnosus
strains (Lr) and L. paracasei strains (Lpp and Lpt). Strains containing at least 6/7 of the
genes were indicated demonstrating that the gene cluster is uniformly distributed over
both lineages independent of strain or internal node. Frequently, even in two strains with
similar gene composition will be divergent in their possession of the cluster (ex. L.
rhamnosus Lr52 and L. rhamnosus Lr35). Of note, the cluster was present in a mix of
strains isolated from dairy, human/animal and plant environments.
The strength of this study compared to other gene-trait matching studies, is in the large
number of strains and genomes. This allowed us to confidently examine the relevance of
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the cysK-ctl-cysE operon and discover potential new pathways. Clear evidence of a novel
gene cluster involved in VSC production has been provided but the intention is not to
claim that cysK-ctl-cysE is irrelevant to VSC production, rather to provide evidence of an
additional pathway. It is conceded that there are superior methods for determining VSC
production, such as GC-MS, but our assay provided clear phenotypic traits allowing us to
demonstrate that cysK-ctl-cysE is not the only pathway for H2S production present in L.
paracasei and L. rhamnosus.
The functions of the genes are putative and remain to be validated but the presence of
domains relating to sulfur transport and metabolism offers interesting insights into
potential mechanisms of action. The putative tauB and tauC genes are notable
considering that taurine is a sulfur containing amino acid and high levels of taurine are
found in many dairy products (Manzi and Pizzoferrato, 2013). In addition, taurine
metabolism is related to methionine and cysteine metabolism. The putative pyridine
nucleotide-disulfide oxidoreductase may be part of the H2S-forming pathway, perhaps
together with the hypothetical protein.
In summary, we identified a novel gene cluster involved in the formation of VSCs which
has been previously unreported in Lactobacillus spp. Future studies are warranted to
determine the function of these proteins in situ, in particular how they affect flavors in
cheese.
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Figure 3-1. VSC production phenotypes observed after 72 h incubation at 37˚C.
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Table 3-1. Co-occurrence of the cysK-ctl-cysE operon and newly identified sulfur
transport/utilization cluster with VSC production.

H2S/VSC Production
Strong
Weak
Negative

Presence/absence of all 7 identified gene orthologs
OG_3429
OG_2927
OG_2928
OG_2929
OG_2915
OG_2687
OG_2800
OG_2891
OG_2569
OG_2520
OG_2307
OG_2570
OG_2344
OG_3045
OG_2965
OG_2324
OG_2751
OG_3224
OG_3085
OG_2892
OG_3246
OG_2880
OG_2332
OG_2917
OG_3357

1

5

Rank

10

15

20

0.08

0.06

0.04

0.02

0.00

25

0.10

1

Sulfur Transport
Cluster1
Present
Absent
12
0
2
10
1
44

cysK-ctl-cysE
Present
Absent
2
10
4
8
13
32

RF Importance

Figure 3-2. Results of gene trait matching demonstrate 7 gene orthologs with
increased importance as identified by a random forest algorithm based approach.

Absent

Present

OG Presence

Ortholog
OG_3429
OG_2927
OG_2928
OG_2687
OG_2915
OG_2929
OG_2800

B.
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No Production
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OG2915
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Weak Production

OG2927

Strong Production

Hypothetical Protein

Taurine ABC Transporter ATP-binding Protein (tauB )

Sulfonate ABC Transporter Subtrate-binding Protein

Taurine ABC Transporter Permease ( tauC )

FAD-dependent pyridine nucleotide-disulfide oxidoreductase

Putative Sulfur Transport Membrane Protein

LysR-family Transcrtional Regulator

CNCM I-1518
Lpp7
Lpp14
Lpp22
Lpp37
Lpp41
Lpp48
Lpp49
Lpp57
Lpp70
Lpp120
CNCM I-3689
Lpp122
Lpp125
Lpp126
Lpp189
Lpp223
Lpp225
Lpp226
Lpp228
Lpp229
Lpp230
CNCM I-3690
Lr23
CNCM I-2493
Lr37
CNCM I-4316
CNCM I-4317
Lr53
Lr60
CNCM I-2493
Lr64
Lr73
Lr91
Lr95
Lr110
Lr111
Lr133
Lr134
Lr136
Lr138
Lr140
Lr141
Lpt7
Lpp43
CNCM I-2877
Lr35
Lr40
Lr71
Lr75
Lr79
Lr82
Lr90
Lr137
Lr139
CNCM I-4648
Lpp46
Lpp123
CNCM I-4649
Lpp219
Lpp221
Lpp227
Lpp251
Lr9
Lr28
Lr32
Lr108

A.
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Figure 3-3. Identification of 7-gene locus in L. rhamnosus Lr9 and L. casei Zhang

(A) and its co-occurrence with VSC production represented in heat map form (B).

0.0

Lpp230
Lpp229
Lpp37
Lpp125
Lpp49
Lpp228
Lpp189
CNCM I-2877
Lpp251

Lpp74
Lpp219

Lpp221
Lpp43

Lpp126
Lpp48
Lpp71
Lpp14
Lpp70
Lpp7
CNCM I-4648
Lpp227
Lpp123
CNCM I-4270
CNCM I-4649
Lpp122

Lr138

Lpt14
Lpt7

Lpp22
Lpp120
CNCM I-3689

Lpp46
Lpp225

Lpp57
Lpp223
CNCM I-1518
Lpp206

Lpp226

Lr92
Lr23

Lr136

Lr91

Lr32
Lr28

Lr37
Lr133
Lr53
Lr95
Lr73

Lr60
CNCM I-4271

Lr141
Lr52
Lr35

Lr74
Lr64

CNCM I-3690
Lr110

CNCM I-2493
Lr9
Lr108
Lr75

Lr139
Lr137

CNCM I-4317

Lr90
Lr82

Lr79

Lr71

Lr40

Lr134

CNCM I-4316
Lr111

Lr140

Lpp41

70

0.1

Figure 3-4. Pan-genome tree of strains studied with strains possessing at least 6/7 of
the identified gene orthologs indicated in red.
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4
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4.1

Introduction

The vaginal microbiota is a dynamic ecosystem that is usually mono dominated by the
Lactobacillus genus in times of health but it can transform quickly to a dysbiotic state
where a range of microorganisms rise in prominence and cause the polymicrobial
bacterial vaginosis (BV) (Ma et al., 2012). The pre-menopausal vaginal microbiota and
its constituents have been extensively studied using genome sequencing, 16S rRNA
community profiling and RNA-seq based meta-transcriptomics (Macklaim et al., 2011;
Ravel et al., 2011; Hummelen et al., 2010b; Macklaim et al., 2013). However, until
recently, few studies have used similar in-depth methods to decipher the vaginal
microbiome of post-menopausal women, despite its impact on quality of life (Santoro and
Komi, 2009; Nappi and Lachowsky, 2009). In previous studies, we have shown using
high-throughput sequencing methods that contrary to conventional knowledge (Cauci et
al., 2002), the vaginal microbiome of post-menopausal women is not significantly
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different from that of pre-menopausal women (Hummelen et al., 2011). Our study
showed that the post-menopausal vagina appeared to have greater stability than the
rapidly fluctuating pre-menopausal microbiome (Hummelen et al., 2011; Gajer et al.,
2012) presumably due to a lack of hormone cycling. We found that similar to
premenopausal women, the healthy post-menopausal vaginal microbiome is dominated
by a combination of Lactobacillus iners and L. crispatus while BV-associated organisms
such as Gardnerella vaginalis and Atopobium vaginae are increased in states of dysbiosis
(Hummelen et al., 2011; Burton and Reid, 2002; Burton et al., 2003). Despite some
deficiencies, Nugent scoring is still the standard technique in most research and clinical
settings to rapidly diagnose bacterial vaginosis (Nugent et al., 1991). The score is
calculated by microscopic examination of a Gram-stained vaginal smear and numeration
of cell morphotypes to assign a score from 0 to 10 where 0-3 is considered normal, 4-6 is
intermediate and 7-10 is BV (Nugent et al., 1991). The intermediate scores are
particularly interesting as they indicate a risk of transition to BV, or they could be a state
that reverts to a healthy lactobacilli dominated microbiota.
Given vaginal contact with sanitary products by menstruating women and the large
proportion of postmenopausal women whom suffer urinary incontinence requiring
products such as incontinence pads, also in proximity to the vagina, these products may
offer a vehicle to deliver a prophylactic probiotic to women that routinely suffer BV or
urinary tract infections. We were interested to determine whether the microbiota and
Nugent scores were altered by the administration of probiotics with the potential view of
perhaps instilling these organisms in such products. Lactobacillus rhamnosus GR-1 and
Lactobacillus reuteri RC-14 used in this prospective study are well-characterized
probiotic strains used in combination to prevent and treat BV (Anukam et al., 2006; Reid
et al., 2003; Martinez et al., 2009; Hummelen et al., 2010a). In addition to clinical and
Nugent scoring, 16S rRNA sequencing was used to examine changes in the microbiota,
GC-MS profiled metabolome changes, the host transcriptional responses were tested
using an Affymetrix microarray and inflammatory mediators by multiplex cytokine
analysis. This approach was designed to provide a holistic understanding of the probioticmicrobiota-host interactome (Bisanz and Reid, 2011).

76

4.2
4.2.1

Results
Participant recruitment and demographics

A total of 22 subjects were screened and 14 participants were enrolled into a 129-day
prospective double-blind, cross-over placebo controlled study (design in Figure S1). A
CONSORT flow diagram is displayed in Figure 4-1.

Figure 4-1. CONSORT flow diagram.
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4.2.2

Clinical outcomes

Nugent score and vaginal pH measurements (data not shown) were taken before and after
treatment with the probiotic and placebo. Table 4-1 shows there were no statistically
significant improvement in Nugent scores between the treatment groups. Furthermore no
statistical differences were observed in vaginal pH measurement.
Table 4-1. Summary of Nugent score change - Proportion of improvement from
baseline
Placebo

One-Day after last Test Article Use

Eight-Days after last Test Article

Probiotics:

Probiotics:

Improved1

Not Improved

p-value2

Improved

0

2(20%)

0.1573

Not Improved

0

8(80%)

Improved

0

2(20%)

Not Improved

1(10%)

7(70%)

0.5637

Use

1

Improvement in Nugent Score: indicated by shift of intermediate score (4-6) at baseline to normal score (0-3) at

follow-up visits. Baseline Nugent score for study Phase-I was collected at visit 3, and baseline Nugent score for study
Phase-II was collected at visit 6.
2

p-value is based on McNemars test to determine results of cross-over treatment regimen.

4.2.3

Microbiome profiling

Sequences were successfully obtained for 104 of 106 samples with the mean number of
reads being 33,396 (range 1,475 to 223,629) across 3 separate 316 Ion Torrent
Sequencing Chips. A total of 221 Operational Taxonomic Units (OTUs) were defined
with clustering at 97% identity (Table S1) at a minimum abundance of 1% in any one
sample. A no template control was also sequenced and high-abundance contaminating
sequences were filtered out in silico before OTU assignment.
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Figure 4-2 shows a heat map of the 50 most abundant OTUs across all samples and time
points. We were able to identify 2 OTUs which were assigned presumptive strain
designations to L. rhamnosus GR-1 and L. reuteri RC-14 (OTU_12 and OTU_23
respectively) based upon 100% ID matches to the 16S rRNA gene of private genome
assemblies of these strains. A separate heat map was created showing only the abundance
of these two OTUs compared to all other OTUs detected (Figure S2). Furthermore with
one notable exception (participant 19), these strains only appeared in combination
following the probiotic treatment period. In the case of participant 19 however, the
proportion of reads is still quite low (2.1% and 0.1%) for both OTUs. The L. rhamnosus
GR-1 is far more abundant than the L. reuteri which may suggest it was a L. casei group
member other than the GR-1 used in the study as this group has high sequence homology,
especially in the V6 16S rRNA region (Vasquez et al., 2005). In one individual
(participant 09) both probiotic strains were detected even though only placebo should
have been received. The probiotic strains could be unambiguously detected after
probiotic treatment in 7 of 12 cases (04, 10, 15, 16, 17, 18, 21), which we termed
responders. While in the non-responders (12, 14, 19, 05 and 07) the probiotic strains were
not detected after the probiotic treatment. The abundance of L. rhamnosus GR-1 did
appear to increase over the study period in participant 12, which may suggest temporary
persistence or colonization. In all other cases, the probiotics were only detected in high
abundance immediately after the treatment suggesting that the washout period chosen for
the study was appropriate.
Samples were clustered based upon unweighted pair group method with arithmetic mean
(UPGMA) using weighted UniFrac distance metrics (Lozupone and Knight, 2005)
showing that participants were generally most similar to themselves over the study period
and as we had previously shown, the post menopausal vaginal microbiome is more stable
than that of pre menopausal women (Figure 4-3).
All samples were plotted on a PCoA using weighted Unifrac distances and overlaid with
the contributions of the 20 most abundant genera (Figure S3). This shows 3 weak
groupings, one dominated by Lactobacillus, another defined by Atopobium and
Gardnerella, and a third defined by a large number of diverse genera.
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Data were summarized to genus level and the relative abundance of Lactobacillus was
considered. Increase in total Lactobacillus is significant (Figure 4-4; FDR<0.05)
following probiotic administration though there is no significant difference in Shannon’s
diversity index (p=0.25, Wilcoxon signed-rank test). After probiotic administration, the
proportion of total lactobacilli increased in all participants except participant 19 who
appears to have had an indigenous L. casei/rhamnosus present. Even those without
significant detection of the probiotic lactobacilli have an increase in indigenous
lactobacilli (fold increases for the ambiguous participants are 1.27, 1.21, 2.35, 14.43 and
52.43). Additionally, in some cases, such as participant 17 (Figure 4-5), it is not only the
probiotics that increased in proportional abundance, but also indigenous lactobacillus
such as L. gasseri/johnsonii, (p=0.011 across all samples) which is not significant in the
placebo group if the case of participant 09 is excluded (where probiotic appears to have
been received rather than placebo). In the 7 individuals where the probiotics could be
easily detected, the average fold increase was 120 fold (range 3.2 to 389). Significant
decreases in the proportion of Atopobium were also observed after probiotic treatment
with a trend of reduction of Gardnerella and Prevotella. Interestingly the placebo appears
to have increased the proportion of Streptococcus (FDR<0.01) while both applications
appear to have increased levels of Staphylococcus.
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Figure 4-2. Microbiota heat map.
Each	
  column	
  represents	
  the	
  microbiota	
  of	
  a	
  single	
  sample	
  with	
  the	
  50	
  most	
  abundant	
  OTUs	
  
displayed	
  with	
  their	
  taxonomies	
  and	
  the	
  remainder	
  pooled.	
  Samples	
  are	
  clustered	
  by	
  the	
  
participant	
  of	
  origin	
  and	
  organized	
  from	
  first	
  to	
  last	
  visit	
  from	
  left	
  to	
  right.	
  The	
  time	
  points	
  
immediately	
  following	
  administration	
  of	
  the	
  placebo	
  or	
  probiotic	
  are	
  indicated	
  with	
  a	
  blue	
  or	
  
green	
  arrow	
  (respectively).	
  OTUs	
  representing	
  the	
  putative	
  OTUs	
  for	
  L.	
  rhamnosus	
  GR-‐1	
  and	
  L.	
  
reuteri	
  RC-‐14	
  have	
  been	
  bolded.	
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Figure 4-3. UPGMA clustering of all participants microbiota based upon weighted
UniFrac distances.
In	
  general,	
  participants	
  cluster	
  most	
  closely	
  with	
  themselves.	
  Tree	
  tips	
  (samples)	
  are	
  colored	
  by	
  
the	
  participant	
  of	
  origin.	
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Figure 4-4. Selected genus relative abundances following probiotic and placebo
interventions.
(A)	
  Lactobacillus,	
  (B)	
  Gardnerella,	
  (C)	
  Atopobium,	
  (D)	
  Prevotella,	
  (E)	
  Streptococcus,	
  (F)	
  
Staphylococcus.	
  Following	
  probiotic	
  administration	
  for	
  3	
  days,	
  the	
  proportion	
  of	
  Lactobacillus	
  is	
  
significantly	
  increased	
  while	
  that	
  of	
  Atopobium	
  is	
  decreased	
  and	
  Staphylococcus	
  is	
  increased.	
  
Placebo	
  interventions	
  increased	
  Streptococcus	
  and	
  Staphylococcus	
  abundance.	
  	
  
*FDR<0.1,	
  **FDR<0.05,	
  ***FDR<0.01	
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Figure 4-5. Time series of participant 17.
During	
  the	
  administration	
  of	
  probiotic	
  between	
  visits	
  6	
  and	
  7,	
  the	
  abundance	
  of	
  lactobacilli	
  
significantly	
  increases,	
  decreasing	
  the	
  proportional	
  abundance	
  of	
  both	
  Atopobium	
  and	
  
Gardnerella.	
  This	
  increase	
  is	
  not	
  due	
  solely	
  to	
  the	
  probiotic	
  strains	
  as	
  a	
  significant	
  increase	
  in	
  
indigenous	
  L.	
  gasseri/johnsonii	
  takes	
  place.	
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4.2.4

Metabolome

Using GC-MS, 68 metabolites were detected and a heat map is displayed in Figure S4.
The Pearson’s correlation coefficient between lactate and lactate producing bacteria was
0.47 (p<0.001), indicating a weak positive correlation (Figure S5). Among those who
responded to probiotic intervention and had sufficient material for metabolomics analysis
(n=4), there was an increase in lactate levels (p = 0.13), whereas there tended to be a
decrease with placebo (p = 0.23). There was no difference in the overall metabolome of
all subjects after probiotic or placebo intervention (Figures S6A and S6B respectfully),
nor was there a significant difference in any one metabolite. It is worth noting that low
yields of metabolites were obtained from some of the collected swabs so lower
abundance analytes may not be detectable.

4.2.5

Cytokine/chemokine analysis

Interleukin 5 (IL-5) was found to be significantly up-regulated following probiotic
treatment but not following placebo treatment. In other cytokines such as IL-1B, IL-6,
TNFa and GM-CSF there were weak positive trends in increase of cytokine levels,
however this was also observed in the placebo in some cases (Figure S7).

4.2.6

Microarray

Due to limited yield from RNA samples, only 2 complete sample sets (before and after
intervention from the same individual, 4 arrays) were obtained from the probiotic
intervention and 3 sets from the placebo intervention (6 arrays). Each sample was
analyzed on its own Affymetrix Human Gene 2.0 ST array. Using a paired t-test design to
account for paired-samples before and after probiotic administration, 90 probe sets were
detected as being differentially expressed (≥2 fold change, p<0.05) of which 57 were
coding genes or long non-coding RNA (a new feature of the Affymetrix 2.0 ST array)
(Table S2A). Two of these were differentially regulated in both conditions (gene list
differentially regulated by placebo is displayed in Table S2B), ANKRD20A5P
psuedogene (ID cluster 16851230) and a long non-coding RNA (ID cluster 16851230)
with no known biological significance.
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Many genes of interest were differentially expressed by probiotic treatment including
Interleukin 18 (IL18; -2.5 fold after probiotic), CR1-complement receptor (CR1; 10.4
fold), Caspase 14 (CASP14; 5.3 fold, previously observed to function in epithelial
development and barrier function (Denecker et al., 2008)) and Toll like receptor 2
(TLR2; 3.84 fold) (Table S2A). To look at functional consequences, GO enrichment was
applied showing the most highly affected functions to be pattern recognition receptor
activity, complement receptor activity, inflammatory response and gram-positive
bacterial cell surface binding (Table 4-2). This was mirrored in the Ingenuity Pathway
Analysis (Figure S8). In comparison, the placebo appears to have acted on functions
related to epithelial cell differentiation, similar to our previous study (Hummelen et al.,
2011).
Table 4-2. Gene Ontology Enrichment in genes differentially expressed by probiotic
intervention.
Genes	
  differentially	
  expressed	
  (≥2-‐fold	
  change,	
  p<0.05)	
  were	
  subjected	
  to	
  GO	
  enrichment	
  
analysis.	
  Functions	
  heavily	
  relate	
  to	
  innate	
  immune	
  system	
  responses	
  including	
  responses	
  to	
  
both	
  Gram-‐positive	
  and	
  Gram-‐negative	
  bacteria.	
  
Enrichment
Score

Enrichment
p-value

# genes in list

% genes in group

GO ID

12.82

2.71E-06

3

18.75

8329

Complement Receptor Activity

10.9319

1.79E-05

2

50

4875

Inflammatory Response

10.4433

2.91E-05

6

1.70455

6954

Gram-positive Bacterial Cell Surface Binding

10.4222

2.98E-05

2

40

51637

LPS Receptor Activity

10.4222

2.98E-05

2

40

1875

Defense Response

9.64889

6.45E-05

9

0.840336

6952

Regulation of GM-CSF Production

8.92362

1.33E-04

2

20

32645

Positive Regulation of Response to External Stimulus

8.83166

1.46E-04

4

2.5974

32103

Response to Wounding

8.61585

1.81E-04

6

1.22449

9611

Positive Regulation of Inflammatory Response

8.25985

2.59E-04

3

4.22535

50729

Function
Pattern Recognition Receptor Activity
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4.3

Discussion

In this study, we aimed to evaluate the effect of 3 days of vaginal administration of L.
rhamnosus GR-1 and L. reuteri RC-14 on the Nugent score of post-menopausal women
as well as effects on the microbiota, metabolome and host. As the subjects under study
had no symptoms of disease, not unexpectedly, the probiotic prophylaxis did not cause
any clinical changes. There were no adverse effects of the probiotic therapy. The
probiotic administration resulted in a temporary increase in the relative proportion of
Lactobacillus in the vagina, which for women whose intermediate score tends to be a
predecessor for BV, may help prevent or delay this transition. The near absence of L.
crispatus (OTU_198), detected in only 1 of 15 women above a 1% threshold and
throughout the study at maximum 1.4%, may indicate that the subjects were at a higher
risk of BV, since L. crispatus is thought to play a protective role in maintaining the
vaginal microbiota (Verstraelen et al., 2009).
The increase in lactobacilli and potential decreases in BV-associated organisms such as
Atopobium following probiotics could have been due to displacement of the host’s
microbes with the total bacterial load remaining the same; or the total bacterial load
increased as a result of adding in exogenous lactobacilli. The observation that Shannon’s
diversity is not affected by probiotic instillation favors the second option. It is interesting
to note the increased relative abundance of Staphylococcus as a result of placebo
treatment, which may be the result of the antimicrobial actions of titanium dioxide used
in the preparation. It is important to note that the probiotics may create an environment
conducive to indigenous lactobacilli such as L. gasseri and L. johnsonii, however this
effect may be short lived. A longer treatment time and follow-up might have determined
if there was an effect on diversity, but we were interested in whether a short term
probiotic application that women might find easy to administer monthly, could increase
the lactobacilli count.
In some individuals it was extremely clear when the probiotic strains had been applied.
The reason for this not being universal is unclear, but could be due to a particularly
resilient indigenous microbiota or women who were non-responders for unexplained
reasons (Reid et al., 2010).
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We identified a positive correlation between lactate abundance and percentage of lactate
producers present r=0.43 (p=9.6x10-6). Although this correlation seems intuitive, to our
knowledge it has never been directly shown. Only the relative abundance of bacterial taxa
are measured, and therefore absolute changes affected lactate levels cannot be directly
observed. Certain species of Lactobacillus have been associated with lower pH and may
produce more lactate compared to others (Ravel et al., 2011). There was a trend towards
an increase in lactate after probiotic and decrease after placebo intervention, but as there
were only four women whom responded to treatment and from whose samples enough
material for metabolite analysis could be extracted, the sample size is likely too small to
reach significance. Still, the observation that probiotics could potentially increase lactate
levels is promising as lactate has been shown to have many beneficial properties in the
vaginal tract such as HIV inactivation (Aldunate 2013).
Overall, the administration of the two lactobacilli strains did not induce any more
changes than placebo in the metabolome, but lack of material makes this result
inconclusive. In our experience and that of others, the metabolomic patterns differ
between health and BV, with the latter showing odorous compounds such as cadaverine
and putrescine, but these trends were not clearly observed in this study (Yeoman et al.,
2013).
In addition to looking at the bacterial communities, we sought to examine host responses
to probiotic treatment. It has been well established that probiotic strains can affect host
transcription in the gut in a strain specific manor (van Baarlen et al., 2011) but this is the
first time similar studies have been carried out in the vagina. Our findings show that L.
rhamnosus GR-1 and L. reuteri RC-14 had an immunomodulatory effect working on
important central inflammatory mediators complement receptor 1, toll like receptor 2 and
IL-18. Though limited in the number of subjects available for analysis, the strength of
this analysis is the use a paired study design. Interleukin 18 is a proinflammatory
cytokine inducing cell-mediated immunity via interferon gamma though it also has
effects on B cells and IgE production (Biet et al., 2002). In the female reproductive tract
it may be of relevance in preterm birth (Jacobsson et al., 2003) indicating microbial
invasion of the amnion, but it also has protective roles against genital herpes simplex 2
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(Harandi et al., 2001). The effect of probiotic treatment on IL-18 expression may not be a
direct interaction, but rather indicative of anti-viral actions of the probiotics resulting
which has previously been hypothesized and shown in vitro (Aldunate et al., 2013;
Bolton et al., 2008). Alternatively it may reflect a general up-regulation of the innate
immune system by the probiotic strains. Unfortunately, our cytokine/chemokine panel did
not cover IL-18 to help support this finding. Alternatively the up-regulation, of
complement receptors 1 and 3a, as well as TLR2 both are indicative of increased antibacterial innate immune system activity. TLR2 specifically is involved in detection of
Gram-positive surface markers (including lactobacilli) (Schwandner et al., 1999) while
the complement receptors are important for phagocytosis and inflammatory cascades in
response to bacterial infections (Zipfel and Skerka, 2009). L. plantarum has previously
been shown to modulate TLR2 expression which may play a role in modifying infection
response (Rizzo et al., 2013). In addition, our cytokine/chemokine multiplex results may
indicate the up-regulation of interleukin 5 which is most commonly associated with
eosinophil activation (Molfino et al., 2012). Though commonly associated with parasites,
eosinophils have also been associated with Actinomyces-like organisms in the urogenital
tract and may display some activity against bacterial infection (Kaya et al., 2012). These
seemingly pro-inflammatory responses may be beneficial in aiding the host immune
system to help clear BV-associated pathogens to restore a more normal microbiota of
symbionts. Microarray analysis failed to corroborate the finding that interleukin 5 was
up-regulated, however the two individuals surveyed by microarray did not show upregulation by cytokine analysis either. If all participants could have been surveyed this
result may have been different.
Interestingly, caspase 14 plays a role in development and barrier function of the
epidermis (Denecker et al., 2008) and we had previously observed its differential
regulation associated with vaginal dryness and dysbiosis in a subset of post-menopausal
women. Its up-regulation following probiotic treatment may be evidence of improvement
in strength and integrity of the vaginal epithelium, though further research is needed to
verify this claim. Indeed probiotics are thought to positively act on barrier function
(Sultana et al., 2013).

89

In conclusion, this study demonstrated the use of a systems-wide interactomics approach
to examine how probiotic application might modulate the vagina in post-menopausal
women. The short duration therapy increased the lactobacilli, as well as modulating
inflammatory markers. As the transition from healthy to intermediate to BV is such a
common occurrence, women may feel that a three day intravaginal probiotic may be
beneficial. A larger study is needed to support this, but the present study showed no harm
and the potential for such a benefit.

4.4
4.4.1

Methods
Participant recruiting and study design

The protocol for this trial and supporting CONSORT checklist are available as supporting
information; see Checklist S1 and Protocol S1. A total of fourteen post-menopausal
women were enrolled in the study from a clinical site in Ontario, Canada. Inclusion
criteria were individuals with an intermediate Nugent Score (4-6) who were postmenopausal (40 to 80 years old, not having had a menstrual period for the last 12 months,
currently in a mutually monogamous sexual relationship or not sexually active, agreeing
to be abstinent 72 hours prior to each study visit and agreeing to refrain from intercourse
for 48 hours after treatment, agreeing to abstain from use of other intravaginal products
throughout the study and in good general health. Exclusion criteria were use of
intravaginal products within three months prior to visit 1, a history of immunosuppressive
drug therapy, chemotherapy or radiation therapy, a medical condition which might
compromise immune system function (ex. cancer, leucopenia, HIV, organ transplant),
antibiotic and/or antifungal medication within the last 4 weeks, oral probiotic use within
3 months prior to visit 1, significant changes in diet during the course of the study (based
on self report), induced menopause due to surgical/medical intervention (ex.
hysterectomy), currently taking estrogen therapy, a history of drug or alcohol abuse,
known allergy to either of the probiotic strains or product excipients and participation in a
clinical trial involving an investigational product/device within the past three months or
who are scheduled to participate in another clinical study concurrently. No formal sample
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size calculation was carried out and the number of subjects to be randomized was based
on feasibility and practical considerations for an exploratory study. The study was
approved by Health Canada (Clinical Trial Application File No. 180061) and is registered
with clinicaltrials.gov under accession number (NCT02139839).
The study design is diagramed in Figure S1. Briefly, after obtaining written informed
consent, participants were enrolled on day one and subsequently returned for baseline
appointments on days 5 and 15 (visits 2 and 3 respectively). On visit 3, the participants
were randomized to either receive 3 days of L. rhamnosus GR-1/L. reuteri RC-14
probiotic (Chr. Hansen, minimum 2.5x109 CFU of each strain) or visually identical
placebo (49mg Gelatin and 1mg titanium dioxide) self-administered by having the
participant insert the capsule as far as comfortable into their vagina and then lying in a
horizontal position for 15 minutes. Randomization was carried out using a random
number generator. Both study staff and study participants were blinded as to the study
treatment being given. The capsules were to be administered twice a day for 3 days with
the participant returning on the fourth day for sampling. A feminine hygiene pad was
applied for several hours after capsule implantation. There was then a 17 day washout
period with sampling again at day 26. At day 36 participants were again sampled,
individuals who received probiotic in the first treatment period then received placebo and
vice versa. On day 40, participants returned for sampling after the treatment period and
were followed up with on day 47 and again on day 129, only if they had positive culture
results for the presence of the probiotic. At all visits, 5 swabs were collected: (i) Dacron
swab for bacterial DNA extraction, (ii) Dacron swab for multiplex cytokine/chemokine
analysis, (iii) Dacron swab for metabolomics analysis, (iv) a cytobrush (Cytobrush plus
GT, Cooper Surgical Inc. USA) brushed against the vaginal wall and stored in 700 µL
RNAlater for total RNA extraction (Life Technologies), and (v) Dacron swab for Nugent
Score. McNemar’s test was applied to examine changes in Nugent score and other
symptoms.

4.4.2

Microbiome profiling

Vaginal swabs for microbiome analysis were extracted using the QIAamp DNA stool
mini kit (Qiagen). Swabs were vortexed in 1 mL buffer ASL before removal of the swab
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and addition of 0.1mm zirconia/silica beads (Biospec Products) with 2, 30 second rounds
of bead beating at full speed with cooling on ice in between (Mini-BeadBeater; Biospec
Products). Sample amplification for sequencing was carried out using the forward primer
(CCATCTCATCCCTGCGTGTCTCCGACTCAGxxxxxCWACGCGARGAACCTTAC
C) and the reverse primer
(CCTCTCTATGGGCAGTCGGTGATACRACACGAGCTGACGAC) where xxxxx was
a sample specific nucleotide barcode, the 5’ end is the adapter sequence for the Ion
Torrent sequencer and the sequences following the barcode are complementary to the V6
rRNA region. Amplification was carried out in 42 µL with each primer present at a 10µL
(3.2 pMol/µL stock), 20 µL GoTaq hot start colorless master mix (Promega) and 2 µL
extracted DNA. The PCR protocol was as follows: initial activation step at 95˚C for 2
minutes and 25 cycles of 1 minute 95˚C, 1 minute 55˚C and 1 minute 72˚C. PCR
products were quantified with a Qubit 2.0 Flourometer and the high sensitivity dsDNA
specific fluorescent probes (Life Technologies). Samples were mixed at equimolar
concentrations and purified with the QIAquick PCR Purification kit (QIAGEN).
All subsequent work was carried out at the London Regional Genomics Centre (LRGC,
lrgc.ca, London, Ontario, Canada). Briefly, samples were prepared with an Ion OneTouch
System (Life Technologies) and sequenced on an Ion Torrent Personal Genome Machine
sequencer on a 316 chip (Life Technologies).
Resulting Reads were extracted and de-multiplexed using modifications of in-house perl
and unix-shell scripts (Hummelen et al., 2011) with OTUs clustered at 97% identity.
Table S3 displays the nucleotide barcodes and it’s corresponding sample. Reads were
deposited to the Short Read Archive (BioProject ID: PRJNA244441). To control for
background contaminating sequences, a no-template control was also sequenced, and any
individual sequence unit belonging to an OTU present at ≥1% abundance in the NTC was
removed before re-clustering with uclust 3.0.612.
Automated taxonomic assignments carried out by examining best hits from comparison
the Ribosomal Database Project (rdp.cme.msu.edu) and manually curated as before
(Hummelen et al., 2011).
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Alpha and beta-diversity analysis were made using the OSX distribution of QIIME
(MacQIIME 1.70, wernerlab.org/software/macqiime). OTU tables were rarified to 1060
reads for all analysis to control for uneven sampling depth. To avoid inappropriate
statistical inferences made from compositional data, log-ratios, a method previously
described by Aitchison and adapted to microbiome data was used (Aitchison, 1981;
Aitchison and Egozcue, 2005; Faust et al., 2012) with paired t-tests for comparisons of
genus and species level data. The False Discovery Rate (FDR) method was used to
control for multiple testing with a significance threshold of FDR=0.1. All statistical
analysis, unless otherwise indicated, was carried out using R (r-project.org).

4.4.3

Microarray analysis

Vaginal cytobrushes were extracted as previously (Hummelen et al., 2011). Briefly a
vaginal cytobrush was centrifuged at 5000xg for 10 min at 4˚C and the supernatant
discarded. The pellet was then extracted with TRIzol (Life Technologies) following the
manufacturer’s protocol before being DNase treated with Turbo DNA-free kit (Life
Technologies). Sample quantity and quality were determined using a Nanodrop 1000
spectrophotometer (Thermo Fisher Scientific, Waltham, USA) and Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, USA). Samples were prepared for
analysis on the GeneChip Human 2.0 ST array (Affymetrix, Santa Clara, USA) at the
LRGC following standard protocols.
Probe level data was imported into Partek Genomics Suite (Partek, St. Louis, USA) using
the RMA algorithm. Gene expression data was deposited in the Gene Expression
Omnibus Database with the accession number GSE54363.
To study the effects of the probiotic and placebo treatments on host gene expression, and
considering the study design, a paired t-test was used to evaluate gene expression changes
in each individual immediately before and after probiotic/placebo administration. This
yielded two individuals (14 and 16) with arrays immediately preceding and following the
probiotic period treatment and three individuals (01, 14, 05) with arrays surrounding the
placebo treatment period. For other participants, insufficient yield and/or quality resulted
in a lack of paired samples, and they were thus excluded from downstream analysis.
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4.4.4

Sample preparation GC-MS

Samples were collected from the mid-vaginal wall using a Dacron Swab. Vaginal swabs
were pre-cut into 1.5 mL tubes and weighed prior to and after sample collection to
determine the mass of vaginal fluid collected. Samples were stored at -80˚C until
analysis. After thawing, brushes were trimmed and eluted in methanol-water (1:1) in 1.5
mL microcentrifuge tubes. The weight of each sample was divided by the weight of the
lightest sample and this fraction was multiplied by 200 µL to determine the volume of
methanol-water to add to each sample. This corresponded to a volume of 200-382 µL,
depending on the mass of vaginal fluid collected. A blank swab eluted in 200 µL
methanol-water was included as a negative control. All samples were vortexed for 10 s to
extract metabolites, centrifuged for 5 min at 10 000 x g, vortexed again for 10 s after
which time the brushes were removed from tubes. Samples were centrifuged a final time
to pellet cells and 150 µL of the supernatant was transferred to a GC-MS vial. Next, 2.5
µL of 2 mg/mL ribitol was added to each vial as an internal standard. Samples were then
dried to completeness using a SpeedVac. After drying, 100 µL of 2% methoxyamine•HCl
in pyridine (MOX) was added to each for derivatization and incubated at 50˚C for 90 min.
100 µL N-Methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) was then added to each
vial and incubated at 50˚C for 30 min, then transferred to micro inserts before running on
GC-MS (Agilent 7890A GC, 5975 inert MSD with triple axis detector, 30m DB5-MS
column with 10m duraguard column). Samples were analyzed once for untargeted whole
metabolome analysis, and a second time on selective ion monitoring (SIM) mode specific
for lactate using the reference ions 117, 147, 191 and 219. Solvent delay was 10 min and
sample injection volume was 1 uL. All samples were run in random order and one was
run multiple times throughout to ensure machine consistency.

4.4.5

Lactate relative abundance quantification

Chromatograms were deconvoluted in Chemstation (Agilent) and lactate relative
abundance determined by peak area using the auto integration function. Lactate relative
abundance was plotted against the percentage of lactate producers (Lactobacillus,
Bifidobacteria, Atopobium, Streptococcus, Staphylococcus, Weisella) present in each
sample to determine the correlation between lactate levels and lactate producing bacteria.
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The correlation value was determined in R using a Pearson’s correlation. Paired Welch’s
t-tests were used to determine if probiotic or placebo intervention had a significant effect
on lactate levels using a significance threshold of p=0.05.

4.4.6

Whole metabolome analysis

Chromatogram files were converted to ELU format using the AMDIS Mass Spectrometry
software (Stein, 1999). Chromatograms were then aligned and abundance of metabolites
calculated using the Spectconnect software (Styczynski et al., 2007), with the support
threshold set to low. In order to determine changes in the metabolome due to probiotic or
placebo, Principle component analysis (PCA) was conducted in SIMCA (Umetrics) using
the relative abundance matrix (RA) output from Spectconnect. Data were mean centered
and pareto scaled prior to PCA. A Mann- Whitney U test was then used to determine
metabolites that were significantly altered by intervention (p < 0.05).

4.4.7

Cytokine/chemokine measurement

Swabs were resuspended in 200 µL extraction buffer (20 mM Tris-HCl ph7.5, 150 mM
NaCl, 1mM PMSF, 0.05% Tween 20 and 1 uL/mL protease inhibitor cocktail (Roche),
vortexed, incubated overnight at 4˚C, swab removed and then 50 µL more extraction
buffer was added before being stored at -80 ˚C. The resulting samples were thawed on ice
and loaded onto a Milliplex Human High Sensitivity Cytokine/Chemokine Panel (EMD
Millipore, Billerica, Mass, USA) and analyzed for IL-1B, IL-2, IL-4, IL-5, IL-6, IL-7, IL8, IL-10, IL-12p70, IL-13, IFNg, GM-CSF, and TNFa. Results for IL-2, IL-7, IL-8, IL10, IL-13, IFNg were not displayed as they were consistently outside the assay range and
there was limited material for reanalysis. The plate was analyzed using a Bio-Plex 200
System (Bio-Rad Laboratories, CA, USA) with cytokine/chemokine levels being
generated automatically from standard curves using the Bio-Plex Manager software
(v.4.1.1 Bio-Rad). In cases where the analyte was detected, but below the limit of
detection, ½ the LOD was used for analysis. Results were normalized to total protein as
determined with the Qubit Protein Assay Kit and Qubit 2.0 Flourometer (Life
Technologies, CA, USA). Paired t-tests were used to make comparisons.
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The microbiota at multiple body sites during pregnancy
in a rural Tanzanian population and the effects of
Moringa supplemented probiotic yogurt.
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5.1

Introduction

The United Nations estimates that 805 million people are chronically undernourished
throughout the world (FAO, 2014). Malnutrition is an additional challenge for pregnant
women in many developing countries, along with access to medical care, exposure to
malaria and HIV, and financial burden. Limited food accessibility, access to food with
poor nutritional value, and cultural traditions result in deficiencies in essential nutrients.
Micronutrients are dietary components, often referred to as vitamins and minerals. Iron,
iodine, vitamin A, folate and zinc are recommended during pregnancy (CDC, 2014),
although unfortunately not all women are recipients. In many developing countries,
including Tanzania, maternal and newborn death and morbidity are major issues, often
propagated by malnourishment (UNICEF, 2013; Tanzania National Bureau of Statistics,
2011). Efforts to reduce infant mortality by supplementation with vitamin A have failed
(Masanja et al., 2014). Fermented foods, including dairy products, have long been part of
tradition in many parts of the African continent. In Tanzania (Franz et al., 2014), while
milk consumption is high (per capita milk consumption of 39 kg/annum), commercial
yogurt is not affordable to many, and no health-promoting probiotic yogurt is sold in
traditional retail outlets. The establishment of community kitchens in Mwanza in 2004
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(Reid et al., 2013) has provided affordable probiotic yogurt to around 4,000 people each
day, with some measurable benefits to immunity and gut health (Irvine et al., 2010;
Hummelen et al., 2011).
There is a clear link between the gut microbiota and nutrient uptake (Hullar and Lampe,
2012), and while the gut microbiota has been reported to be relatively stable in nonpregnant healthy individuals (Roager et al., 2014), changes have been reported in
pregnant American and European women, where Firmicutes, along with Bacteroides
dominate. However, during the first and third trimesters, Proteobacteria and
Actinobacteria increase while richness decreases (Collado et al., 2008; Koren et al.,
2012; Jost et al., 2014). Given the role of diet on shaping the microbiota (De Filippo et
al., 2010; Cotillard et al., 2013) and the potential additional nutritional stresses within
impoverished African rural settings, we sought to assess the gut microbiotas of Tanzanian
pregnant women. Also, since vaginal and oral microbiomes are suspected to influence
pregnancy outcomes (Mysorekar and Cao, 2014), and longitudinal studies seldom have
included sampling after birth, we aimed to better characterize these microbiotas
longitudinally.
Few studies have been undertaken on the human milk microbiota of African women,
even though the transfer of these organisms to infants is critical to development,
immunity, risk of disease later in life and cognitive function (Gruszfeld and Socha, 2013)
In a Mozambique study, human milk was found to contain mostly lactic acid bacteria, but
proportions were altered by HIV infection (Gonzalez et al., 2013).
The probiotic Lactobacillus rhamnosus GR-1 was selected for use as an intervention in
this study as it has a safe history of use (Irvine et al., 2010; Hummelen et al., 2011;
Martinez et al., 2009) and was already produced in Mwanza, Tanzania as part of the
Western Heads East network of microenterprise community-run kitchens (Wenner,
2009). For the purposes of the present study, the yogurt was further supplemented with
dried ground Moringa oleifera (Moringa), a readily available plant, rich in vitamin A,
proteins, carbohydrate, fibre, minerals, calcium, magnesium, phosphorus, potassium,
copper, iron, zinc, and manganese (van Tienen et al., 2011) and used commonly in
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management of malnutrition (Thurber and Fahey, 2009). An open label study was
conducted to test a Moringa-supplemented probiotic yogurt, and to determine if it altered
the oral, vaginal, gut or breast milk microbiotas, and had an impact on gestation and
health parameters in newborns.

5.2
5.2.1

Materials and Methods
Study design and participants

The study protocol was approved and received ethical clearance from both the Medical
Research Coordinating Committee of the National Institute for Medical Research
(Mwanza, Tanzania) as well as from the Health Sciences Research Ethics Board at
Western University (London, Canada). The study was registered with clinicaltrials.gov
(NCT02021799). Participants provided written consent, and in the case where they could
not write, a thumbprint was obtained before sample collection and subsequent analysis.
Women who were attending the antenatal clinic at Nyerere Dispensary in Buswelu,
district of Ilemela, Mwanza Region, Tanzania, were recruited into the study if they were
between the ages of 18 and 40 as well as between the gestational ages of 12 and 24
weeks. Gestational age was determined by last menstrual period as identified in the
participant’s clinic records. To confirm, or if last menstrual period was unavailable,
approximation of gestational age was based upon measurement of fundal height.
Originally, participants were further grouped into states of nutritional status (nourished or
under-nourished) based upon having a mid-upper arm circumference (MUAC) less than
235 mm if undernourished, and deviations from expected weight for gestational age
(Gueri et al., 1982). As this was a pilot study, sample size was based on participant
availability.

5.2.2

Probiotic yogurt

Subjects were randomly assigned (using a random number generator) to the intervention
group (produced fresh daily yogurt containing ~1x1010 CFU Lactobacillus rhamnosus
GR-1 per 250 g unit confirmed by regular quality control tests, and 4.3 g of dried ground
Moringa oleifera leaves), or control group (no intervention). Administration of the yogurt
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amounted to 13% required daily intake of protein (9.95 g), 39% calcium (385 mg), 35%
vitamin A (269 RAE), 81% vitamin B2 (1.1 mg) and 4% iron (1.2 mg). The probiotic
group received the 250 g yogurt six days a week from the time of recruitment until
exiting the study, which occurred one week to one month postpartum. Due to a lack of
cold storage available to most participants, yogurt was delivered daily by a study
employee who observed and recorded compliance. Participants in the probiotic group
consumed yogurt for an average of 88 days ± 31 SD, while the control group had no form
of intervention.

5.2.3

Assessment and sample collection

At the initial and monthly follow up visits from recruitment until birth, which occurred
between August 2012 and April 2013, weight was measured to the nearest 0.1 kg using
an analogue scale and MUAC was measured to 1mm using a tape measure. A physical
examination was also performed at these visits, which included measurement of blood
pressure, heart rate and general medical history. Two vaginal swabs were collected at the
mid-point of the vagina using CultureSwab polyester-tipped swabs (BD Biosciences,
Mississauga, Ontario); one was used for evaluation of bacterial vaginosis (BV) by
Nugent Scoring (Nugent et al., 1991), while the second was used for microbial DNA
extraction. Fecal samples and saliva samples were also collected in sterile collection
containers and frozen at -80oC until analysis. A mid-stream urine sample was analyzed
for urinary tract infection using a multi-test dipstick system (Rapid Response Urine
Dipstick, BTNX Urinalysis, Laja Pharmacy, Mwanza, Tanzania). Hemoglobin levels
were determined using a HemoCue® Hb 201+ analyser (HemoCue, Ängelholm, Sweden)
Blood samples were collected from all participants at the first, mid and final visits in
Vacutainer tubes containing potassium EDTA (BD Biosciences, Mississauga, Ontario).
Plasma was separated from the samples before being frozen at -80oC until analysis.
Vitamin A levels were determined by HPLC, while the total plasma protein levels were
determined by a colorimetric Biuret assay by the London Health Sciences Laboratory
Services Group (London, Canada).
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The first post-partum visits occurred at 3 days after birth and the final visit occurred one
week to one month after the first post-partum visit. The same information and samples
were collected as during the follow-up visits, however, a human milk sample was
collected in sterile collection containers from the mother and stored at -80oC until
analysis. Anthropometric data were collected from the infant including, weight as
measured on an analogue baby scale to the nearest 0.1 kg, while head circumference,
length and MUAC were measured using a tape measure to the nearest 0.1 cm. In addition,
the sex of the infant, place of birth, and whether the baby was born vaginally or by
caesarean section were recorded. Fecal samples were collected from the infant’s diaper,
and infant saliva samples were collected using a BBL™ CultureSwab™ (BD diagnostics,
Mississauga, Ontario) and stored at -80oC until analysis.

5.2.4

Dietary recall analysis

Forty-eight hour dietary recall interviews were conducted by a trained study translator at
each visit. Information from these interviews was analyzed for nutritional content and
caloric intake using the ESHA Food Processor SQL (version 9.8) which provides access
to an extensive database of comprehensive nutrition information to allow evaluation of a
subject's diet and fitness. Although this program utilizes North American food
composition tables, nutritional data for local Tanzanian foods and recipes were imputed
into the software from Tanzanian food composition tables prepared by Muhimbli
University of Health and Allied Sciences, Tanzania Food and Nutrition Center and
Harvard School of Public Health (Lukmanji and Hertzmark, 2008). In addition, when
serving sizes per se, or sizes of specific food items were not clearly stated in the
interview, the average portion quantity, as outlined by the Tanzanian Food Composition
Tables, was used. Nutritional data for Moringa were obtained (M. Broin, unpublished
data) and also inputted into ESHA. The average intake of calories, protein, fat,
carbohydrates, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty
acids, calcium, vitamin A, folate and zinc were calculated over the 48-hour period to
determine daily consumption. The same was done for the 48-hour dietary recalls
collected at the first post-partum and final visits, to obtain a value representing the daily
average intake of the above listed nutrients postpartum.
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5.2.5

Microbial DNA extraction and sequencing

DNA was extracted from all samples using the PowerSoil®-htp 96 Well Soil DNA
Isolation Kit from MoBio (Carlsbad, California) as per the manufactures protocol with
modifications as outlined by the Earth Microbiome Project (version 4_13).
Approximately 250 mg of fecal sample, 500 µL of saliva and 500 µL of breast milk were
used for the extractions. Samples were sequenced by amplifying the V4 hypervariable
region of the 16S rRNA gene using bacterial/archaeal primers 515F and 806R according
to previously described methods (Caporaso et al., 2012) modified for the Illumina MiSeq
platform.

5.2.6

Microbial community analysis

Obtained reads were quality filtered and de-multiplexed using the open source software
QIIME (split_libraries_fast.py with default parameters for Illumina sequencing)
(Caporaso et al., 2010). A total of 974 samples were sequenced, yielding 15,596,127
sequences total with an average of 16,012 sequences ± 11,840 SD per sample. Samples
that generated less than 1000 sequences after quality filtering were discarded. The
remaining sequences were then binned into operational taxonomic units (OTUs) using
closed-reference OTU picking based on 97% identity using the May 2013 build of the
Greengenes reference database (McDonald et al., 2012). Demultiplexed reads and
associated metadata were deposited in the Qiita and EBI databases available through
study ID 2024 (qiita.ucsd.edu).

5.2.7

Statistical analysis

All statistical analyses were carried out in R using unpaired Welch’s t-tests with
Benjamini Hochberg’s false discovery rate (FDR) method with a q<0.05 cutoff unless
otherwise indicated. Analysis of alpha (Shannon diversity index) and beta diversity
(weighted UniFrac and Bray Curtis) were performed in QIIME. All plotting was carried
out in R with OTUs summarized to genus level and filtered to only include organisms
which composed >1% of the total dataset (vaginal heat map Figure 5-6C ) or >0.01%
(entire dataset: Figure 5-3). For association of individual genera with yogurt/control
treatment in infant fecal samples, the dataset was filtered to include only infant fecal
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samples, summarized to the genus level and genera were only kept if they represented a
minimum 0.1% of the total reads. Significantly differentially abundant genera were
determined by comparing groups using ALDEx2 (version 0.99.2) (Fernandes et al., 2013;
Fernandes et al., 2014) by Wilcoxon rank-sum test with FDR correction of centered logratio transformed data using 1000 Monte-Carlo instances drawn from the Dirichlet
distribution with a minimally informative uniform prior of 0.5. Taxa that had 0 counts in
all samples were removed. This approach accurately estimates the range of technical
variation inherent in microbiome datasets for all taxa, including those where some
samples contain a 0 and some where they contain a positive count (Fernandes et al.,
2013; Fernandes et al., 2014).

5.2.8

Human milk analysis

The breast milk samples collected at the final visit for all women in the study were
analyzed for fat, protein and lactose content. From the calculated lactose amount, total
carbohydrates were estimated. A total of 12 milk samples were excluded from this
analysis due to the provider being HIV positive. Thus, data was obtained for 9
participants from the control group and 6 participants form the probiotic yogurt group.
Samples were homogenized for 10 seconds prior to a 500 µL aliquot being removed for
DNA extraction using a sonicator (VCX 130; Chemical Instruments AB, Sollentuna,
Sweden). The remaining sample (approximately 500 µL – 1 mL) was used for nutrient
analysis. Lactose content was measured as described by Fusch et al. (Fusch et al., 2011).
Fat was extracted from the milk using Mojonnier ether extraction and then
gravimetrically analyzed to get total fat content (Choi et al., 2013). Protein content of the
breast milk was determined as per the methods of Choi et al. (2013). The true protein
content was determined by subtracting the non-protein nitrogen from the total nitrogen
and multiplying this by 6.25 (Lonnerdal et al., 1984).
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5.3
5.3.1

Results
Clinical outcomes

The women were enrolled from a 20 km area around the Nyerere Dispensary on the
outskirts of Mwanza. No verbal or written complaints or side effects were reported from
consumption of the yogurt. Figure 5-1 shows a CONSORT-compliant study flow chart.
Baseline demographic data for the nourished, undernourished, probiotic and control
groups are presented in Table 5-1 and showed no differences between groups, except for
weight related metrics between the nourished and undernourished groups. For
interpretative purposes, a blood level for vitamin A of 0.9 mmol/L equals 25.8 mg/dL just
below the normal range of 30-65 µg/dL.
Using 48-hour dietary recalls, women in both groups who were initially categorized as
nourished or undernourished were found to have consumed similar calories and
macronutrients. In comparison to reference dietary intake (RDI) values for Canadian
pregnant women, the Tanzanian women only met requirements for carbohydrates and
iron throughout pregnancy – all other micro- and macronutrients were below 90% of the
Canadian RDI, including folate. Yet, only three babies (5%) were delivered preterm,
while all other births occurred without adverse events, and overall, babies examined by
the local physician were deemed to be healthy. It was noted at the study midpoint
whereby there was increased calorie, carbohydrate, thiamine, folate and zinc intake in the
probiotic group while blood protein levels were also higher, however these were not
statistically supported after multiple testing corrections (Table 5-2). We noted that
calcium levels in the probiotic group were significantly higher than all others (Tables 5-2
and 5-3).
Fat, carbohydrate and protein content of the breast milk and hemoglobin, blood retinol,
and blood protein concentrations were not altered by yogurt intake, nor was gestational
weight gain or newborn weight at the final visit (Table 5-3).

Analysis

Follow-up

Allocation

Enrollment
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Assessed for eligibility (n=61)
Excluded (n=5)
-Obese (n=5)
Randomized (n=56)

Allocated to probiotic (n=26)
- Received allocated intervention (26)

Allocated to no intervention (n=30)
- Received no intervention (30)

Follow up at study midpoint (n=23)
-Participant did not return for
unknown reasons (n=3)

Follow up at study midpoint (n=24)
-Participant did not return for unknown
reasons (n=6)

Follow up postpartum (n=20)
-Participant relocated for birth (n=2)
-Participant did not give birth by study
end date (n=1)

Follow up postpartum (n=21)
-Participant relocated for birth (n=3)

Analysis midpoint (n=20)
Excluded from analysis (n=3)
-Missed appointment (n=3)

Analysis midpoint (n=22)
Excluded from analysis (n=2)
-Missed appointment (n=2)

Analysis postpartum (n=9)
Excluded from postpartum analysis
if not meeting criteria (n=11):
-Adherence <75% at birth visit
-Age of infant at final visit between
7 and 30 days

Analysis postpartum (n=15)
Excluded from postpartum analysis
(n=9)
-Age of infant at final visit not between
7 and 30 days

Figure 5-1. CONSORT flow diagram.
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Table 5-1. Enrolment demographics for probiotic, control, undernourished and
nourished groups (values ± SD unless otherwise indicated).
Table 1. Enrolment demographics for probiotic, control, undernourished and nourished groups (values ± SD unless
otherwise indicated).

Gestational age (weeks)

Probiotic

Control

(n=23)

(n=24)

q-value

Undernourished

Nourished

(n=29)

(n=18)

q-value

21 ± 3

20 ± 5

0.915

21 ± 4

21 ± 4

0.976

Age (years)

23.30 ± 4.42

24.38 ± 5.01

0.915

24.31 ± 5.47

23.11 ± 3.12

0.958

Height (m)

1.60 ± 0.07

1.62 ± 0.06

0.915

1.61 ± 0.06

1.62 ± 0.07

0.976

54.8 ± 5.8

57.5 ± 7.4

0.915

52.6 ± 4.3

62.0 ± 5.9

3.11E-05

72.71 ± 10.14

96.75 ± 6.58

2.19E-11

261 ± 22

262 ± 22

0.965

256 ± 22

271 ± 19

0.109

110.48 ± 13.68

103.38 ± 17.21

0.915

107.34 ± 16.70

106.06 ± 14.75

0.976

HIV (n)

2

3

3

2

Malaria (n)

3

4

4

3

Syphilis(n)

2

2

4

0

Previous pregnancies (n)

2.09 ± 2.07

2.00 ± 1.48

0.965

2.29 ± 1.94

1.67 ± 1.46

0.935

Age of first pregnancy

18.06 ± 9.54

18.88 ± 9.20

0.965

18.19 ± 1.86

19.00 ± 1.97

0.976

Calories (kcal/day)

1695 ± 752

1759 ± 781

0.965

1719 ± 754

1742 ± 789

0.976

57 ± 23

58 ± 21

0.965

57 ± 21

58 ± 25

0.976

278 ± 118

276 ± 121

0.965

277 ± 122

277 ± 116

0.997

46 ± 33

52 ± 33

0.915

48 ± 32

51 ± 35

0.976

Vitamin B12 (µg/day)

0.69 ± 0.62

0.88 ± 0.81

0.915

0.80 ± 0.76

0.77 ± 0.69

0.976

Thiamine (mg/day)

0.78 ± 0.39

0.90 ± 0.44

0.915

0.86 ± 0.39

0.82 ± 0.46

0.976

Calcium (mg/day)

187 ± 119

236 ± 175

0.915

199 ± 168

233 ± 120

0.976

316 (70-869)

546 (123-1019)

0.915

261 (98-846)

636 (170-1018)

0.958

249 ± 212

294 ± 199

0.915

269 ± 206

276 ± 208

0.976

Iron (mg/day)

49 ± 51

40 ± 41

0.915

41 ± 45

50 ± 48

0.976

Zinc (mg/day)

5.4 ± 2.7

5.9 ± 2.4

0.915

5.8 ± 2.5

5.5 ± 2.6

0.976

Blood vitamin A (mmol/L)

0.90 ± 0.27

1.02 ± 0.43

0.915

1.00 ± 0.31

0.88 ± 0.44

0.958

Blood protein (g/L)

64.4 ± 8.9

63.5 ± 6.9

0.965

65.8 ± 4.7

60.9 ± 10.7

0.398

Weight (kg)
% Deviation

a

b

MUAC (mm)
Hemoglobin (g/L)

Protein (g/day)
Carbohydrates (g/day)
Fat (g/day)

c

Vitamin A (RAE /day, median [IQR])
Folate (µg/day)

a

% Deviation was calculated based on the participants gestational age (calculated from participant recall of the last menstrual period) and height as measured at baseline.
These were used to determine the ideal weight of the participants as outlined by Gueri et al. (25) The weight of participants measured at baseline was then used to calculate the
% deviation from the ideal weight.
b
MUAC: Mid-upper arm circumference
c

!

RAE: retinol activity equivalents
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Table 5-2. Comparison of probiotic and control group at the study midpoint. Values
given
averagesofand
standard
deviation
stated.
Table are
2. Comparison
probiotic
and control
groups at unless
the studyotherwise
midpoint. Values
given are averages and
standard deviation unless otherwise stated.

Gestational age (weeks)
Age (years)
Height (m)
Weight (kg)
a
MUAC (mm)
Hemoglobin (g/L)
Malaria (n)
Calories (kcal/day)
Protein (g/day)
Carbohydrates (g/day)
Fat (g/day)
Vitamin B12 µg/day)
Thiamine (mg/day)
Calcium (mg/day)
b
Vitamin A (RAE /day, median
[IQR])
Folate (µg/day)
Iron (mg/day)
Zinc (mg/day)
Blood vitamin A (mmol/L)
Blood protein (g/L)
a
MUAC: Mid-upper arm circumference
b
RAE stands for retinol activity equivalents
*Uncorrected p-value <0.05

Probiotic
(n=20)
32 ± 2
23.5 ± 4.7
1.59 ± 0.06
58.5 ± 5.9
260 ± 23
102 ± 16
2
2065 ± 656
67 ± 12
326 ± 96
60 ± 35
1.47 ± 0.83
1.00 ± 0.28
488 ± 148
353 (129-985)

Control
(n=22)
30 ± 4
24.6 ± 5.1
1.62 ± 0.06
60.1 ± 7.8
263 ± 24
106 ± 24
1
1701 ± 486
63 ± 19
264 ± 96
49 ± 19
1.41 ± 1.48
0.82 ± 0.19
190 ± 92
155 (102-268)

q-value
0.582
0.582
0.304
0.582
0.682
0.619
0.160*
0.582
0.160*
0.386
0.851
0.141*
1.77E-7*
0.336

301 ± 160
44 ± 34
6.4 ± 2.3
0.82 ± 0.25
62.3 ± 8.6

224 ± 106
30 ± 22
5.1 ± 1.0
0.88 ± 0.31
54.8 ± 12.45

0.211*
0.304
0.142*
0.607
0.142*
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Table 5-3. Demographics and birth data for participants in the probiotic and
control groups at the final visit. Values represent a mean and standard deviation
unless
indicated.
Table 3.otherwise
Demographics
and birth data for participants in the probiotic and control groups at the final visit.
Values represent a mean and standard deviation unless otherwise indicated.
Probiotic
(n=9)

Control
(n=15)

q-value

Gestational age at birth
(weeks)
Age (years)
Height (m)
Weight (kg)
a
MUAC (mm)
Hemoglobin (g/L)
No. of twin sets

40 ± 1

40 ± 2

0.976

24.9 ± 3.4
1.58 ± 0.05
56.2 ± 2.9
267 ± 19
107 ± 12
2

26.0 ± 5.6
1.62 ± 0.05
55.5 ± 6.7
260 ± 23
111 ± 18
0

Male
Female
Age (days)
Weight (kg)
Length (cm)
Head circumference (cm)
a
MUAC (mm)

5
6
13 ± 3
3.5 ± 0.5
50.7 ± 2.9
35.9 ± 1.3
11 ± 1

6
9
12 ± 2
3.4 ± 0.4
48.7 ± 4.0
35.3 ± 1.2
11 ± 1

0.787
0.787
0.598
0.598
0.787

1775 ± 565
83 ± 38
283 ± 131
44 ± 14
1.36 ± 1.14
0.85 ± 0.25
394 ± 139
190 (107-252)

2068 ± 383
61 ± 18
363 ± 53
49 ± 24
0.51 ± 0.66
1.00 ± 0.29
109 ± 11=2
85 (31-302)

0.646
0.598
0.598
0.787
0.598
0.598
0.003
0.899

137 ± 66
67 ± 38
5.1 ± 2.1

157 ± 65
56 ± 46
6.4 ± 1.6

0.787
0.787
0.141

1.29 ± 0.34
62.13 ± 9.09

1.58 ± 0.59
62.73 ± 12.22

0.598
0.598

2.54 ± 0.26
5.75 ± 0.18
1.09 ± 0.06

2.80 ± 0.46
5.78 ± 0.16
1.14 ± 0.15

0.598
0.787
0.787

0.787
0.598
0.973
0.787
0.787

Infant

Diet
Calories (kcal/day)
Protein (g/day)
Carbohydrates (g/day)
Fat (g/day)
Vitamin B12 (mcg/day)
Thiamine (mg/day)
Calcium (mg/day)
b
Vitamin A (RAE /day, median
[IQR])
Folate (mcg/day)
Iron (mg/day)
Zinc (mg/day)
Blood
Blood vitamin A (mmol/L)
Blood protein (g/L)
Breast milk
Fat (g/dL)
Carbohydrates (g/dL)
Protein (g/dL)
a
MUAC: Mid-upper arm circumference
b
RAE: retinol activity equivalents
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5.3.2

Microbiome findings

Nutritional status did not correlate with a difference in microbiota profiles between
groups at any body site both by diversity indices (Figure 5-2) or individual taxa (data not
shown; determined by analysis with ALDEx2, which determines differential abundances
for taxa that are robust to technical replication and that pass a stringent false discovery
rate cutoff (Fernandes et al., 2013; Fernandes et al., 2014)). It can be noted there was a
non-significant trend of increased microbial diversity in undernourished mother’s breast
milk and their infants oral cavities; this was not significant after multiple testing
correction. After initial analysis of dietary data, blood protein and Vitamin A (Table 5-1),
and bacterial communities, the classification based on nutritional status was rejected and
participants were grouped as those receiving Moringa enriched probiotic supplementation
(n=23, 14 undernourished) or those who did not (n=24, 7 undernourished).
The mothers’ gut microbiotas were generally dominated by Prevotella (Figure 5-3) but
the L. rhamnosus probiotic is not visible as it comprises a near-undetectable fraction of
the fecal microbiota. For the oral microbiota, Streptococcus, Prevotella, Fusobacterium,
Porphyromonas and other known oral commensals and pathogens were detected while
the vaginal profiles were predominantly dominated by Lactobacillus (Figure 5-3). Clear
clustering by body site was observed in PCoA using the Bray-Curtis dissimilarity
measure, with the observation that the infants' oral and fecal microbiota seemed most
closely related to breast milk (Figure 5-4A). Both 0-10 days and 10-25 days after birth,
there was more similarity between the infant's oral microbiota and their mother’s breast
milk microbiota, than between the infant’s feces and their mother’s milk (Figure 5-4B,
p<0.0001, FDR corrected Welch’s T-test).
To determine the effect of probiotic administration, differences in the microbiota of each
group at each body site were examined chronologically relative to enrollment using
weighted UniFrac distances (Figure 5-5A), and no clear trend was detected comparing
probiotic to control groups. When the infants of mothers in the probiotic and control
groups are compared by PCoA of weighted UniFrac distances, weak clustering by
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treatment group was observed (Figure 5B). The OTUs were summarized to genus level
which revealed a 3-fold increase in relative abundance of Bifidobacterium and a 16.8-fold
decrease in unclassified Enterobacteriaceae in the feces of infants whose mothers
consumed the yogurt (p<0.05 FDR-corrected Wilcoxon Rank Sum, Figure 5-5C). This
trend was not observed in the breast milk nor was the primary macronutrient composition
of the milk altered by yogurt intake (Table 5-3).
The vaginal microbiota showed a distinct change in beta diversity over gestational time
irrespective of treatment group while the oral and fecal microbiotas did not (Figure 55A). To analyze this finding further, Shannon diversity index was considered over time
(Figure 5-6A) showing a significant increase in alpha diversity in the 10 days following
birth to a predominantly bacterial vaginosis (BV)-type communities as indicated by
Nugent Score (Figure 5-6B, p<0.001 Welch’s t-test). In the postnatal period, there was a
decrease in Lactobacillus with an increase in BV associated organisms such as
Prevotella, Veillonella, Poryphromonas and Megasphaera (Figure 5-6C, n=32
participants, p<0.05 FDR-corrected paired Wilcoxon test).
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Adult Fecal
PC2 (23%)

Adult Oral

Adult Vaginal

PC2 (18%)

PC2 (18%)

PC1 (34%)

PC1 (32%)
PC3 (8%)

Breast Milk
PC2 (28%)

Infant Fecal (Birth)

Infant Oral (Birth)

PC2 (14%)

PC2 (25%)

PC1 (35%)

PC1 (42%)

PC3 (9%)

PC3 (11%)

Undernourished

B.
n=27
●

n=17

n=29

n=8

n=11

Shannon Diversity Index
1
2
3
4
5

n=13

n=15
●

n=29

UN Adult Vaginal

n=10 n=15

UN Infant Oral

N Infant Oral

UN Breast Milk

N Breast Milk

UN Adult Oral

N Adult Oral

UN Adult Fecal

N Adult Fecal

0

n=18

N Adult Vaginal

●
●

PC1 (37%)

PC3 (14%)

Nourished

6

n=16

PC1 (58%)

PC3 (5%)

UN Infant Fecal

PC3 (8%)

N Infant Fecal

A.

Figure 5-2. (A) PCoAs of weighted UniFrac distances and (B) Shannon’s diversity
index of samples taken at enrollment and birth show no effect of nourishment-status
(N nourished, UN undernourished) on the microbiota at studied body sites.
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Figure 5-3. Heat map of all samples (n=974) at the genus level.
	
  
Samples	
  were	
  UPGMA	
  clustered	
  be	
  weighted	
  UniFrac	
  distances	
  showing	
  strong	
  clustering	
  of	
  
samples	
  by	
  body	
  site	
  (as	
  indicated	
  in	
  lower	
  heat	
  map).	
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1.2
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10-25 Days after Birth

Figure 5-4. Clustering of samples and comparison of infant and mother microbiotas.
(A)	
  PCoA	
  of	
  Bray-‐Curtis	
  dissimilarities	
  shows	
  distinct	
  clustering	
  of	
  samples	
  based	
  on	
  body	
  site.	
  
The	
  infant’s	
  oral	
  and	
  fecal	
  microbiomes	
  cluster	
  most	
  closely	
  with	
  the	
  breast	
  milk.	
  Analysis	
  of	
  
weighted	
  UniFrac	
  distances	
  shows	
  that	
  the	
  oral	
  sample	
  of	
  a	
  baby	
  is	
  more	
  similar	
  to	
  their	
  own	
  
mother	
  than	
  their	
  fecal	
  sample	
  (B).	
  At	
  both	
  0-‐10	
  days	
  and	
  10-‐25	
  days	
  after	
  birth,	
  there	
  was	
  
more	
  similarity	
  between	
  the	
  infant’s	
  oral	
  sample	
  and	
  their	
  mother’s	
  breast	
  milk	
  (n=22	
  0-‐10	
  days,	
  
n=27	
  10-‐25	
  days),	
  than	
  between	
  the	
  infant’s	
  fecal	
  sample	
  (n=25	
  0-‐10	
  days,	
  n=29	
  10-‐25	
  days)	
  to	
  
their	
  mother’s	
  breast	
  milk	
  (p<0.0001,	
  FDR	
  corrected	
  Welch’s	
  T-‐test).	
  There	
  is	
  also	
  a	
  non-‐
significant	
  trend	
  that	
  an	
  infant’s	
  oral	
  microbiota	
  is	
  more	
  similar	
  to	
  their	
  own	
  mother’s	
  breast	
  
milk	
  microbiota	
  than	
  that	
  of	
  other	
  mothers.	
  

1.2

1.2

0.4

0.4

150

100
50
0
Days to Birth

B.

−50
C.

100
50
0
Days to Birth
Probiotic Control

−50

150

Infant Fecal
100

P = 2.4E-2

100
50
0
Days to Birth

−50

Breast Milk

P = 2.5E-2
o

% Abundance

PC2 (20%)

0.0

150

Infant Fecal

Vaginal

0.8

Fecal

0.8

Oral

0.0

A.

Weighted UniFrac Distance
(to Enrollment)
0.0 0.4 0.8 1.2

118

10
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o

PC3 (13%)

PC1(41%)
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o

1
Bifido

Entero

Bifido

Entero

Figure 5-5. Change in the microbiota over time and the effect of yogurt on mother
and infant microbiotas.
(A)	
  Microbiota	
  analysis	
  by	
  weighted	
  UniFrac	
  distances	
  comparing	
  samples	
  to	
  enrollment	
  show	
  
that	
  Moringa-‐supplemented	
  probiotic	
  yogurt	
  does	
  not	
  affect	
  the	
  microbiota	
  structure	
  and	
  that	
  
the	
  oral	
  and	
  fecal	
  microbiotas	
  remain	
  stable	
  over	
  pregnancy.	
  The	
  vaginal	
  microbiota	
  appears	
  to	
  
be	
  significantly	
  altered	
  at	
  birth	
  regardless	
  of	
  consumption	
  of	
  yogurt.	
  (B)	
  The	
  fecal	
  microbiota	
  of	
  
infants	
  aged	
  10-‐25	
  days	
  who	
  consumed	
  the	
  yogurt	
  weakly	
  clusters	
  separately	
  from	
  controls	
  by	
  
PCoA	
  of	
  weighted	
  UniFrac	
  distances	
  (Red=	
  Control,	
  Blue=Probiotic).	
  (C)	
  There	
  is	
  in	
  an	
  increase	
  in	
  
the	
  relative	
  abundance	
  of	
  Bifidobacterium	
  (Bifido)	
  and	
  decrease	
  in	
  Enterobacteraceae	
  (Entero)	
  
(FDR	
  corrected	
  Wilcoxon	
  Rank	
  Sum	
  Test<0.05)	
  in	
  the	
  feces	
  of	
  the	
  infants	
  whose	
  mother’s	
  
received	
  probiotic	
  yogurt	
  intervention	
  (n=10)	
  as	
  compared	
  to	
  controls	
  (n=12).	
  This	
  difference	
  
was	
  not	
  present	
  in	
  the	
  breast	
  milk	
  (P>0.05).	
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Figure 5-6. Vaginal microbiota over pregnancy reveals dysbiosis at birth.
(A)	
  Time	
  series	
  of	
  vaginal	
  samples	
  shows	
  increasing	
  diversity	
  and	
  leading	
  up	
  to	
  and	
  after	
  birth.	
  
Nugent	
  score	
  based	
  on	
  microscopy	
  (wherein	
  0-‐3	
  is	
  considered	
  normal,	
  4-‐6	
  intermediate,	
  and	
  7-‐
10	
  is	
  a	
  state	
  of	
  microbial	
  dysbiosis	
  referred	
  to	
  as	
  bacterial	
  vaginosis)	
  is	
  also	
  displayed.	
  (B)	
  
Comparison	
  of	
  Shannon’s	
  diversity	
  shows	
  an	
  increase	
  within	
  10	
  days	
  after	
  birth.	
  (C)	
  Heat	
  map	
  of	
  
genera	
  composing	
  >1%	
  of	
  vaginal	
  organisms	
  shows	
  a	
  loss	
  of	
  lactobacilli	
  and	
  an	
  increase	
  in	
  
bacterial	
  vaginosis-‐associated	
  organisms	
  such	
  as	
  Prevotella.	
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5.4

Discussion

This study reports the oral, gut, vaginal and breast milk microbiotas of pregnant
Tanzanian women, and assesses the effects of consumption of micronutrientsupplemented probiotic yogurt. None of the mothers or infants died during labor. This
finding, plus the low incidence of preterm labor, no underweight births, and no serious
malnutrition, suggested that this particular rural population did not typify the Tanzanian
situation as a whole, where maternal mortality rate are 38.3 times higher than Canada and
infant mortality under 1 year of age is 7.6 times higher (UNICEF, 2013). Sample size
aside, according to the UNICEF statistics we would expect 2 infant deaths in a cohort of
this size. There is an association between an aberrant urogenital microbiota and preterm
labor (Giraldo et al., 2012), but the incidence of the latter was low in this patient group
(32%) and similar to that found in London, Canada (unpublished data, Mottola, Enos and
Reid). Likewise, periodontal disease with poor oral hygiene has been linked with preterm
labor (Macedo et al., 2014), but the Tanzanian women studied here did not present with
acute periodontal disease as identified during their examinations, and their oral
microbiotas showed no obvious abnormality. Thus, with two risk factors for preterm
delivery being absent, it was not surprising to find such a low rate of premature births.
Nevertheless, this is all the more laudable since many subjects had poor caloric intake. In
Tanzania, normally only around 50% women have a skilled attendant at birthing
according to UNICEF, and many women have poor access to obstetrical care. The
provision of the latter in our study, may have reduced the preterm labor rate and
improved maternal outcome, albeit the majority of the women delivered at home.
In these settings, access to Moringa and cow’s milk is good, making it feasible to have
the yogurt produced locally. Whilst the yogurt was provided here free of charge, the
community kitchen continues to operate and sell the product at a price (around $0.15)
affordable to members of the community. This is important for sustainability.
We had expected that the daily Moringa yogurt consumption would have improved
nutritional parameters in women presenting with mid-upper arm circumference (MUAC)
less than 235 mm (undernourished group), since this food provided a good portion of the
required daily intake of calcium, vitamins, and proteins. However, the baseline levels of
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hemoglobin, blood retinol and protein concentrations suggested they were not actually
overtly malnourished. It is highly probable our study suffered from a lack of power, and
with an increased sample size, we may have been able to conclusively demonstrate
clinical outcomes as a result of the Moringa-supplemented yogurt consumption. A
previous study in Mwanza, Tanzania using a different combination of micronutrients
supplemented in yogurt showed benefits to HIV positive subjects (Hummelen et al.,
2011).
The mothers’ gut microbiotas were generally dominated by Prevotella, in agreement with
previous reports on children from Burkina Faso, Malawi, and Tanzania (De Filippo et al.,
2010; Bisanz et al., 2014; Smith et al., 2013) and adults (Yatsunenko et al., 2012).
Potentially, this reflects a high carbohydrate diet which was noted in the dietary recalls.
The vaginal profiles were dominated by Lactobacillus species, similar to previous
findings for American and Brazilian non-pregnant women (Romero et al., 2014; Aagaard
et al., 2012; Gajer et al., 2012; Reid, 2008; Martinez et al., 2008) and for pregnant
Canadian women (unpublished data, Mottola, Enos and Reid). It has long been believed
that the vaginal tract is seeded from the rectum (Reid, 2008), and thus pathogens ascend
and colonize. One would therefore expect that significantly different fecal microbiota
patterns would result in differences amongst vaginal bacterial profiles. But this is not the
case here or in other studies, suggesting that the reproductive tract has evolved receptivity
to certain constituents of the gut, mainly lactobacilli, and an ability to repel others. This
niche adaptation warrants further investigation.
Rapid development of an aberrant vaginal microbiota immediately after birth is also an
interesting finding. A similar discovery was recently reported by Huang et al. (2014),
however, that study was limited in the following ways: it was a cross-sectional design as
opposed to longitudinal in the present study; postpartum samples were an average of 7
weeks after birth as opposed to 0-10 days in the present study; and sample size of
postpartum individuals was only 5. Since our study showed stability in the fecal
microbiota from the second trimester until after birth, this adds to previous findings of the
microbiome across pregnancy in Finnish women (Collado et al., 2008) where first and
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third trimesters showed dramatic community shifts. A strength of this study is that unlike
previous reports, we examined all three communities (fecal, oral, vaginal)
simultaneously.
The significant increase in the relative abundance of Bifidobacterium spp. and a decrease
in Enterobacteriaceae in the newborn gut of babies born to mothers who had received the
yogurt is noteworthy. All the mothers breast-fed, so, since glycans in the milk promote
bifidobacterial growth (Sela and Mills, 2014), it is not clear why only the milk from
probiotic treated mothers further increased relative abundances of these organisms. We
found no significant difference in milk microbiotas, fat, carbohydrate or protein
concentrations between the two groups of women. Given the complex cocktail of
bifidogenic glycans and bioactive compounds in breast milk, it will be necessary to apply
further glycomic, proteomic and metabonomic approaches to study the mechanisms
through which micronutrient and probiotic supplementation may affect breast milk
composition and the infant’s microbiota. Perhaps specific milk oligosaccharides increase
following micronutrient/probiotic supplemented yogurt consumption.
The milk clearly supported a diverse range of organisms, which then colonized the
newborn’s intestine and oral cavity. Unlike North American society where caesarian
delivery and use of infant formula is widespread, the women in this Mwanza community
almost all deliver vaginally and breast-feed their babies. With inflammatory bowel
disease and allergies increasing in Canadian children, potentially linked to environmental
factors including caesarian section and formula feeding (Benchimol et al., 2014; Elmatary et al., 2014), other lessons may be learned from studying pregnant women in
eastern Africa.
In summary, daily ingestion of yogurt supplemented with probiotic L. rhamnosus GR-1
and locally sourced micronutrient-rich Moringa supplemented probiotic yogurt provided
a safe, inexpensive food for pregnant women in rural Tanzania, without adversely
changing gut or oral microbial diversity. The baseline nutritional deficiencies illustrated
the problems faced by pregnant women in this region, however no effects of yogurt
supplementation were observed in clinical parameters. The resultant improvement in the
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gut microbial profile of infants, suggests consumption of this yogurt could be beneficial
in this and other developing world settings but requires further work to understand the
mechanism of action.
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Randomized open-label pilot study of the influence of
probiotics and the gut microbiome on toxic metal levels
in Tanzanian pregnant women and school children
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6.1

Introduction

Toxins in the environment are ubiquitous and exposure is often unavoidable. Their
effects on human and animal life are usually seen over time, and can be serious. Acute
exposure to high toxin levels is particularly detrimental. Anthropomorphic activity has
only served to increase levels of toxins, such as heavy metals and pesticides, in the
environment (Muir et al., 2009). Due to lax regulations and exploitation, many
environmental toxins disproportionately affect the developing world. Aflatoxin for
example, is ubiquitous in East Africa due to Aspergillus contaminated cereal and grain
crops (Wagacha and Muthomi, 2008). Metals such as mercury are released due to human
activity such as mining, as seen along the shores of Lake Victoria, Africa, where the
metal reaches the food web (Campbell et al., 2003). Fish, while not as popular in the
west, are one of the most important sources of dietary protein for many cultures (Tidwell
and Allan, 2001). The effects of low-level mercury exposure include delayed
neurological and cognitive development in children and more controversially, immune
and cardiovascular diseases (Karagas et al., 2012).
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Metal chelating drugs such as dimercaptosuccinic acid (DMSA) and
ethylenediaminetetraacetic acid (EDTA) are indicated for the treatment of acute
exposure, however they are not intended for long term use and there is a lack of
regulatory approved consumer products for chelation. Thus, alternative approaches are
needed. Species of lactic acid bacteria including the L. rhamnosus GR-1 strain used here
in the probiotic yogurt are known to have an affinity for many toxic metals including lead
and cadmium in vitro (Ibrahim et al., 2006), and we have also shown activity against
mercury, arsenic and various organic pesticides (manuscripts in preparation). The
mechanism is thought to be passive sequestration, however we have also discovered
putative probiotic strains that have active enzymatic pathways for detoxification such as
mercury demethylation and reduction. The concept of probiotic-mediated detoxification
has recently been demonstrated in murine models (Tian et al., 2012), but we explored
whether such food-grade microbes could prevent up-take in the gastrointestinal tract
(Monachese et al., 2012).
Logic dictates that if probiotic organisms have these protective capacities, endogenous
microbes of the GI tract, termed the microbiota, could also be of importance.
Experiments contrasting conventional and germ free animals have shown the importance
of the microbiota in protection against accumulation of mercury (Nakamura et al., 1977),
lead and cadmium (Breton et al., 2013a). Furthermore, levels of indigenous lactobacilli
appear to increase in response to metal exposure in murine models (Breton et al., 2013b),
perhaps conveying a natural protective effect. We sought to better understand the
composition of the human gut microbiota exposed to toxic metals.
Two of the most vulnerable populations at risk from environmental toxin exposure are
pregnant mothers and children. We suspected that in Mwanza, Tanzania, due to its
proximity to Lake Victoria, and the fish-rich diet, women and children would have
elevated toxic metal exposure and be ideal candidates for intervention. Furthermore,
Mwanza is site to a network of community run probiotic yogurt kitchens that service
people at the bottom-of-the-pyramid (Reid et al., 2013). The aims of this study were: (i)
determine the blood metal levels in the local population and from potential fish sources,
(ii) measure if consumption of a probiotic yogurt has an effect on blood metal levels, and
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(iii) characterize the gut microbiome of children to determine if there are bacterial genera
associated with metal levels.

6.2
6.2.1

Results
Participant recruitment

Between November 2012 and December 2012, a total of 44 individuals were recruited
into the 25-day study of school-aged children (SAC), with 22 in the control group
receiving milk and 22 in the group receiving probiotic yogurt. Eight individuals withdrew
during the course of the study, one due to suspected lactose intolerance which was not
known to the child’s guardian at the time of enrollment, and 7 for unknown reasons
including not being present for final sample collection. A total of 24 individuals were
selected for inclusion into blood metal analysis in the pregnant women (PW) group based
on adherence of over 75% and matching of nutritional status and fish intake. A summary
of recruitment is provided in Figure 6-1. Relevant participant demographics are
represented in Table 6-1. Z scores based on weight-for-age indicate that the children
enrolled were not malnourished at the point of enrollment. Based on the SAC enrollment
questionnaire, 37% of children consumed local fish on a daily basis, 55% consumed
multiple courses of fish a week and 8% multiple times a month. No guardians reported
their children did not consume fish regularly as part of their diet.
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School aged Children (SAC)

Assessed for eligibility (n=60)

Excluded (n=0)

Allocation

Randomized (n=60)

Allocated to probiotic (n=22)
- Received allocated intervention (n=21)

Allocated to control (milk) (n=22)
- Received allocated intervention (n=22)

Allocated to probiotic (n=26)
- Received allocated intervention (26)

Allocated to control (no intervention) (n=34)
- Received allocated intervention (34)

Follow-up

Randomized (n=44)

Excluded (n=0)

Follow-up at Day 25 (n=18)
Lost to followup (n=4)
- Withdrew for unknown reasons (n=3)
- Suspected lactose intolerance (n=1)

Follow-up at Day 25 (n=18)
Lost to followup (n=4)
- Withdrew for unknown reasons (n=4)

Follow-up at Birth (n=17)
Lost to followup (n=9)
- Participant relocated for birth (n=9)

Follow-up at Birth (n=20)
Lost to followup (n=14)
- Participant relocated for birth (n=14)

Analysis

Enrollment

Assessed for eligibility (n=44)

Pregnant Women (PW)

Analysis (n=20)
- Change in blood metal analysis (n=18)
- Fecal microbiome analysis (n=20)
Excluded (n=0)

Analysis (n=20)
- Change in blood metal analysis (n=17)
- Fecal microbiome analysis (n=20)
Excluded (n=1)
- Noncompliance (n=1)

Analysis (n=12)
- Change in blood metal analysis (n=12)
Excluded (n=5)
- Adherence < 75%

Analysis (n=12)
- Change in blood metal analysis (n=12)
Excluded (n=8)
- Only matched controls analysed

Figure 6-1. CONSORT flow diagram detailing participant enrollment, allocation,
follow-up and analysis.
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Table 6-1. Participant demographics for pregnant women (PW) and school-aged
children (SAC) control and yogurt groups (mean ± SD).
All	
  relevant	
  metrics	
  are	
  not	
  statistically	
  significant	
  between	
  groups.	
  Z	
  scores	
  were	
  calculated	
  
from	
  WHO	
  5-‐19	
  year	
  old	
  children	
  BMI-‐for-‐age	
  tables	
  
(who.int/growthref/who2007_bmi_for_age/en/index.html).	
  
PW
Control
Participants

n=12

Age (years)

SAC
Yogurt

Control

Yogurt

n=12

n=22

n=21

24.5 ± 3.9

23.5 ± 3.6

8.3 ± 1.1

8.4 ± 1.2

Weight (kg)

58.0 ± 6.8

55.0 ± 4.9

23.1 ± 3.6

23.6 ± 3.2

Height (cm)

162.0 ± 3.9

157.0 ± 5.0

119.3 ± 7.5

119.6 ± 5.8

BMI (kg/m2)

22.0 ± 1.9

22.3 ± 2.0

16.2 ± 1.9

16.5 ± 2.0

-0.4 ± 1.1

-0.3 ± 0.8

6/16

6/15

89.8 ± 10.0

86.1 ± 11.4

Z score
Gender (M/F)
Fish Intake (g/day)

150.4 ± 60.1

120.7 ± 52.9

Adherence (%)

6.2.2

90.6 ± 5.4

Dietary and blood metal levels

Levels of metals across fish types for cadmium, lead, total mercury and total arsenic are
shown in Table 6-2. Surprisingly the smaller fish type, Silver cyprinid, contained
significantly higher levels of mercury and arsenic compared to the other piscine species
tested.
Measures of blood lead, total mercury, total arsenic and cadmium are presented in Table
6-3 for both the SAC and PW groups. When comparisons were made to levels present in
a developed country (Canada), lead and mercury were found to be elevated in both SAC
and PW by up to 6.8 times. Levels of arsenic and cadmium appeared on par or lower than
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the Canadian population values. The PW group tended to display lower levels of metals
than the SAC group.
Table 6-2. Toxic metal levels in commonly consumed fish in the Mwanza Region.
Mercury and arsenic are reported as total levels.
Species

Tilapia

Mercury

Lead

Arsenic

Cadmium

(ng/g ±SD)

(ng/g ±SD)

(ng/g ±SD)

(ng/g ±SD)

18.3 ± 17.1

58.0 ± 13.0

22.3 ± 2.5

158 ± 254

56.0 ± 15.1

86.7 ± 18.2

30.3 ± 14.3

33.7 ± 37.5

77.3 ± 40.5

78.0 ± 18.3

664.3 ± 159.9

113.0 ± 54.7

(Oreochromis niloticus)
Nile Perch
(Lates niloticus)
Silver cyprinid
(Rastrineobola argentea)
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Table 6-3. Blood metal levels at the time of recruitment and comparisons to levels
found in a developed country.

Average (±SD)

Range

Canadian
Average1

Reference
Range2

Fold Difference

SAC
Pb (µg/L)

47.1 ± 16.2

22.5 - 91.3

9.0

0.0 - 17.7

5.2

Hg (nmol/L)

9.5 ± 5.3

3.0 - 37.4

1.4

0.0 - 5.5

6.8

As (nmol/L)

6.5 ± 2.1

2.7 - 10.8

7.8

0.0 - 21.4

-1.2

Cd (nmol/L)

1.2 ± 0.7

0.9 - 4.4

0.89

0.0 - 4.6

1.3

22.6 ± 9.6

7.3 - 40.5

8.9

0.0 - 45.0

2.5

Hg (nmol/L)

8.8 ± 3.1

4.0 - 16.0

3.5

0.0 - 18.0

2.5

As (nmol/L)

3.0 ± 1.6

1.3 - 6.7

11.7

0.0 - 21.4

- 3.9

Cd (nmol/L)

1.1 ± 0.6

0.0 - 2.7

3.2

0.0 - 8.9

- 2.9

PW
Pb (µg/L)

1

Canadian averages are geometric means of males and females aged 6-11 (SAC) and
females aged 20-39 (PW) based on the Canadian Health Measures Survey (2007-2009
(Health Canada, 2010). 2 Reference ranges provided by Trace Elements LaboratoryLondon Laboratory Services Group.
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6.2.3

Effect of probiotic yogurt on blood metal levels

Before and after intervention, samples were successfully collected from 36 individuals in
the SAC group, 18 in each group. One individual was excluded from the control group
after gut microbiome analysis showed a high number of reads presumptively mapping to
the probiotic strain indicating non-compliance. After quantification by HR-SF-ICP-MS,
no statistically significant differences were detected in blood metal levels of SAC
receiving probiotic or milk control though it is noted that there was a weak trend of
reduced lead and arsenic (Table 6-4). In the PW cohort, this effect was noted to a
statistically significant level (P<0.05). It is noteworthy that levels of mercury and arsenic
increased in the control groups (P<0.05) but remained stable in the probiotic group,
indicating a protective effect of probiotic consumption.

a

6.1 ± 2.3

Arsenic
(nmol/L)

25 ± 9.0

8.2 ± 3.5

1.2 ± 0.59

2.4 ± 1.5

Lead
(µg/L)

Mercury
(nmol/L)

Cadmium
(nmol/L)

Arsenic
(nmol/L)

n=12

1.4 ± 1.1

Cadmium
(nmol/L)

4.9 ±
2.5

1.3 ±
0.46

11 ±
2.5

34 ± 13

6.3 ±
2.9

1.3 ±
1.2

9.4 ±
3.5

49.7 ±
21.8

Followup

2.5

0.1

2.8

9

0.2

-0.1

0.5

1.1

Difference

0.0032

0.57

0.042

0.011

0.78

0.58

0.52

0.79

Pvalueb

0%

8%

-0.21
to
0.37
1.0 to
3.9

25%

8%

35%

13%

29%

53%

Responder
Rate (%)c

0.12
to 5.6

2.4 to
15

-1.5
to 1.9

-1.1
to 2.1
-0.27
to
0.12

-7.7
to
10.01

95%
CI

3.5 ± 1.7

1.1 ± 0.65

9.4 ± 2.7

20 ± 9.7

n=12

6.7 ± 2.2

1.2 ± 0.4

10.3 ± 7.5

46.3 ±
16.7
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Enrollment

3.7 ±
1.1

1.4 ±
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9.0 ±
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6.3 ±
2.3

1.1 ±
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9.7 ±
4.9

47.3 ±
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0.2

0.3

-0.4

13

-0.4

-0.1

-0.6

1.0

Difference

Probiotic

0.68

0.017

0.60

0.0013

0.41

0.43

0.51

0.41

Pvalueb

-0.85
to 1.3

0.080
to
0.70

-2.1
to 1.2

6.1 to
19

-2.6
to 1.3
-0.37
to
0.17
-1.6
to
0.67

-1.6
to 3.6

95 %
CI

33%

0%

50%

0%

44%

22%

44%

35%

Responder
Rate (%)c

-2.3

0.2

-3.2

4

-0.6

0

-1.1

-0.1

0.011

0.13

0.035

0.35

0.49

0.79

0.36

0.98

-4.6
to 12
-6.32
to 0.25
0.092
to
0.69
-4.0
to 0.57

-2.6
to 1.3

-3.6
to 1.4
-0.29
to
0.37

-9.0
to 8.8

Between-groups Comparison
Difference
(ProbP95 %
Con) valued
CI

Values are mean ± SD, b Paired t-test used for within-group comparisons, c Responder defined as showing a decrease in blood metal levels over study period, d t-test used for between-group comparison

PW

8.9 ± 2.8

Mercury
(nmol/L)

48.6 ±
16.1

n=17

SAC

Lead
(µg/L)

Enrollment

Metal
Analyzed

Control

Table 4 Blood metal levelsa between control and probiotic groups before and after intervention in school aged children (SAC) and
pregnant women (PW)
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Table 6-4. Blood metal levels between control and probiotic groups before and after

intervention in school aged children (SAC) and pregnant women (PW)

140

6.2.4

Gut microbiome and association with metal levels

A total of 74 fecal samples from the children were collected and processed for
sequencing. For all but one of these samples, 16S rRNA gene sequences were
successfully obtained with a total number of reads being 1,150,628 averaging 15,762
reads per sample. With clustering at 97% nucleotide identity, 177 OTUs were obtained at
≥1% abundance. These data were summarized to the family level and presented in Figure
6-2. Nearly all samples contained Prevotella as the dominant genera and the
Prevotellaceae as the dominant family. Administration of the probiotic was not observed
to have an effect on the gut bacterial community composition based on analysis of
weighted and unweighted UniFrac metrics (Lozupone and Knight, 2005; data not shown),
as previously reported (McNulty et al., 2011). The use of 16S rRNA sequencing also
gave the unique opportunity to presumptively validate probiotic administration, as one
OTU could be mapped back to the genome of L. rhamnosus GR-1 (OTU_140). This OTU
was not observed in any sample prior to the start of the study and with only one
exception, was only observed in the group that received probiotic yogurt. The exception
(PDTX25) was excluded from analysis of probiotic efficacy in the SAC group.
To analyze the association between blood lead levels and the microbiotas, the initial
analysis focused on only the first visit and the most extreme cases (n=3 per group) based
upon visual inspection of the distribution of blood levels. Two OTUs were found to be
elevated in conditions of high blood lead and to have a raw P-value <0.05: OTU_1
(P=0.0205) and OTU_215 (P=0.0498) representing Succinivibrionaceae and
Gammaproteobacteria respectively. Due to the relatively small sample numbers used in
this analysis, significance was not obtained with multiple testing corrections. In order to
leverage the full power of the dataset, all samples regardless of visit or participant were
considered. Quartile values for Q1 and Q3 based on blood lead concentration were used
as cut offs to separate the microbiota samples (n=16 low, n=18 high). These two
conditions were then compared using an FDR cutoff of 0.05, and again the increased
proportional abundance of OTU_1 (2.9-fold, FDR=0.022) and OTU_215 (3.7-fold,
FDR=0.023) with elevated lead levels was found (Figure 6-3). Significant associations
were not found in the cases of mercury and arsenic.
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Figure 6-2. Heat map representation of the gut microbiomes of SAC at beginning

and end point of study.
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Figure 6-3. Association of (A) OTU_1 (Succinivibrionaceae) and (B) OTU_215
(Gammaproteobacteria) with elevated blood lead levels in a comparison of upper
and lower quartiles of all samples (FDR<0.05).

6.3

Discussion

This is the first study to simultaneously evaluate toxic metal levels, associated microbiota
and the potential for probiotics to convey a detoxification effect. It is also the first to
assess the impact of a probiotic food on toxic metals in people living in the developing
world.
Levels of metals in the fish tested were consistent with previous reports in Lake Victoria
(Campbell et al., 2003; Oyoo-Okoth et al., 2010). Mercury limits in fish are well
described but they are less well defined in the case of lead, cadmium and arsenic. It is
greatly concerning to observe such high levels of metals in Silver cyprinid, as its daily
consumption is common, especially in the economically disadvantaged due to its
affordable price. This creates a disproportional burden on these individuals. Furthermore,
this goes against the typical dogma that larger fish species are a greater concern for toxic
metal exposure due to biomagnification (Bryan et al., 1979).
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Metal exposure from dietary fish intake likely explains why we see elevated levels of
mercury in both the SAC and PW groups when compared to reported levels in Canadians,
but the case of Cd and As is interesting as these were not dissimilar between the two
countries. It is difficult to speculate why this was the case, and further studies of lake
metal levels, and concentrations in other foods are needed. Unfortunately metal levels,
particularly lead, were highly elevated in the SAC group where their effects may be
particularly deleterious. The difference between the adults and children could be due to
longer term exposure in adults as only 5-15% of ingested lead is absorbed in the gut
while in children absorption can be up to 40% (International Programme on Chemical
Safety, 1996).
The studies provided the first positive evidence for the use of yogurt containing probiotic
lactobacilli to combat toxic heavy metal exposure in vulnerable human populations. The
results comparing the short term and long term interventions (SAC vs PW) suggest that
probiotic consumption does not have a fast acting effect like DMSA or EDTA, but rather
acts over longer-term. This is likely because the mechanism of action is preventing
uptake into the body from the GI tract, rather than scavenging what is already in the body
as in chelation therapy. Alternatively it may be reflective of differing metabolic or
hormonal differences and/or different indigenous microbes in the PW as compared to the
SAC. Further studies involving time course interventions will be necessary to resolve this
discrepancy and to rule out potential effects of nutrition affecting metal uptake.
Interestingly, in both study groups the mercury and arsenic increased in the control
groups. A delay between sample collection and analysis was unavoidable due to the lack
of instrumentation locally. But, sample storage of mercury, should not interfere with the
analysis (Varian-Ramos et al., 2011), and is more likely explained by seasonal changes in
diet/exposure. Thus probiotic administration may be especially advocated at peak
exposure times.
A high degree of homogeneity in a Prevotella-dominated microbiota is noteworthy. This
profile, referred to as enterotype two (Arumugam et al., 2011) has been previously
observed to be predominant in African populations (De Filippo et al., 2010) and is
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presumed to be due to a carbohydrate rich diet (Wu et al., 2011). Interestingly, enterotype
two is often co-associated with Desulfovibrio spp. (Wu et al., 2011). While we cannot
definitively show the presence of these organisms due to their low abundance and lack of
sequence diversity in the V6 rRNA region, they are associated with mercury methylation
through a mechanism that was only recently understood (Parks et al., 2013), and which
could facilitate increased mercury uptake in the gut. In addition, mucin-degradation by
this microbiome configuration could facilitate increased metal uptake by affecting gut
barrier function (Wright et al., 2000), putting these individuals at greater risk from metal
exposure.
There are a number of mechanisms through which the Succinivibrionaceae and
Gammaproteobacteria may function to facilitate greater lead uptake, including hostinteractions and influencing other members of the microbiota. In fact, the mechanism
may be relatively simple, since the cell wall structure of Gram-negative bacteria has
lower metal binding activity than Gram-positive organisms (Beveridge and Fyfe, 1985).
Given that probiotic treatment was not found to affect relative abundance of either of
these two groups, or any bacterial population, this suggests the mechanism of action is
independent of altering the microbiota, at least at the community structure level.
In summary, this work has demonstrated the potential value of long-term probiotic-based
interventions to counter mercury and arsenic exposure in vulnerable populations,
particularly in pregnant women. This approach can be disseminated at an affordable cost
(equivalent of pennies) in developing countries where individuals are at high risk,
however it could also be applied to developed world citizens and wildlife, for example
those living near mining facilities. We hope that these studies help provide a framework
for further human trials. Though it is reasonable to presume health benefits due to
reduced toxin levels, long-term multi-year studies would help determine if reduction in
toxin levels by probiotic foods results in improvements in physical and cognitive
development in children.
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6.4
6.4.1

Materials and Methods
Study design and participants

Two populations were recruited in the Mwanza region, Tanzania for this study: (i) 44
school aged children aged 6-10 years which will be further referred to as SAC, and (ii) a
subset of 60 pregnant women in their first trimester who were being recruited for a
separate study on nutrition and the microbiome which will be referred to as PW.
In the SAC group, consent was obtained from the child’s guardian, as identified by
school records, and assent was obtained from the child. If a signature could not be
provided, a thumbprint was used in its place. Inclusion criteria was that the child was
aged 6-10 years and in good health, the only exclusion criteria was known milk allergies
and/or lactose intolerance. The guardians were surveyed for basic dietary information
about their child, including the frequency with which they consumed fish and the species
consumed. Blood was collected for determination of metal levels and feces was collected,
stored on ice for less than 4 hours and stored at -80˚C until processing and DNA
extraction. Participants were then randomly assigned (using a random number generator)
to receive either a locally produced yogurt containing 1x1010 CFU Lactobacillus
rhamnosus GR-1 per 250 gram unit or an equivalent portion of ultra-heat treated milk as
a control devoid of lactic acid bacteria. For 19 of the next 24 days, the children were
supervised during administration of either yogurt or milk. Five days were missed due to
logistical issues in administration/yogurt production. Upon completion of the study,
blood and fecal samples were again collected.
As part of a separate study on maternal nutrition and the microbiome (PW), 60 pregnant
women were recruited, of which 26 received a probiotic yogurt containing 1x1010 CFU L.
rhamnosus GR-1 per 250 gram unit and supplemented with 4.3 g of Moringa, a
micronutrient rich plant to enhance maternal nutrition. All women recruited were
between 12 and 24 weeks pregnant and aged 18 to 40 years. Until their final visit after
birth, individuals in the yogurt group received the product for six days a week with an
average number of days consuming yogurt of 102 days ± 19 SD. The control group had
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no form of intervention. For blood trace metal analysis, individuals with ≥ 75%
compliance in the probiotic group were selected along with controls of appropriate age,
nutritional status, and matched fish intake resulting in 12 PW per group. Given that this
was a pilot study, sample size was based upon participant availability.
Both studies were registered with clinicaltrials.gov (NCT01904513, NCT02021799) and
approved in Canada by the Health Sciences Research Ethics Board at Western University
(#102881, #18850) and in Tanzania by the Lake Zone Institutional Review Board.

6.4.2

Dietary exposure

To assess potential exposure to dietary toxic metals via fish consumption, three of the
most commonly consumed fish were collected. All samples were obtained from the main
fish market in downtown Mwanza in early December 2012. Three specimens of each fish
species were collected: Nile Perch (Lates niloticus), Tilapia (Oreochromis niloticus) and
Dagaa/Silver Cyprinid (Rastrineobola argentea). Each was caught from a different area
along the Mwanza coastline. Muscle tissue was removed from the Nile Perch (Lates
niloticus) and Tilapia (Oreochromis niloticus) and frozen at -80 ˚C until analysis. Dried
R. argentea was frozen whole. Samples were digested in aqua regia and analyzed for
lead, mercury, arsenic and cadmium by ICP-MS (Agilent 7700) at the UWO, Analytical
Services Laboratory, London Canada.

6.4.3

Blood metal quantification

Samples were collected in Vacutainer Trace Elements Blood Tubes (Becton Dickinson)
and frozen at -80˚C until analysis. Whole blood samples were digested in ultrapure nitric
acid before being analyzed on an ELEMENT 2 HR-SF-ICP-MS (Thermo Scientific)
according to the standard operating procedures of the Trace Elements Laboratory of the
London Health Sciences Centre for a panel of toxic metals (mercury, arsenic, cadmium,
lead).
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6.4.4

Microbiome analysis

DNA was extracted from frozen fecal samples of the SAC group using the E.Z.N.A Stool
Kit (Omega Biotek) according to the manufacturers’ instructions. Amplification of the
V6 region of the 16S rRNA gene was carried out using the primers
CCATCTCATCCCTGCGTGTCTCCGACTCAGnnnnnCWACGCGARGAACCTTACC
and CCTCTCTATGGGCAGTCGGTGATACRACACGAGCTGACGAC where nnnnn
is a sample specific nucleotide barcode. Amplification was carried out in 42 µL reactions
with 10 µL of 3.2 pMol/µL of each primer, 20 µL GoTaq hot start colorless master mix
(Promega) and 2 µL purified DNA. The PCR protocol was: 2 minutes 95 ˚C, and 25
cycles of: 1 minute each 95˚C, 55˚C, 72˚C. PCR yield was assessed with a Qubit
Flourometer (Life Technologies) and samples were pooled at equimolar concentrations
before a final cleanup with the QIAquick PCR Purification kit (Qiagen). Library
preparation and sequencing was carried out at the London Regional Genomics Centre
(London, Canada) on an Ion Torrent Personal Genome Machine (Life Technologies) with
316 chip following the manufacturers’ instructions.
Resulting reads were extracted, de-multiplexed and grouped into operational taxonomic
units (OTUs) at 97% identity in the manor previously reported (Gloor et al., 2010). Reads
were deposited into the Short Read Archive (BioProject ID: PRJNA244107) and
barcodes and their corresponding sample IDs are available in Supplemental Table 1.
Taxonomic assignments were made by extracting best hits from the Ribosomal Database
Project (rdp.cme.msu.edu) Seqmatch tool. These were manually curated by comparison
to the NCBI non-redundant database and the Green Genes database (greengenes.lbl.gov).
OTU IDs, sequences and taxonomies have been supplied in Supplemental Table S2.
Further analysis was carried out using Quantitative Insights Into Microbial Ecology
(QIIME) (Caporaso et al., 2010) and R (R-project.org). To better handle comparisons of
compositional data, the centered log ratio transformation of Aitchison (1982) adapted to
microbiome data (Fernandes et al., 2013; Fernandes et al., 2014) was used and then
tested using ANOVA with FDR multiple testing corrections. Cadmium was excluded
from analysis due to the limited range of concentrations observed.
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Chapter 7

7

Mercury-resistant lactobacilli to remediate toxic metals
in vitro and in vivo.

Bisanz JE, Trinder M, Gloor GB, van Hylckama Vlieg JET, Smokvina T, Burton JP, Ple
C, Foligne B and G Reid.

7.1

Introduction

Many heavy metals including copper and chromium serve biological functions within
multicellular organisms through specialized functions including as acting as enzyme cofactors (Mertz, 1981). Some metals such as mercury, lead, cadmium and arsenic have
virtually no biological function and are considered detrimental at any concentration.
Nonetheless, these compounds exist in our environment and have increased in
concentration due to anthropogenic activity (Lamborg et al., 2014; McConnell and
Edwards, 2008). The detrimental effects of these elements often include delayed
neurological development in children (Dovydaitis, 2008), cancer (Hughes et al., 2011)
and more controversially cardiovascular and autoimmune disease (Gallagher and
Meliker, 2012; Karagas et al., 2012). New concepts are required to counter these
problems for human and animal health. Most interventions within the field of
bioremediation focus on environmental applications; however given that much exposure
to toxic metals is through the diet, we ask the question: if we cannot remove metals from
food supply, can we prevent their absorption from the gut? The use of food-grade
organisms, including probiotic strains, offers one such possibility.
We have recently shown that probiotic yogurt containing lactobacilli can counter toxic
metal uptake in children (aged 6-10) and pregnant women (Bisanz et al., 2014). We
selected the Lactobacillus rhamnosus GR-1 strain based on unpublished in vitro metal
binding data and the strain’s safe history of use in vulnerable populations (Anukam et al.,
2006; Hummelen et al., 2010; Hummelen et al., 2011a). When a 25 day intervention was
applied in children, toxin adsorption lowered but the levels failed to reach statistical
significance; however, a significant effect was observed in protection against mercury
and arsenic in pregnant women given the intervention for an average of 88 days.
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It had previously been established that lactobacilli have strong affinity for lead and
cadmium (Halttunen et al., 2007b) so it is puzzling that effects were seen in the case of
mercury and arsenic, but not cadmium or lead. This suggested there may be additional
mechanisms of action that are not directly related to a surface binding mediated
sequestration as the literature would suggest. The results of our human studies indicated
that we need to develop new and improved strains specifically tailored for remediation of
toxic metals to improve efficacy. This required further mechanistic studies.
We hypothesize there may be at least four distinct mechanisms involved in probiotic
mediated protection against toxic metals: (i) passive sequestration as previously reported
against cadmium, lead and arsenic (Halttunen et al., 2007a; Halttunen et al., 2007b), (ii)
direct enzymatic detoxification to metal species of reduced toxicity or uptake in the GI
tract, (iii) modulation of host xenobiotic metabolic pathways to favorable alter host
metabolism and elimination of toxic substances, and (iv) modulation of microbiota
composition or function.
As toxic metals are elements, they cannot be truly destroyed, but rather converted to less
toxic forms. In the case of mercury, this is possible through the organomercurial lyase
and mercuric reductase enzymes frequently found in bacterial mercury resistance
(Nascimento and Chartone-Souza, 2003). The end product of this pathway, volatile
elemental mercury (Hg0), is negligibly absorbed in the GI tract while the starting product,
methylmercury (MeHg) is nearly fully absorbed with the intermediate inorganic mercury
(InHg) being absorbed at variable rates (Gochfeld, 2003). Not all interactions of bacteria
and mercury are favorable as it is known many strains also have the capacity to methylate
mercury and at least one human gut isolate (Methanomassiliicoccus luminyensis) has
been show to possess the necessary determinants for mercury methylation (Parks et al.,
2013). This suggests modulating of the microbiota’s capacity for mercury species
interconversion may impact host mercury uptake. Our previous work would suggest there
is no shift in microbiota composition after L. rhamnosus GR-1 consumption which
partially discounts this theory with the caveat of 16S rRNA sequencing being a somewhat
course method to study composition which tells little about function.
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Modulation of host xenobiotic metabolism represents a novel and unreported potential
mechanism relevant to both toxic metals and a range of environmental pollutants as well
as having pharmacological implications. Zhai et al., (2014) demonstrated that orally
administered Lactobacillus strains could protect against liver damage from
intraperitoneally administered cadmium despite not having an impact on cadmium uptake
and tissue distribution. Furthermore, studies in germ-free mice have indicated microbes
play a role in expression of metallothioneins (Breton et al., 2013) and cytochrome p450
enzymes at distal sites such as the liver (Toda et al., 2009). Mechanistic studies of how
microbes can impact function at distal sites are an exciting avenue in probiotic and
microbiome research requiring further studies.
Given previous reports of strain specific toxin sequestering activity (Halttunen et al.,
2007b; Hernandez-Mendoza et al., 2009; Ibrahim et al., 2006) we sought to screen a
collection of 80 L. rhamnosus and L. paracasei strains with draft genomes (Smokvina et
al., 2013) for activity against toxic metals to allow the opportunity to apply comparative
genomics to identify the genetic basis for strain variability and potential effectors.
The goals of this study were to identify novel strains specifically tailored for activity
against toxic metals. Binding and mercury resistance assays were used as a proxy to
uncover lactobacilli harboring mercury-detoxifying enzymes. The strains were further
characterized and the genomic basis of resistance was determined. Finally these strains
were applied in murine models to determine the effect of mercury detoxifying enzymes in
vivo.

7.2
7.2.1

Results
Binding of lead and mercury by strains of L. rhamnosus.

Consistent with previous reports of passive sequestration of lead by lactobacilli, all
studied L. rhamnosus strains were capable of binding a significant portion of the 50
µg/mL lead inoculum in a strain variable manor (Figure 7-1A). Binding efficiencies
varied from 42% (Lr64) to 99% (Lr60 and Lr63). Binding to InHg (as Hg2+) was assayed
in strains Lr64 and Lr60 at 1 µg/mL (Figure 7-1B) and 10 ng/mL (Figure 7-1C)
concentrations revealing up to 95% InHg removal by strain Lr60 with greatest removal at
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higher concentrations. At the 1 µg/mL concentration, Lr60 demonstrated significantly
higher InHg removal than strain Lr64 which was not observed at 10 ng/mL. Neither
strain resulted in production of MeHg from InHg. Removal of MeHg (as CH3Hg+) was
also assayed again at 1 µg/mL and 10 ng/mL (Figures 7-1D and 7-1E) showing
significant removal with a maximum of 45% MeHg removed from solution by strain
Lr60. The effect of viability was also examined in strain Lr60 where it was found that
there was a statistically significant loss of mercury removal ability with a heat-killed
strain, while other strains including Lr136 show no difference. The loss of mercury
removal by Lr60 was coupled with a 16% difference in recovery of mercury by nitric
acid digestion suggesting a loss of mercury from the system.
To examine passive binding, electron microscopy was used. TEM micrographs show the
presence of metal precipitates in association with the cell in the case of both lead and
mercury (Figure 7-2A-C). These precipitates do not appear to be in the surrounding
capsule but rather in close association with the cell. To confirm the composition of the
precipitates, SEM/EDX (representative image of Lr60 with InHg Figure 7-2E) was
applied confirming the composition of the mercury precipitates (Figure 7-2F) and lack of
metals in control cells (Figure 7-2D).
To further characterize the Lr60 strain as well as to screen the collection for the presence
of mercury detoxifying enzymes, mercury resistance was screened in all strains. No strain
showed increased resistance to MeHg and no L. paracasei strain displayed clear
increased resistance to InHg (data not shown). Two strains showed elevated resistance to
mercury in liquid media (strain Lr60 and Lr63), the organisms previously identified as
displaying the highest lead sequestering activity (Figure 7-3A). Lr60 and Lr63
additionally displayed elevated resistance in disk diffusion assays with a difference of 6
mm in the zone of clearing (Figure 7-3B). To determine if resistance to mercury was an
adaptive response, strains Lr60 and Lr63 were precultured in ½ of their minimum
inhibitory concentration (MIC) (6.25 µg/mL) and then were tested again in a MIC assay.
Both strains showed a 2-fold increase in MIC as well as a reduced lag-phase during
growth at 6.25 µg/mL (Figure 7-3C; Lr60 shown as representative of both strains).
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Figure 7-1. Removal capacities of lead and mercury by L. rhamnosus strains.
(A)	
  Lead	
  binding	
  by	
  40	
  strains	
  of	
  L.	
  rhamnosus.	
  Mercury	
  removal	
  by	
  select	
  L.	
  rhamnosus	
  strains	
  
at	
  1	
  µg/mL	
  InHg	
  (B),	
  10	
  ng/µL	
  InHg	
  (C),	
  1	
  µg/mL	
  MeHg	
  (D)	
  and	
  10	
  ng/mL	
  MeHg	
  (E).	
  The	
  effect	
  of	
  
viability	
  on	
  mercury	
  removal	
  by	
  strains	
  Lr60	
  and	
  Lr137.	
  Error	
  bars	
  ±	
  SEM,	
  *	
  p<0.05	
  vs.	
  control	
  
unless	
  otherwise	
  noted.	
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Figure 7-2. TEM and SEM/EDX analysis of metal precipitates in association with L.
rhamnosus Lr60.
TEM	
  micrographs	
  of	
  L.	
  rhamnosus	
  Lr60	
  incubated	
  with	
  Pb2+	
  (B),	
  Hg2+	
  (C),	
  or	
  HEPES	
  control	
  (A).	
  
EDX	
  compositional	
  analysis	
  of	
  individual	
  metal	
  precipitates	
  for	
  mercury	
  (F)	
  and	
  control	
  (D).	
  
Representative	
  SEM	
  image	
  of	
  Lr60	
  incubated	
  with	
  Hg2+	
  for	
  selecting	
  individual	
  precipitates	
  for	
  
EDX	
  analysis	
  (E).	
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Figure 7-3. Mercury resistance screening in L. rhamnosus strains.
Growth	
  across	
  a	
  gradient	
  of	
  InHg	
  by	
  L.	
  rhamnosus	
  strains	
  demonstrates	
  two	
  strains	
  of	
  increased	
  
resistance	
  (A).	
  Disk	
  diffusion	
  assays	
  confirm	
  increased	
  resistance	
  (6mm)	
  in	
  Lr60	
  and	
  Lr63	
  as	
  
compared	
  to	
  Lr136	
  and	
  Lr64	
  (B).	
  Induction	
  in	
  ½	
  MIC	
  reduces	
  growth	
  inhibition	
  upon	
  re-‐culturing	
  
at	
  ½	
  MIC	
  as	
  compared	
  to	
  Non-‐induced	
  control	
  (C).	
  

7.2.2

Genetic determinants of mercury resistance in L. rhamnosus

At the time of this genomics work (2012-2013), no publically available genome of
Lactobacillus were found to contain a full-length mercuric reductase (merA) or
organomercurial lyase (merB). There has been a recently sequenced genome (Tanizawa
et al., 2015) of Lactobacillus hokkaidonesis JCM 18461 isolated from silage that likely
contains a merA gene. It was determined that many Lactobacillus genomes contain a
miss-annotated dihydrolipoamide dehydrogenase gene which is identified as merA due to
homology in the pyridine nucleotide-disulphide oxidoreductase and dimerization
domains. The dihydrolipoamide dehydrogenase critically lacks the N-terminal heavy
metal associated domain containing two cysteine residues to bind the mercury ions. A
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clustal alignment of the MerA of Lr60 and two miss-annotated dihydrolipoamide
dehydrogenases is included in Figure 7-4.
To determine the genetic basis for increased mercury resistance in L. rhamnosus Lr60
and Lr63, a comparative genomics approach based on the machine learning approach
used in chapter 3 was attempted which failed to yield meaningful results. Direct searches
for merB and merA by BLASTP to validated Gram-positive genes discovered the
presence of a full-length merA exclusively in the genomes of strains Lr60 and Lr63. It
was determined that during clustering of orthologous protein groups, the true merA of
Lr60 and Lr63 was inappropriate clustered with the dihydrolipoamide dehydrogenase
present in other strains.
Due to low coverage in the initial genome sequencing, the genomes of strain Lr60 and
Lr63 were resequenced via Illumina MiSeq. This resulted in draft genome assemblies for
Lr60 (28-fold coverage, n50=125430bp) and Lr63 (27-fold, n50=100067bp) that were
sufficient to resolve the genomic context of the merA gene. The mercuric reductase was
found in a presumed operon structure with a merR transcriptional regulator (Figure 75A). Co-transcription of the merR and merA genes was verified by nested PCR from
cDNA (Figure 7-5B) while their up-regulation in response to mercury was verified by
qPCR (Figure 7-5C). Maximal up-regulation (10.6-fold merA; 11.3-fold merR) after 1
hour was observed at ½ MIC (6.25 µg/mL).
The merRA operon appears to be found in an identical 10 kb horizontally acquired region
in both Lr60 and Lr63 as determined by a significant GC-skew and interpolated variable
order motif analysis (Vernikos and Parkhill, 2006) (Figure 7-5A). Additionally the
insertion appears to have occurred in the vicinity of tRNA genes and it has remnants of
transposon machinery, which is further indicative of horizontal gene transfer. The
transfer also appears to have carried a cadD cadmium efflux protein as well as copper
resistance determinants. Comparison to the Insertion Sequence database (https://wwwis.biotoul.fr) reports no hits. The merA has high nucleotide identity to that of oral
streptococci (99% nucleotide ID, 96% coverage; S. oralis Genbank: AJ582645.1, S. mitis
Genbank:AJ582646) though the putative horizontally acquired region appears to be a
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mosaic of other organisms, including regions homologous to Bacillus cereus RC607, thus
it is not possible to identify a single possible source of the gene transfer. Additionally it
was determined that Lr60 and Lr63, both isolates from fermented cereal, are extremely
similar sharing 99.97% average nucleotide identity (ANI). This level of similarity may
indicate they are in fact isolates of the same strain. For reference, Lr60 and L. rhamnosus
GR-1 have a 99.20% ANI while the earlier 454 assembled draft genome of Lr60 and the
newer MiSeq assembly have an ANI of 99.95%. The 16S rRNA, cpn60, gyrB, dnaJ and
ldhL genes are also identical in nucleotide composition. Finally predictions of unique
genes, based on reciprocal blasts of all predicted protein coding sequences suggest few
genes with assignable functions unique to each strain. Further studies focused solely on
strain Lr60 given the extreme similarity between the Lr60 and Lr63 strains.

Figure 7-4. Clustal alignment of the MerA of Lr60 with the dihydrolipoamide
dehydrogenase frequently misannotated as a mercuric reductase.
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Figure 7-5. Genomic and transcriptional characterization of mercury resistance in
L. rhamnosus Lr60.
(A)	
  A	
  minimal	
  mercury	
  resistance	
  operon	
  (merRA)	
  was	
  located	
  in	
  a	
  horizontally	
  acquired	
  region	
  
as	
  indicated	
  by	
  skewed	
  GC	
  composition	
  and	
  interpolated	
  variable	
  order	
  motif	
  analysis	
  prediction	
  
of	
  horizontally	
  acquired	
  regions	
  (in	
  blue).	
  (B)	
  It	
  was	
  determined	
  that	
  merR	
  and	
  merA	
  are	
  co-‐
transcribed	
  as	
  indicated	
  by	
  a	
  1889	
  bp	
  product	
  bridging	
  the	
  genes	
  amplified	
  from	
  cDNA	
  prepared	
  
from	
  DNA-‐free	
  RNA	
  from	
  Lr60.	
  (C)	
  merRA	
  is	
  up-‐regulated	
  by	
  exposure	
  to	
  InHg	
  in	
  a	
  dose-‐
dependent	
  manor.	
  

7.2.3

Validation of merA function

Given that a mercuric resistance operon (merRA) has never been described in a
Lactobacillus species, we sought to validate the function of the genes through mutant
analysis. The merRA operon from Lr60 was cloned into pLAB1301, a Lactobacillus-E.
coli shuttle vector and electroporated into the mercury sensitive L. rhamnosus GR-1.
MIC analysis of the resultant GR-1 pLAB1301-merRA showed a 4-fold increase in MIC
as opposed to the WT and vector controls (Figure 7-6A). The merRA of Lr60 was
knocked out through allelic exchange with chloramphenicol acetyltransferase (cat) (Lr60
∆merRA::cat) revealing a 4-fold loss in MIC which was complemented by pLAB1301merRA (Figure 7-6B). To demonstrate that the merRA operon results in volatilization of
mercury as expected from the merA, the X-ray film method was used which demonstrated
volatilization from the Lr60 WT and complemented strains, but not in the Lr60
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∆merRA::cat strain (Figure 7-6C). Mercury volatilization is determined by darkening of
the film due to reaction of Hg0 with the silver halides in the film.

Figure 7-6. Validation of merA function by mutant analysis and volatilization assay.
(A)	
  Expression	
  of	
  merRA	
  amplified	
  from	
  Lr60	
  in	
  the	
  mercury	
  sensitive	
  L.	
  rhamnosus	
  GR-‐1	
  strain	
  
results	
  in	
  a	
  4-‐fold	
  increase	
  in	
  resistance	
  to	
  mercury	
  as	
  indicated	
  by	
  MIC	
  assay.	
  (B)	
  Knock-‐out	
  of	
  
merRA	
  in	
  Lr60	
  results	
  in	
  a	
  4-‐fold	
  loss	
  in	
  mercury	
  resistance	
  which	
  is	
  reverted	
  by	
  
complementation.	
  (C)	
  X-‐ray	
  film	
  demonstrates	
  production	
  of	
  Hg0,	
  as	
  indicated	
  by	
  a	
  dark	
  spot	
  
over	
  the	
  film,	
  in	
  WT	
  and	
  complemented	
  Lr60,	
  but	
  not	
  the	
  knock-‐out	
  strain.	
  

7.2.4

Protective effects of lactobacilli in murine models of acute
and sub-chronic metal exposure

To test the effect of lactobacilli on both acute and sub-chronic dosing schemes of both
mercury and a combination of toxic metals (Hg, Pb, Cd; Figure S1), as well as to
determine the effect of the Lr60 merRA operon in vivo, Balb/C mice were used. The
ultimate endpoint was quantification of blood and tissue metals that will differentiate the
effect of mercury resistance determinants. This analysis has been pending for 5 months
due to logistical issues at the University Hospital of Lille and thus is unavailable for the
purposes of this thesis.
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As a marker of heavy metal toxicity, kidney histology was examined due to the extreme
toxicity that these metals have for the kidney. Figure 7-7A shows representative images
of the H&E stained transverse kidney sections from the saline control while 7-7B and 77C show the sections from the Hg and heavy metal cocktail (HMC) groups. It can be
noted in both the mercury and HMC groups, that there is a loss of regularity and
noticeable hypertrophy at the renal corpuscle. In the groups treated with L. rhamnosus
Lr60, this damage seems to have been negated demonstrating a protective effect of Lr60
in vivo. Similar effects were observed in the sub-chronic dosing scheme but no
differences were observed between the mutants of Lr60.

Figure 7-7. Histological analysis of effect of strain Lr60 on protection against
mercury and a mixture of toxic metals.
H&E	
  stained	
  kidney	
  sections	
  of	
  mice	
  in	
  acute-‐dosing	
  study	
  from	
  control	
  (A),	
  mercury	
  (B),	
  heavy	
  
metal	
  cocktail	
  (C),	
  mercury	
  +	
  Lr60	
  (D)	
  and	
  heavy	
  metal	
  cocktail	
  +	
  Lr60	
  (E)(representative	
  
images).	
  Kidneys	
  treated	
  with	
  metals	
  alone	
  (B	
  and	
  C)	
  show	
  damage	
  at	
  the	
  level	
  of	
  the	
  renal	
  
corpuscle	
  (arrows).	
  This	
  damage	
  appears	
  to	
  be	
  negated	
  by	
  treatment	
  with	
  Lr60	
  (D	
  and	
  E).	
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7.2.5

Modulation of xenobiotic metabolism by L. rhamnosus GR-1

Given the previous effects of L. rhamnosus GR-1 in human populations and its
previously observed abilities to act at distal sites from the gut (Gan et al., 2014), it was
selected for potential studies on modulation of xenobiotic metabolism. Balb/C mice were
orally gavaged with either L. rhamnosus GR-1 or saline vehicle control daily for 3 days
before sacrifice. The liver, kidneys and duodenum were harvested and RNA extracted
and transcriptionally profiled by microarray and qPCR. Genes determined to be
significantly differentially expressed (p<0.05, ±2-fold) were subjected to GO enrichment
analysis demonstrating that xenobiotic metabolic processes were significantly enriched in
transcripts in the liver but not the kidney (p<0.05). Table 7-1 contains a list of genes of
interest related to xenobiotic metabolism and damage and which were found to be
differentially regulated by L. rhamnosus GR-1. A subset of these genes was confirmed by
qPCR (Figure 7-8) demonstrating significant increased expression of Por (8.3-fold),
Fmo2 (7.1-fold) and Fmo3 (5.0-fold) in the liver after administration of L. rhamnosus
GR-1.
Table 7-1. Differentially regulated liver transcript by L. rhamnosus GR-1 with
functions related to xenobiotic metabolism.

Gene

Annotation

Fold-Change
(GR-1 vs. Control)

Por

P450 Oxidase

2.58324

Fmo2

Flavin containing monooxygenase 2

2.45478

Fmo3

Flavin containing monooxygenase 3

2.07543

Il1b

Interleukin 1 beta

-2.68131

Cyp2b10

Cytochrome P450 2b10

-2.82371

Gstm3

Glutathione S-transferase (mu-3)

-2.13694
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Figure 7-8. qPCR validation of por, fmo2, and fmo3 genes show up-regulation of
transcripts by L. rhamnosus GR-1. *p<0.05

7.3

Discussion

The work described in this manuscript represents our intent to mechanistically understand
how strains of lactobacilli may have protective effects against toxic metals in vitro and
builds upon previous knowledge of binding-only mediated mechanisms.
Our results agree with others (Halttunen et al., 2007b; Peltonen et al. , 2001; Stidl et al.,
2008) indicating lactobacilli have the capacity to interact with a variety of environmental
pollutants via a passive binding. Given the surface of most Gram-positive bacteria is
negatively charged, it makes sense that they should be able to interact with metals
through electrostatic interactions and the nature of strain-variable binding of metals
suggests altered composition of the cell surface (Beveridge and Fyfe, 1985). By far, the
worst metal binding strain observed in these studies was strain Lr64, which is interesting
as it is has a unique mucoid phenotype when grown on solid media suggesting the
presence of a large amount of extracellular polysaccharide (EPS). Though not the focus
of these particular studies, the machine learning approach previously applied (chapter 3)
would suggest that there is a negative association between a number of EPS-related
glycosyltransferases and lead binding capacity. Furthermore, our TEM figures show little
evidence of metal precipitates in the extracellular polysaccharides surrounding Lr60, but
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rather in close association with the cell. Further localization would require ultra thinsectioning but recent work would suggest that localization within the cell may depend on
the particular metal under study (Monachese, 2012). The capsule has been suggested as a
potential binding site for metals (McLean and Beauchemin, 1990) however the present
data suggest the EPS of lactobacilli lacks this capacity. The observation of distinct
precipitates on the cell begs the question of what may be the nucleation site and if there
may be a more specific site of binding than negatively charged groups in the
peptidoglycan and teichoic acid (Beveridge, 1989).
While binding has been shown to be the predominant mechanism of interaction with lead
and cadmium, the case of mercury is more interesting given its known bacterial pathways
of detoxification (Nascimento & Chartone-Souza, 2003). Highest mercury removal was
obtained with InHg, but significant levels of removal were still observed with MeHg. The
reduced capacity may be due to the lower positive charge of MeHg, however significant
binding still occurred at very low levels (10 ng/mL). Our initial hypothesis that mercuryresistant lactobacilli would be superior remediators of metals resulted in the discovery of
the Lr60 and Lr63 strains. While in vitro, the predominant mechanism is most likely
binding, as indicated by elevated rates of removal by non-viable Lr60, there is a highly
reproducible loss of removal efficiency coupled with increased recovery of mercury from
the system indicating a volatilization mechanism as well. The sensitive Lr136 strain, also
a strong binder of metals, shows no difference in mercury removal when killed. We
would hypothesize that improved metal removal would be expected from non-viable
strains due to a dissipation of the proton motive force increasing the net negative charge
of the cell surface (Mera et al., 1992).
The identification of mercury resistance in L. rhamnosus Lr60 and Lr63 is a novel
finding in lactobacilli. Unlike common antibiotics in typical clinical isolates, agencies
such as the Clinical and Laboratory Standards Institute have not established thresholds
for mercury resistance in lactobacilli. The term resistance is used in this work due as the
observed phenomenon fits two key criteria of resistance: (i) the resistant strains can grow
in concentrations that kill the majority of the strains of the same species, (ii) the presence
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of genetically encoded resistance elements with an observable phenotype when
transferred to sensitive strains.
The discovery of a novel horizontally acquired minimal mercury resistance operon
(merRA) present in the Lr60 and Lr63 strains is a unique observation. While there appear
to be remnants of transposon machinery, the region is unlikely to still be mobile as it
lacks the typical inverted repeats of a bacterial transposon (Foster et al., 1981) and may
represent a composite of multiple gene rearrangements in this region. Given that the
acquired region also contains cadmium and copper resistance elements, it can be
suggested that this acquisition was due to the exposure of the strain to toxic metal levels
in the past, which could have occurred for any number of reasons. Despite being
speculative, it is possible that transfer from streptococci could have occurred in the oral
cavity due to mercury exposure from dental amalgam fillings.
To test the hypothesis that mercury-detoxifying enzymes confer increased mercury
remediation capacity in vivo required the use of animal models, however due to logistical
issues outside the control of the investigators, not all of this data are available for this
thesis. Nonetheless, preliminary investigation by histology has demonstrated a protective
effect against kidney damage by both the Lr60 and GR-1 strains in agreement with the
observations of our previous human studies (Bisanz et al., 2014).
Finally, the exploratory analysis of how oral probiotics may affect distal function in the
liver is an exciting area for future research. The finding of the cytochrome P450
reductase (por) expression up-regulated by L. rhamnosus GR-1 is significant given that
Por is an obligate electron donor for many of the cytochrome P450 enzymes which are
key components in xenobiotic metabolism. Thus the altered regulation of cytochrome
P450 reductase likely represents a significant alteration in the broad functions of many
CYP enzymes. There is likely cross-over between the mechanisms by which the gut
microbiota, and orally administered probiotics can modulate xenobiotic metabolism.
Differential regulation of a number of the other CYP enzymes including Cyp2B10 is also
noteworthy given links between gut microbiota modulation of xenobiotic metabolism
through the CAR receptor (Björkholm et al., 2009). Altered expression of the
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inflammatory mediator interleukin 1 beta (IL1B) could represent one mechanism by
which decreased liver damage could be observed without direct interaction of the metals
and lactobacilli as demonstrated by Zhai et al. ( 2014) in models of intraperitoneally
cadmium and oral lactobacilli administration. While modulation of cytochrome P450
function is of less significance to toxic metals, up-regulation of glutathione S-transferase
(gstm3) is directly relevant as the glutathione S-transferases are important in countering
metal-mediated oxidative damage as well as direct conjugation of metals to glutathione
(Casalino, 2004; Gregus and Varga, 1985). In this case however, expression of gstm3
was down-regulated by L. rhamnosus GR-1 which demonstrates on our limited
understanding of how microbes may affect xenobiotic metabolism. This set of
experiments sheds light on modulation of host xenobiotic metabolism as a potential
mechanism through which lactobacilli may exert beneficial effects. This is not limited to
toxic metals, but a broad range of dietary toxins as well as having implications for
pharmacology.
We hypothesized multiple mechanisms involved in probiotic mediated protection against
toxic metals and have provided evidence of three in the current manuscript: (i) passive
sequestration, (ii) direct enzymatic detoxification, and (iii) modulation of host xenobiotic
metabolic pathways to alter host metabolism and elimination of toxic substances. In
addition we have characterized new strains specifically tailored to counter toxic metals.
The strength of this study is that it provided multiple lines of evidence and attempted to
describe probiotic function at the gene level. Future analysis and studies branching from
this work will help to increase our understanding of probiotic function and create strainlevel microbial therapies to counter environmental toxins.

7.4
7.4.1

Materials and Methods
Culture conditions

All Lactobacillus strains except L. rhamnosus GR-1 were obtained from the Danone
Research collection (Palaiseau, France) and were maintained on de Man, Rogosa and
Sharpe (MRS; BD Biosciences) agar at 4˚C after culture at 37˚C for 48 hours under
anaerobic conditions (BD GasPack, BD Biosciences). Master stocks were maintained at -
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80˚C in MRS supplemented with 20% glycerol. L. rhamnosus GR-1 was obtained from
an in-house strain collection and was originally isolated from the urogenital tract of a premenopausal woman (Reid et al., 1987). When required, MRS was supplemented with 5
µg/mL erythromycin or 15 µg/mL chloramphenicol. Lactobacilli were heat-killed as
needed by incubation at 60˚C for 30 min followed by confirmation by plating on MRS
agar and 72 hour incubation in anaerobic conditions at 37˚C. Strains were subcultured
twice in MRS broth (1 % v/v inoculum) before use in assays. Electrocompetent
Escherichia coli TOP10 was obtained commercially (Thermo Fischer/Life Technologies)
and used as the host for all cloning experiments. E. coli TOP 10 was maintained on LB
(lysogeny broth; BD Biosciences) or BHI (Brain Heart Infusion; BD Biosciences)
supplemented with 100 µg/mL ampicillin or 200 µg/mL erythromycin where appropriate.
Bacillus megaterium MB1, a mercury resistant strain used a positive control was obtained
from CC Huang (National Chung Hsing University, Taiwan).

7.4.2

Metal binding assays

Lead binding assays were carried out in duplicate experiments with 3 technical replicates
each using modified methods of Halttunen et al. ( 2007b). Strains were normalized to an
OD600nm=2.0 corresponding to a count of ~2x109 CFU/mL and 200 µL of normalized
culture was centrifuged at 5,000 g for 20 minutes before being washed twice in Milli-Q
H2O (pH=5) and recentrifuged as before with the supernatants discarded. Cells were then
resuspended in 200 µL Milli-Q H2O (pH=5) containing 50 µg/mL Pb2+ (prepared from 10
mg/mL analytical standard; Sigma Aldrich) before incubation for 4 hours at 37˚C. After
incubation, cells were centrifuged at 5,000 g for 20 minutes and the supernatant removed.
The supernatant was acidified with 40 µL of 20% Nitric Acid (VWR) and frozen for
analysis by inductively coupled plasma- atomic emission spectroscopy (ICP-AES) at the
Biotron Facility (University of Western Ontario). Results were normalized to an
uninoculated control and 50 µg/mL standard and converted to a percentage bound by the
following formula 100 x (1-([sample]/[uninoculated control])).
Mercury removal assays were performed by using 10 mL of culture normalized as before
which was centrifuged for 20 minutes at 5,000 g. The supernatant was removed and
replaced with 10 mL of MRS containing either 1 µg/mL or 10 ng/mL InHg (HgCl2;
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Sigma Aldrich) or MeHg (CH3HgCl; Sigma Aldrich) from 10 mg/mL stocks prepared in
Milli-Q H2O or 100% ethanol respectively. After 24h of incubation at 37˚C, the cultures
were centrifuged as before and the supernatant immediately frozen for analysis by cold
vapor atomic absorption spectroscopy at the Biotron Facility (University of Western
Ontario). Samples were normalized as before. When cultures were digested in 20% nitric
acid to recover bound mercury, they were resuspended in 12 mL nitric acid and heated at
60˚C overnight. Wet mass (average = 300 mg) and cell concentration (average = 2x109
CFU/mL) after experiments were recorded to ensure consistent normalization of cultures.

7.4.3

Electron microscopy

For both transmission electron microscopy (TEM) and scanning electron microscopy
(SEM), 1 mL cultures were centrifuged at 5,000 g for 10 minutes and washed 3 times in
50 mM HEPES buffer before being resuspended in 10 mL 50 mM HEPES buffer
containing 1 mM Hg2+ or Pb2+. Cultures were incubated for 4 hours at 37˚C. For TEM, 10
µL was spotted directly on to electron microscopy grids (Formvar carbon film on 400
mesh copper, FCF400-CU; EMS Diasum) and allowed to dry. The whole mounts were
then imaged using a Philips 420 Transmission Microscope at an accelerating voltage of
80 kV and approximate magnification of 19,000X. For SEM, the cultures were filtered
through a 0.22 µM nitrocellulose filter that was then dried and coated with osmium
tetroxide (5 nm; OPC80T Filgen Biosciences and Nanosciences). The filters were then
imaged with a LEO 1540XB scanning electron microscope (Zeiss) fitting with EDX
module (Oxford Instruments) for determining elemental composition at 10 kV and a
working distance of 8.6 mm using backscatter electron detector mode.

7.4.4

Mercury resistance phenotyping.

Cultures normalized to an OD600nm=2.0 were subcultured at 2.5% v/v into MRS media
containing various concentrations of mercury prepared from mercury stocks as previously
described in 96-well microplates (Corning Life Sciences). Plates were incubated for 24
hours at 37˚C. Plates were either scanned after 24 hours or continuously read every 30
min (Figure 7-3C) at OD600nm in a Multiskan Ascent (Thermo Fisher) plate reader.
Minimum inhibitory concentration was defined as the lowest mercury concentration in
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which no growth could be observed. Disk diffusion assays were prepared by swabbing
(BD Culture Swab, BD Biosciences) cultures normalized to 1x108 CFU/mL (equivalent
cell density to 0.5 McFarland E. coli standard) on 55 x 16 mm petri dishes (VWR)
containing 10 mL MRS agar. Disks were prepared by placing 100 µg HgCl2 in Milli-Q
H2O on ¼ inch diameter paper disks (BD Biosciences) and air drying. Mercury
volatilization assays were carried out using the X-ray film method of Nakamura and
Nakahara (1988) with Amersham Hyperfilm ECL film (GE Life Sciences) using Bacillus
megaterium MB1 as positive control (Oyetibo et al., 2015). Mercuric reductase
expression was induced by 24 hours growth in 1 µg/mL HgCl2 before assaying.

7.4.5

Genome sequencing

Original draft genomes were prepared by 454 pyrosequencing as previously described
(Smokvina et al., 2013). Resequencing of L. rhamnosus Lr60 and Lr64 was carried out
by extracting gDNA from late-exponential cultures grown in MRS using the Purelink
Genomic DNA kit with RNase kit (Life Technologies/ Thermo Fisher). The sequencing
library was prepared with the Illumina Nextera XT kit and sequencing by Illumina MiSeq
(London Regional Genomics Centre) using paired 2x150 bp reads. Reads were assembled
using the Velvet short read assembler (Zerbino, 2010) using a 31 bp k-mer size and
automatic coverage estimation with a minimum contig length of 100 bp. Gene predictions
and annotations were carried out using the Rapid Annotation using Subsystem
Technology pipeline (RAST.nmpdr.org). Comparison of genomes was carried out using
command-line BLASTN and BLASTP (BLAST+ v2.2.30+) and average nucleotide
identity was calculated using online tools (LM Rodriguez and K Konstantinidis; enveomics.ce.gatech.edu/ani/). Prediction of horizontally acquired regions was carried out
using GC-skew (Artemis Genome Browser) and interpolated variable order motif
analysis (Vernikos & Parkhill, 2006).

7.4.6

Gene expression

RNA was extracted for all samples using TRIzol reagent (Invitrogen) and the Purelink
mRNA Minikit with on-column DNase treatment following the manufacturers protocols
(Life Technologies/ Thermo Fisher). RNA concentration and purity was accessed using
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Qubit 2.0 Fluorometer (Life Technologies/ Thermo Fisher) and Nanodrop ND-1000
(Thermo Fisher) where required. RNA integrity was confirmed by Bioanalyzer analysis
(Agilent Technologies) when required.
Bacterial samples were pretreated before RNA extraction by preservation in 2 volumes of
Bacterial RNA Protect (Qiagen) following the manufacturers recommendation followed
by 30 minute enzymatic treatment with 20 mg/mL lysozyme and 50 U/mL mutanolysin
(Sigma Aldrich) at 37˚C in pH=7 TE buffer. Cultures for merRA relative quantification
were harvested at mid exponential growth (~6 hours) and repeated in triplicate
experiments.
cDNA was prepared using the high-capacity reverse transcription kit (Life Technologies/
Thermo Fisher) from between 200ng-2µg total RNA following the manufacturers
protocols. qPCR was performed in 10 or 20 µL reactions using Power SYBR Green
master mix (Life Technologies/ Thermo Fisher) using gyrB and B-actin as endogenous
reference genes for Lr60 and Mus musculus respectively. qPCR results were analyzed
using SDS RQ 6.3 manager software (Applied Biosystems). Primers used for qPCR
analysis and their amplification efficiencies are listed in Table S7-1. All target probe sets
had an amplification efficiency within 5% of the endogenous reference gene. Nested PCR
of cDNA to confirm co-transcription of merR and merA was accomplished using the
merA forward and merR reverse qPCR primers to confirm an 1889 bp amplicon.
Microarrays were prepared and analyzed as before (Hummelen et al., 2011b) with the
Affymetrix Mouse Gene 2.0 ST array platform.

7.4.7

Mutant construction

The erythromycin resistance carrying pLAB1301 plasmid was derived from the
CMPG10208 plasmid provided by S. Lebeer (U Antwerpen, Belgium) by the excision of
the dlt promoter in the EcoRI site and re-ligation. The merRA fragment was amplified
from Lr60 gDNA using the primer pair merRA_f_EcoRI and merRA_r_EcoRI and
ligated into the EcoRI site of pLAB1301. Primers used for cloning are provided in Table
S7-2. Orientation was confirmed by double-digest, PCR and sequencing. The construct
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was then electroporated into L. rhamnosus GR-1 following the protocol of De
Keersmaecker et al. (2006) followed by recovery on MRS supplemented with
erythromycin. Potential transformants were screened by colony PCR using the primer
pair merRA_f_ECOR1 and merA reverse qPCR primer to screen for successful
transformants. Colony PCR of L. rhamnosus was accomplished by microwaving for 3
minutes on high (Proctor Silex model 87007 microwave oven) prior to 35 cycles of PCR
with AmpliTaq Gold hot start enzyme (Life Technologies/ Thermo Fisher). The parent
strain was verified by ERIC-PCR to ensure the correct genetic background (Ventura &
Zink, 2006).
For knockout of merRA, the method of Li et al. (2011) using the temperature sensitive
plasmid pG+host5 carrying erythromycin resistance (Biswas et al., 1993) was applied.
1000 bp of upstream (HR1) and downstream regions (HR2) of the merRA operon was
amplified using the primer pairs KO_merRA_HR1_f_SalI/KO_merRA_HR1_r_EcoRV
and KO_HR2_f_BamHI/KO_HR2_r_XbaI. These were sequentially cloned into
pG+host5 flanking the chloramphenicol resistance gene (cat) of pLi50 amplified using
the primer pair pLI50_cat_f_EcoRV/pLI50_cat_r_BamHI. The new plasmid, pG+host5HR1-cat-HR2 was electroporated into Lr60 as before and transformants were selected on
5 µg/mL erythromycin with 48 hours incubation anaerobically at 30˚C. To facilitate
integration, successful transformants were then incubated at 40˚C under chloramphenicol
selection. Recovered clones carrying chloramphenicol and erythromycin resistance were
then reverted to 30˚C without selection for sequential subculturing without antibiotic
selection to facilitate excision and curing of the plasmid. Final clones were screened for
chloramphenicol resistance (due to merRA/cat exchange) with the absence of
erythromycin resistance. Allelic exchange was verified by colony PCR and sequencing of
the locus.

7.4.8

Mouse experiments

For the metal experiments, a total of 88 female Balb/C aged 6 weeks were randomly
assorted into 11 groups of 8 as outlined in Figure S1. The mice were housed with ad
libitum food and water at a temperature of 22˚C on a 12h light/ 12h dark light cycle.
These experiments were performed according to the policies of the Institut Pasteur de
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Lille Animal Care and Use Committee. The study was covered under the protocol
approved (number: 04/2011) by Nord-Pas-de-Calais Ethics and Welfare Committee for
Experiments on Animals. All animals received daily oral gavage with 1x109 CFU of L.
rhamnosus GR-1, Lr60 WT, Lr60 ∆merRA::cat, Lr60 ∆merRA::cat pLAB1301-merRA or
saline vehicle control. After 3 days of wash-in, metal dosing began. In the acute dosage, a
single oral gavage was given of either mercury alone (5 mg/kg b.w. in a 2:1 ratio of
MeHg:InHg mimicking human daily exposure) or a heavy metal cocktail (1 mg/kg Hg,
10mg/kg Pb2+ and Cd2+). After 24 hours, sacrifice occurred. Similarly, in the sub-chronic
dosing scheme, after 3 days wash-in, mercury (0.5 mg/kg/day) or a cocktail (0.3
mg/kg/day Hg, 1 mg/kg/day Cd and Pb) were administered through the drinking water for
28 days along with continual daily oral gavage of lactobacilli as before. Every 4 days,
food and water consumption were measured to ensure consistent metal dosing between
groups. On day 28 sacrifice occurred.
Prior to sacrifice by cervical dislocation, blood was collected by retro-orbital bleeding.
Immediately after sacrifice, a portion of liver, kidney and a 1 cm segment of the
duodenum were collected in RNA later while SI and caecal contents were collected for
microbial DNA and RNA extraction (analysis pending). A portion of kidney, liver and
spleen were additionally collected for metal quantification as well as histology by
preservation in 4% formalin/PBS.
For the xenobiotic metabolism experiments, mice were orally gavaged with either L.
rhamnosus GR-1 (n=7) or saline vehicle control (n=7) daily for 3 days before sacrifice.
The liver, kidneys and duodenum were harvested and RNA extracted and
transcriptionally profiled by microarray and qPCR as described in section 7.4.6.

7.4.9

Histology

After ≥48 hours of fixation in 4% formalin/PBS, tissue samples were sequentially
passaged through 50% and 70% ethanol for 30 minutes each, 95% ethanol for 2 hours,
and 100% ethanol over night. The ethanol was then replaced with toluene for 30 minutes
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before being transferred to paraffin wax overnight. Samples were then embedded in
paraffin blocks before sectioning into 5 µM sections using a Leica RM2235 microtome
(Leica Biosystems). After drying overnight, samples were deparaffinized and rehydrated
through subsequent xylene and ethanol baths before staining with haematoxylin and eosin
(Sigma Aldrich). Slides were then rehydrated and mounted using Permount medium
(Sigma Aldrich). Images were obtained with a Zeiss Axioscope microscope with a total
magnification of 100X using Northern Eclipse software (EMPix Imaging).
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Figure S1. Murine study design.
Table S1. Primers used for qPCR.
Efficiency

R2

CGTCAGCCGGATGTTCCATA

94.2

0.998

GCGCTCGTTAATCGGGAAAC

ATGCGCCCCTAACACTTTCA

97.6

0.999

merR

CAAGAACCTCACCGAACGGA

CCCAACACGCTTAACGTCATC

93.8

0.999

B-actin

GATGTATGAAGGCTTTGGTC

TGTGCACTTTTATTGGTCTC

96.1

0.997

fmo2

AAAGAGTTAACCTGTTTGGG

GTACTGGTAGGAATTACAGGG

92.0

0.991

por

CTCCAAGATCAGGTATGAATC

GGAACGGATGCTTCTTATTC

92.4

0.979

fmo3

CCTTTAAACAGAACACTCAGG

GTGAACTCCTTTACATTAGGC

93.1

0.969

Gene

Forward Primer Sequence

Reverse Primer Sequence

gyrB

CCGCAGTTGTTTCGGTCAAG

merA
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Table S2. Primer sequences used for cloning.
Primer

5' Extension

RE site

Primer

merRA_f_EcoRI

GGTGGT

GAATTC

TCCGTCGATGTGGAGAAATTGT

merRA_r_EcoRI

ATCATC

GAATTC

TCCCAGAAGGTAGATCCGCA

KO_merRA_HR1_f_SalI

GGTGGT

GTCGAC

ACTGTAGGTGCCGTCAGTTG

KO_merRA_HR1_r_ECORV

ATCATC

GATATC

ACATCCCACCAGAAAATCCGA

pLI50_cat_f_EcoRV

GGTGGT

GATATC

ACTTCAACGCACCTTTCAGC

pLI50_cat_r_BamHI

ATCATC

GGATCC

TTATAAAAGCCAGTCATTAGGCC

KO_merRA_HR2_f_BAMHI

GGTGGT

GGATCC

CTCCCTATTCAAGTGAACCAGC

KO_merRA_HR2_r_XbaI

ATCATC

TCTAGA

AGCCCGTGCCTAGATATTGC
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Chapter 8

8

General Discussion

Harnessing the power of the microbiome is increasingly finding its way into medical
practice and indeed everyday life. This can be seen through the recent fascination with
the effects of fecal transplants (Kelly et al., 2015). Despite a recent boom in the
probiotics sales, consumer interest and demand invariably requires constant
documentation of benefits, an understanding of probiotic mechanisms, and support from
caregivers who use them in clinical practice. Education programs on how microbemediated therapies can be best manipulated for health have not yet reached mainstream
healthcare providers.
A relative of mine was recently prescribed Lactobacillus after visiting their general
practitioner. No mention of what strain, formulation, or dosing regime was given: simply
a written note saying “Lactobacillis”. More personally, on a recent visit to the dentist
where I was prescribed antibiotics, my dentist, unaware of my background, advised that I
should probably take probiotics to avoid antibiotic associated diarrhea (AAD). This is
commendable. The problem lies in that they then recommended I take Activia, or that if I
wanted a “real probiotic”, I should go to the health food store. There is no literature that
suggests Activia would be effective in preventing AAD, despite a number of
formulations providing protective effects (Goldenberg et al., 2013). Additionally the
current regulatory environment seems inappropriate where the word probiotic is all but
banned in the European Union (Reid, 2011) yet it can be used virtually without restriction
in the natural health supplements in Canada and the USA. Recently, when making a
protein-shake I discovered that for the past 2 years I have been unknowingly consuming
L. fermentum probiotics in the protein powder I purchase. There is no mention of the dose
nor do I suspect that L. fermentum can survive particularly well in protein powder.
Furthermore, no information on the strain is supplied despite many probiotic effects
being strain specific.
The difficulty lies in that any competent microbiologist could go to the farmer’s market,
bring home an artisan cheese, and isolate a handful of “probiotic” lactobacilli. Without
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adequate testing in human populations we can never be sure of function. My intent is not
to solely place the blame on clinicians or regulatory agencies, but perhaps we in the
probiotics research field must also do more to force better control over products and
generate understanding on how strains work. For probiotics to move into routine medical
practice, convincing and reproducible clinical data is required with some understanding
of mechanisms of function. Certainly in the case of AAD or necrotizing enterocolitis,
convincing data is available (AlFaleh and Anabrees, 2014; Goldenberg et al., 2013). It is
also hard to convince clinicians when probiotic studies are frequently underpowered and
apply different probiotic strains in different formulations that may affect efficacy. One
cause of this is that probiotic research lacks the levels of the funding frequently found in
the pharmaceutical industry. Unlike a drug with a defined chemical structure, it is more
difficult to obtain a proprietary strain that cannot be easily copied. In the case of general
probiotic function, there is nothing to suggest that company X’s probiotic could be any
better than company Y’s. Thus it is difficult to justify the considerable financial
investment in developing new probiotic technologies, as it would be difficult to get
adequate intellectual property protection. I believe the answer to these problems is the
development of new strains and formulations with defined mechanisms of action.

8.1

Effect of formulation on probiotic function

The results of chapter 2, while not conclusive, are valuable for the questions they raise. In
probiotic formulation, there is a general assumption that if the product can maintain a
consistent viable bacterial count over the shelf life, other aspects are fairly irrelevant.
While the transcriptional responses of a probiotic strain will differ between its time in the
product and those in varying portions of the gastrointestinal system, how the strain has
adapted to initial entry into the body is of importance. Bacteria can transcriptionally
respond to stimuli in a matter of minutes (Selinger et al., 2003) but when we consider that
an orally consumed probiotic will transit from the mouth to the stomach in a matter of
seconds (Cordova-Fraga et al., 2008), surely any effect of formulation that affects acid
resistance will be of importance in aiding survival through the gut as was observed in
chapter 2.
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While fermented foods were primarily the focus of this thesis, chapter 4 used a probiotic
administered as a suppository in capsule form, which presents a range of additional
considerations in function. Because the bacteria in these capsules have been lyophilized
and preserved, we must consider the time it takes for them to return to an active
metabolic state from their dormancy. Enteric-coated tablets seem like an attractive
approach for delivering probiotics as they will protect the cells through the harsh acidic
conditions of the stomach and begin to release the cells in the small intestine. In this case
however, the site of action must be carefully considered. If the site of action is suspected
to be in the small intestine, as we would suspect protection against toxic metals or altered
nutrient uptake would be, perhaps an enteric coated capsule is the wrong formulation to
be delivered as we want metabolically active cells through their entire passage in the SI.
The capsules applied in chapter 4 were indeed formulated for oral consumption and
proved difficult to dissolve in water for metabolite analysis (observations of A.
McMillan). This could partially explain why probiotic administration could not be
observed in all participants as if the capsules did not fully dissolve in the vagina, dosing
would have been highly inconsistent. Furthermore, when considering the appropriate
control, many placeboes contain nothing more than a sugar. In the case of studies on
microbial populations, perhaps a placebo containing a fermentable sugar is the incorrect
control as the sugars could be readily metabolized by the indigenous microbiota and thus
inadvertently be biologically active.
Formulations offer potential ability to potentiate probiotic function. In the case of
mercuric reductase, there is a basal level of expression, but it is greatly up-regulated upon
exposure to mercury. Ideally we would want to administer a probiotic that has already
up-regulated its mercury detoxifying machinery before coming into contact with mercury
in the body. It would seem foolish to attempt to induce the machinery by including
mercury in the formulation, but perhaps there are other non-toxic metals that could drive
increased expression. Alternatively, in the case of genetically engineered strains, the
genes could be expressed from strong constitutive promoters active both in culture
outside the body and during passage through the GI tract such as ldhlP (Oozeer et al.,
2005). This would ensure the strain was always prepared to detoxify mercury upon
exposure. Additionally, perhaps probiotic function in the gut can be altered by diet. In the
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case of E. lenta, its digoxin metabolizing pathways are repressed by arginine allowing
dietary protein to modulate its function (Haiser et al., 2013). Though these examples of
formulation affects function solely at the level of individual organisms, they are also
relevant when considering the manipulations of the microbiome.

8.2

What is a healthy microbiome?

As identified in the Chapter 1, what constitutes health in the pre-menopausal vagina is
well established. Until the work carried out in chapter 4 and its predecessor study
(Hummelen et al., 2011), what constituted health in post-menopause was less well
established. Since production of glycogen is under the control of estrogen, estrogen is
depleted after menopause, and vaginal lactobacilli use glycogen as a nutrient source, it
had been suspected that the vaginal microbiota of post-menopausal women was also
depleted in lactobacilli (Cauci et al., 2002). Work presented in this thesis showed this to
be incorrect where in fact, the majority of healthy post-menopausal women are in fact
colonized predominantly by Lactobacillus species. The work in chapter 4 was unique in
that it attempted to enroll only women in the intermediate stage between health and
bacterial vaginosis. Despite an abundance of L. iners, there was virtually no L. crispatus
identified in these women which fits with the hypothesis that L. crispatus is protective
against transitioning to dysbiotic states (Verstraelen et al., 2009). The one detail which
does differ significantly between pre- and post-menopausal women lies in the stability of
the microbiome. We found that the microbiota was extremely stable in post-menopausal
women and that over time, the majority of women bore the greatest similarity with
themselves. In pre-menopausal women the community shifts over the estrus cycle (Keane
et al., 1997).
The case of what defines healthy in the gut remains a complex issue. The children studied
in chapter 6 had remarkably similar microbiotas that were nearly all dominated by
Prevotella species (enterotype 2). Due to this homogeneous background we were able to
determine that there was an association between Succinovibrionaceae and increased
blood metal levels. Of the three predominant enterotypes (Arumugam et al., 2011), there
is not one that is healthier per se. Rather I suspect that the effects are contextual and that
there is no one size fits all microbiome configuration that is beneficial in all settings. We
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hypothesized in chapter 6 that a Prevotella enriched microbiota might predispose one to
higher uptake of toxic metals and that perhaps a Gram-positive dominated microbiota
such as the Ruminococcus-dominated enterotype 3 may be beneficial. However given that
Ruminococcus, as a member of the Firmicutes, may have the effect of increased nutrient
uptake (Ley et al., 2005), this could predispose an individual to obesity. In the context of
a resource-poor developing country such as Tanzania, this could be favorable to aid in
nutrient absorption while in the context of the North American diet, be a dangerous
predisposition to obesity and metabolic disease. Perhaps given the extreme control diet
appears to have over microbiome composition, it is possible to modulate the microbiota
to whatever configuration may best suit the current concerns of an individual at a given
time (Carmody et al., 2015; David et al., 2014; Halmos et al., 2015).

8.3

How can probiotics modulate the microbiota?

As identified in the previous section, using probiotics to modulate the composition of the
gut may be putting the cart before the horse as we do not necessarily know exactly how
we want to modulate the microbiome. There are certain cases such as inflammatory
bowel disease where we may clearly want to increase Faecalibacterium (Sokol et al.,
2008) but for the most part, the desired modulation is unknown. Both the work presented
in chapters 6 and 7 demonstrated that L. rhamnosus GR-1 is unable to modulate the gut
microbiota composition, yet it can still confer a benefit. It has also been observed that the
B. animalis subsp. lactis strain studied in chapter 2 is unable to modulate the microbiota
(McNulty et al., 2011) yet its inclusion in a yogurt modulated the function of the
microbiota. It is not necessarily the bacteria present in the ecosystem that are important,
but their functional roles. A recent study (Zhang et al., 2014) has identified that L. casei
Zhang may be capable of modulating microbiota composition, but it should be noted that
this study lacked a control group and included samplings across large time frames in a
population with a seasonal diet.
Again the vagina (chapter 4) appears to be unique. We found that the vaginally applied L.
rhamnosus strain is capable of modulating the composition of the microbiota. While there
was an immediate influx of lactobacilli driven by administration of 109 CFU of probiotic
added, they were unable to colonize in the majority of individuals. Nonetheless they were
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capable of restoring levels of the indigenous lactobacilli such as L. gasseri/johnsonii. The
mechanism for this was not fully determined, however it could be speculated that the
large influx of exogenous lactobacilli was able to re-acidify and condition the vaginal
ecosystem to one more conducive to the growth of lactobacilli and deleterious for vaginal
dysbionts.
Given the inability of probiotics to modulate gut microbiota composition, perhaps
alternative methods such as prebiotics or dietary interventions should be considered.
While prebiotics are conventionally defined as selectively or specifically enriching
certain microbes (Manning and Gibson, 2004), a new controversial definition supported
by recent metagenomic studies (Bindels et al., 2015) includes a broader definition of
altering ecological and functional features of the microbiota. Ultimately without a greater
understanding of mechanisms of both how the microbiota and probiotics affect health, we
will never know exactly how it is we wish to modulate the microbiota of the gut.

8.4

Novel probiotic strains

Traditional selection of probiotic strains focused on traits such as acid/bile resistance,
adhesion and colonization abilities, bacteriocin production, and immunomodulatory
capability (Papadimitriou et al., 2015). While these are justified desirable traits as for a
general-purpose strain, I firmly believe the future of probiotics in clinical practice lies in
strain-specific niche applications.
The final chapter of this work attempted to identify novel strains specifically selected to
counter toxic metal exposure and resulted in the identification of L. rhamnosus Lr60.
This strain delivered superior removal of both lead and mercury and its’ ability to
actively detoxify mercury was further investigated leading to the first description of a
mercury resistant Lactobacillus with gene function validated through cloning and
characterization of mutants. Given the apparent rarity of mercury resistance elements in
Lactobacillus species, this discovery is all the more exciting in that we found a proverbial
needle in a haystack.
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While we were able to find a strain of L. rhamnosus carrying mercury-resistance
elements, it would also be possible to engineer one for this purpose given the ubiquity of
known genetic sequences for merA and merB. With the apparent absence of
organomercurial lyase activity (merB) in the L. casei group, it is possible to engineer
strains to carry it. In fact, work on this has already begun through a synthetic construct of
a ldhl promoter fused to a codon optimized version of merB from Bacillus megaterium
(Huang et al., 1999). If a more broad-range metal sequestering strain was required, it
would also be possible to express metallothioneins on the bacterial cell surface to
potentiate sequestering activity (Deng and Wilson, 2001). Given the difficulties in
genetically manipulating strains of Lactobacillus, this approach could be applied in
Lactococcus species that are far more amenable to genetic manipulation (Pontes et al.,
2011).
While we tend to constrain our thoughts of new probiotics to those granted generally
recognized as safe status (GRAS) by the FDA, the use of new species such as Bacillus
coagulans (Fitzpatrick et al., 2011) expands the landscape of available strains to apply.
Indeed, it may be worth further studies on Bacillus megaterium MB1 to determine its
safety profile to see if it could be applied directly to human and animal hosts forgoing the
need for heterologous expression in food-grade vector organisms.
While the focus of these studies was primarily in the context of human health, these
concepts should not be limited to humans or even mammals, as they are equally relevant
to agricultural applications. An exciting and yet unexplored application of the mercury
sequestration/detoxification probiotic technology lies in aquaculture. Probiotics are an
emerging concept for commercial fish farming (Irianto and Austin, 2002; Mohapatra et
al., 2012) and it has been noted that levels of environmental pollutants are just as high or
higher in commercially farmed fish (Bustnes et al., 2011). Strains such as Lr60 could be
incorporated into the feed as an additive. These approaches should be tested in
aquaculture to determine if they could be used to potentially lower mercury in farmed
fish, which may ultimately improve both production yields, and lower mercury in the
human food supply.
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8.5

How can we improve study design?

As identified in the general discussion, probiotic studies frequently suffer from problems
of inconsistent strain selection, formulations and a lack of statistical power and the
studies presented in this work possess some of the same issues.
The issue of sample size and power estimations is difficult in microbiota and probiotic
studies as they present a number of unique traits not found in typical drug studies. If the
primary end point of the study is an easily definable clinical parameter then traditional
power estimations are valid. Where pre-existing literature on the effect is limited, as is
the case with metal-detoxication, a pilot study is warranted to give a rough estimate of the
effect size and variance of the response. While options to repeat the studies found in
chapter 6 are being investigated, we can now predict based on the data obtained in the
pregnant women that we would need 86 participants to show a 2 nmol/L difference
(~23%) in mercury levels with power of 0.9, i.e. a 90% probability that the study will
detect a treatment difference in a two-treatment parallel-design study. Alternative study
designs such as a cross-over study should be also considered as should formulation of the
probiotic yogurt. Milk, or no intervention depending on the cohort, was applied in the
control group in the studies in chapter 6 due to logistical challenges of operating in
Tanzania. It would be more ideal to carry out the study in a double-blinded method using
a non-fermented control dairy product such as acidified, gelatinized, or heat compressed
milk heat to rule out potential effects of nutrients affecting uptake (Zhai et al., 2015).
Furthermore, while the study in chapter 5 was not designed to differentiate the effects of
micronutrients and probiotics, future studies should isolate the two effects and exclude
the micronutrients from the formulation to allow study of probiotic function.
Alternatively, a capsule formulation could be applied given careful design and testing to
ensure timely release to be active in the small intestine.
How to estimate power in studies of microbiota modulation is far more complicated (La
Rosa et al., 2012). One issue lies in the sheer number of potential measurable outcomes
such as alpha and beta diversity, or modulation of individual taxa. Number of reads per
sample, which is often difficult to precisely control and estimate, heavily affects power as
does the diversity of the environment. The vaginal sample of an average healthy women
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may only have 1-3 major constituents, but the gut will have hundreds or thousands.
Furthermore, the number of taxa (as measured by operational taxonomic units) is heavily
influenced by upstream data processing, clustering and minimum abundance thresholds
which vary from study to study. To control for multiple testing, approaches such as False
Discovery Rate corrections are frequently applied (Fernandes et al., 2013). This issue lies
in that with the sheer number of OTUs frequently encountered in complex microbiome
datasets, statistical significance can be near impossible to obtain even in the case of
biological truth. The 16S rRNA dataset presented in chapter 6 demonstrates this
phenomenon. At enrollment, no participant has detectable levels of any L. casei group
member (the limit of resolution of the V6 hypervariable region is to the L. casei group so
this group includes the probiotic L. rhamnosus GR-1). After intervention, the L. casei
group is only detected in the group who received probiotic with one exception.
Nonetheless, after multiple testing corrections for false discovery rate, this finding is not
significant. One solution to this problem is to use these datasets as discovery tools and
confirm all changes by a complimentary approach such as qPCR or culture. Alternatively
the sample size could be greatly increased. Alternatively animal models informed by
observations in human populations are becoming a tool to confirm effects of the
microbiota as at the end of the day “phenotype trumps all” (personal communication, GB
Gloor, 23 April 2015).

8.6

Future directions

There were many observations of the microbiota and probiotic function in this work that
cannot be immediately pursued by me. Excellent examples lie in our observations that the
infants of women who received the L. rhamnosus GR-1 probiotic yogurt have elevated
levels of Bifidobacterium (chapter 5) or our hypotheses of microbiota structure effecting
toxic metal uptake. Human-animal crossover models represent opportunities to address
these questions in a controlled and mechanistic fashion. Traditionally this has involved
the adoptive transfer of human communities to germ-free mice in an attempt to reproduce
human phenotypes (Smith et al., 2013). Alternatively gnotobiotic mice, with a defined
microbiota controlled by the researcher can be applied or even built with a defined
humanized gut microbiota (McNulty et al., 2011). By feeding a humanized-microbiota
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mouse breast milk from either women who received L. rhamnosus GR-1 or controls and
selectively culturing or qPCR enumerating bifidobacteria, this finding could be
confirmed. Individual components of the breast milk could be identified and tested in this
model to identify the effectors. To study how microbiota affects metal uptake,
gnotobiotic mice could be seeded with monocultures of Succinovibrionaceae,
Desulfovibrio or Lactobacillus. Additionally, whole fecal samples from individuals with
communities representative of the major enterotypes could be seeded to test our
hypotheses.
Prior to initiating a new collaboration with Benoit Foligne at the Institut Pasteur de Lille,
we did not have the capacity to carry out animal models with environmental toxins and
this past winter we started our first experiments armed with the tools we need to establish
the mechanisms behind probiotic mediated detoxication in vivo. Our studies have
branched out from mercury to include a range of other environmental toxins such as
aflatoxin, pesticides, nitrosamines and heterocyclic aromatic amines and it is my hope
that these studies will lead to the development of new technologies which can be
disseminated into both industrial and medical practice. Indeed through our partnerships
with WORLDiscoveries, we are currently investigating opportunities worldwide.
A unique opportunity in this thesis was to have a great amount of interaction with
industry sponsors (Danone and Kimberly Clark), which gave me a unique view on
translation of basic research. At the end of the day, the work carried out needed to have
relevance to practical applications. Although this created unique obstacles and
frustrations not experienced by many of my peers, it also provided uncommon
opportunities for which I am truly grateful. As I go forward in my research career I will
constantly draw from the diverse and varied skill set that my graduate studies fostered. It
is my sincere wish that both the work included in this thesis and the other publications
resulting from my graduate studies have improved our understanding of probiotic
function and formulation while creating new areas of studies into novel probiotic
applications.
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